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Exploring the interplay of structure, stability, activity and localization in tRNA nucleotidyltransferase 
function 
Matthew Leibovitch, PhD 
Concordia University, 2016  
The enzyme tRNA nucleotidyltransferase is of central importance in eukaryotic cells since it is 
required in multiple intracellular locations (nucleus, cytosol, mitochondria and plastids) for the 
production of mature tRNAs needed for protein synthesis. Therefore, tRNA nucleotidyltransferase 
serves as an excellent model protein to explore the complex roles that localization, activity, structure 
and stability play in defining protein function. I investigated how changes in the amino acid sequence of 
tRNA nucleotidyltransferase affect its structure, stability, activity and localization and may be linked, 
ultimately, to human disease. 
Using Arabidopsis thaliana as a model organism, I was the first to show that amino acid 
substitutions located within a region of tRNA nucleotidyltransferase required for enzyme activity, but 
outside of the enzyme’s classical amino-terminal organellar targeting sequence, affect localization to 
plastids and mitochondria. These studies suggest a direct link between intracellular distribution and how 
tightly the protein has folded. Moreover, these data indicate that the same seven amino acid changes 
that result in altered stability also reduce tRNA binding and enzyme activity. To more clearly define the 
role that these amino acids have in enzyme structure and function and to determine whether changes in 
protein stability, substrate binding, or structure bring about altered localization, I have fine-structure 
mapped the region encompassing residues 399-420 and shown that a single amino acid substitution 
(K418E) can dramatically alter tRNA binding and enzyme activity without detectable effects on enzyme 
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structure. Localization studies are now underway to determine whether the K418E substitution, or other 
single substitutions within this region, alters the intracellular localization of tRNA nucleotidyltransferase. 
Using a second model organism, Saccharomyces cerevisiae, I have further explored the link 
between stability and activity in protein function. I showed that a single amino acid substitution (E189F) 
resulted both in a 5ºC decrease in thermal stability and a 25-fold decrease in enzyme activity and caused 
a temperature-sensitive phenotype. Moreover, converting arginine 64 to tryptophan in the variant 
enzyme restored enzyme activity and suppressed the temperature-sensitive phenotype, but did not 
restore thermal stability. These data suggest that the temperature-sensitive phenotype is defined by the 
reduction in activity and not thermal stability. Moreover, these data were the first to suggest a role for 
conserved motif C in active site organization and tRNA nucleotidyltransferase function. 
Finally, I applied the techniques and insight acquired from my studies of the Arabidopsis and 
yeast enzymes to explore how seven distinct amino-acid substitutions in human tRNA 
nucleotidyltransferase, all previously identified in patients suffering from sideroblastic anemia with B 
cell immunodeficiency, periodic fevers and development delay (SIFD), affect enzyme structure, stability 
and function in vitro. I showed that each of these mutations affects some combination of tRNA 
nucleotidyltransferase structure, activity, or stability. As expected, substitutions (T154I, M158V, L166S, 
R190I and I223T) within the conserved catalytic amino terminal region of the protein altered stability 
and/or activity but more interestingly two substitutions (I326T and K416E) in the less well conserved 
carboxy-terminal region of the enzyme altered catalytic efficiency, tRNA binding and quaternary 
structure.  
These studies have shown that a protein’s function can be defined by a combination of some or all of its 
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1.1 The interplay in protein function of structure, stability, activity and localization 
The central dogma of molecular biology “DNA makes RNA makes protein” (Crick, 1970) is a 
satisfying explanation for how the DNA contained in a cell can define that cell’s fate. However, the story 
obviously is more complicated than this. A cell’s fate is defined not only by the genes that it contains, 
but also by how transcription of those genes is regulated, how the resulting RNAs are processed, and 
how the final gene products are generated. Every protein that is produced plays an important role in the 
cell, either as an enzyme, perhaps playing a role in metabolism, e.g., hexokinase; or as a structural 
component, e.g., actin or tubulin in the cytoskeleton; or as a transport protein, e.g., hemoglobin (which 
carries oxygen through the bloodstream) or the glucose transporter (which transports glucose across the 
plasma membrane); or as a signaling molecule, e.g., insulin; or in protection, e.g., antibodies, toxins. The 
roles of each of these proteins are defined by the interplay of factors including structure, stability, 
activity and localization that establish their functions. For example, the structure of an enzyme must be 
such that active site residues are arranged for the appropriate substrate to bind and catalysis to take 
place.  A transport protein like hemoglobin must be stable enough to carry oxygen through the blood 
stream from the lungs to the tissue where it is needed. Even if a protein has the appropriate stability, 
structure and activity, if it is not directed to the appropriate destination it cannot function properly. For 
example, the glucose transporter must be directed to the plasma membrane and inserted in the correct 
orientation to play its part in glucose transport. Finally, a single protein may have more than one 
activity, for example, enolase which catalyzes the penultimate step in glycolysis is also involved in the 
import of tRNA into yeast mitochondria (Entelis et al., 2006). Clearly, it is the combination of a protein’s 
localization, activity, structure and stability that define its function. Consequently, changing any of these 
parameters may affect a protein’s function and cause problems. For example, altered protein structure 
can lead to disease as is the case in Creutzfeldt-Jakob disease where a misfolded protein generates more 
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misfolded proteins and protein aggregation (Diack et al., 2014). Other diseases such as cystic fibrosis and 
hereditary emphysema (caused by α-antitrypsin deficiency) (Ramirez-Alvarado, 2008) may result from 
protein misfolding caused by changes in structure leading to mislocation of a protein. Therefore, a 
better appreciation of how structure, stability, activity and localization define a protein’s function is of 
more than fundamental interest and may aid in understanding human disease. 
1.2 Regulation of protein function 
Protein function is regulated through transcriptional, translational and post-translational 
processes. As described above and in the simplest sense, the amount of a protein produced in a cell is 
dependent on the regulation of transcription and translation to generate the appropriate gene product. 
These processes themselves often are tightly regulated. While some proteins are constitutively 
produced others are only synthesized when needed. The canonical example of this is the lac operon 
where the enzymes required in bacteria for lactose metabolism are only produced when lactose is 
present (Lewis, 2013). In addition, protein production can be regulated temporally and spatially, e.g., 
cell differentiation during embryogenesis (Sulston et al., 1983). The level of a protein in a cell also 
depends on the stability of that protein and proteins differ in their stabilities (Bachmair et al., 1986) and 
may be targeted for rapid degradation (Bloom and Cross, 2007). Protein function also may be controlled 
post-translationally (Walsh et al., 2005). Covalent modification is a classical way to control a protein’s 
function. For example, phosphorylation or dephosphorylation of glycogen phosphorylase induces a 
conformational change near the active site that can regulate its activity (Agius, 2015). Post-translational 
modifications of proteins also can lead to altered cellular distribution, for example, nuclear e.g., Swi5, 
Ace2 (Moll et al., 1991, Sbia et al., 2008) and plastid (Lamberti et al., 2011) targeting may be regulated 
by phosphorylation at or near targeting signals. As these proteins need to be directed to their proper 
destinations to exert their activities, altering localization is another example of how function can be 
regulated.   
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1.3 ATP(CTP):tRNA nucleotidyltransferase as a model protein 
ATP(CTP):tRNA nucleotidyltransferase represents an excellent protein for study to develop a 
deeper understanding of how protein localization, activity, structure and stability may play a role in 
defining protein function. This enzyme is responsible for the addition of the 3’-terminal cytidine-
cytidine-adenosine (CCA) sequence to tRNAs that lack it (Deutscher, 1990). The chemistry behind this 
reaction has been the subject of much interest as it represents the addition of a specific nucleotide 
sequence without the use of a nucleic acid template (Cho et al., 2002, Cho et al., 2006, Cho et al., 2007, 
Tomita and Weiner, 2001, Tomita et al., 2004, Shi et al., 1998, Pan et al., 2010, Hoffmeier et al., 2010, 
Hanic-Joyce and Joyce, 2002, Shan et al., 2008). In addition, in the eukaryotic species studied to date, 
i.e., Saccharomyces cerevisiae (Chen et al., 1992), Kluyveromyces lactis (Deng et al., 2000), human 
(Reichert et al., 2001), Xenopus (Keady et al., 2002), Candida glabrata (Hanic-Joyce and Joyce, 2002) and 
Arabidopsis (Schmidt von Braun et al., 2007), a single gene codes for ATP(CTP):tRNA 
nucleotidyltransferase which then is targeted to multiple destinations, e.g., nucleus, cytosol, 
mitochondria and plastids (when present). This combination of interesting enzymology and intracellular 
targeting makes this enzyme an excellent choice for the study of the multiple factors that regulate a 
protein’s function.   
1.3.1 Structure, stability and activity 
Eukaryotic and bacterial tRNA nucleotidyltransferases belong to the Class II family of 
nucleotidyltransferases (Yue et al., 1996). This class is defined by sequence conservation distributed 
throughout the 25 kDa amino terminal portion of the proteins (Yue et al., 1996). Class II tRNA 
nucleotidyltransferase enzymes for which crystal structures have been solved, i.e., human (Augustin et 
al., 2003, Kuhn et al., 2015), Thermotoga maritima (Toh et al., 2009), Aquifex aeolicus (Tomita et al., 
2004), and Bacillus stearothermophilus (Li et al., 2002) CCA-adding enzymes and the Aquifex aeolicus CC-
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adding (Yamashita et al., 2014) and A-adding (Tomita et al., 2004) enzymes show a common higher 
order structure reminiscent of a sea horse (Li et al., 2002) with four structurally conserved regions: 
head, neck, body and tail from N-terminus to C-terminus (Fig. 1.1).  
 
Figure 1.1: Crystal structures of Class II tRNA nucleotidyltransferases.  Structures of tRNA 
nucleotidyltransferases from Thermotoga maritima (Toh et al., 2009), Aquifex aeolicus (Tomita et al., 
2004), Homo sapiens (Kuhn et al., 2015), and Bacillus stearothermophilus (Li et al., 2002) are labeled A-
D, respectively. Their PDB numbers are 3H37, 1VFG, 4X4W and 1MIV, respectively.  The crystal 
structures were viewed with PyMol (Schrödinger). 
 
1.3.1.1 Conserved motifs 
Five conserved motifs (A-E) in the head and neck regions of Class II tRNA nucleotidyltransferases 
which help to define the active site were initially identified through sequence comparisons of the 
Bacillus stearothermophilus CCA-adding enzyme, Escherichia coli CCA-adding enzyme, Aquifex aeolicus 
A-adding enzyme, Bacillus subtilis CCA-adding enzyme, and Saccharomyces cerevisiae CCA-adding 
enzyme (Li et al., 2002).  
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Motif A contains two conserved aspartic acid residues involved in coordinating the magnesium 
ions involved in catalysis and in binding the triphosphate moiety of each nucleotide triphosphate (Fig. 
1.2) (Joyce and Steitz, 1994, Steitz, 1998).  
 
Figure 1.2: The role of Motif A (Betat et al., 2010 modified from Steitz, 1998). The grey balls represent 
the two magnesium ions and are coordinated by the two carboxylates (aspartates). Magnesium ion “A” 
deprotonates the terminal 3’ hydroxyl group of the tRNA and activates the 3’ attack on the α-phosphate 
of the incoming nucleotide triphosphate (NTP). Magnesium ion “B” stabilizes the triphosphate moiety of 
the NTP in order to promote pyrophosphate release. 
 
Motif B has a role in discriminating between deoxyribonucleotides and ribonucleotides by 
recognizing the 2’ OH group found on ribose (Li et al., 2002). A conserved arginine-arginine-aspartate 
sequence allows the central arginine to hydrogen bond with the 2’ hydroxyl group found only on ribose 
(Fig. 1.3) allowing the enzyme to discriminate against deoxyribose (Cho et al., 2007). A substitution of 
the central arginine by an isoleucine resulted in a functional protein that had lost the ability to 




Figure 1.3: Nucleotide binding site of Bacillus stearothermophilus CCA-Adding enzyme (modified from 
Cho et al., 2007). Stick model of catalytically important arginine 111 side chain interacting with 2’ 
hydroxyl of ribose of substrate. Nitrogen is shown in blue; oxygen in red; carbon is yellow in the 
polypeptide and light blue in the nucleotide. Hydrogen bonds are shown as black dashed lines. Amino 
acid 111 corresponds to the central arginine in Motif B. 
 
Motif C has low sequence conservation and initially was believed to act simply as a connection 
between the head and neck domains of the protein (Li et al., 2002). However, we have shown (Shan et 
al., 2008) that changing a single residue (glutamate 189) in motif C in the Saccharomyces cerevisiae tRNA 
nucleotidyltransferase can alter the structure, activity and thermostability of this enzyme such that a 
temperature-sensitive phenotype results suggesting a role for this domain. Recent data (Ernst et al., 
2015) implicate a highly conserved aspartic acid residue in AMP incorporation and in interdomain 
movements in the enzyme. This further supports a role for motif C suggesting that this region is used as 
a flexible spring element modulating the relative orientation of the head and body domains to help 
accommodate the growing 3’ end of the tRNA substrate. This transition helps initiate the rearrangement 
of the templating amino acids in motif D to switch specificity from CTP to ATP during tRNA maturation 
(Ernst et al., 2015).  
Motif D forms a nucleotide binding pocket specific for CTP or ATP (Li et al., 2002) (Fig. 1.4) and 
discriminates against UTP and GTP (Yue et al., 1996, Shi et al., 1998, Cho et al., 2007). Three well 
conserved amino acids, glutamate, aspartate, and arginine form Watson-Crick-like hydrogen bonds with 
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incoming nucleotides (Cho et al., 2007, Li et al., 2002) to recognize specifically cytidine, cytidine and 
adenosine bases and discriminate against incorrect ribonucleotides in the binding pocket of the protein 
(Li et al., 2002) (Fig.  1.4). After the addition of the first two CTPs, the binding pocket is reorganized and 
enlarged to change the specificity of the pocket from CTP recognition to ATP recognition (Li et al., 2002). 
Site-directed mutagenesis of the appropriate amino acids resulted in the reengineering of the CCA-
adding enzyme into a UUG- or dCdCdA-adding enzyme or a poly(C,A) or poly(U,G) polymerase (Cho et 
al., 2007).  
 
Figure 1.4: Watson-Crick-like base pairing of specific tRNA nucleotidyltransferase residues with ATP or 
CTP (Betat et al., 2010, Li et al., 2002). The nucleotide binding site is formed by the EDxxR conserved 
amino acids found in motif D (Li et al., 2002). The incoming CTP or ATP forms three or two Watson-Crick-
like hydrogen bonds, respectively. 
  
 
The function of motif E is not well understood, however, it may help in stabilizing the helix-turn 
structure in motif D (Li et al., 2002) and might interact with the growing 3’end of the tRNA substrate 
(Cho et al., 2007). 
While motifs A-E largely are conserved among CCA-adding, CC-adding and A-adding enzymes, 
the A. aeolicus CC-adding enzyme differs at motif D in that the conserved glutamic acid residue is 
replaced by an arginine which through repulsion with the conserved arginine constrains the NTP binding 
pocket to favour CTP binding by preventing the larger ATP from entering (Li et al., 2002). Furthermore, a 
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flexible loop between motifs A and B is present in CCA-adding enzymes but not in CC-adding enzymes 
(Neuenfeldt et al., 2008). A single glycine to aspartate substitution in this region of the E. coli CCA-
adding enzyme altered AMP but not CMP incorporation (Zhu et al., 1986). Interestingly, transplanting 
the conserved loop into a CC-adding enzyme restored complete CCA addition (Neuenfeldt et al., 2008) 
further demonstrating the link between structure and function. For A-adding enzymes, the biochemical 
basis for their restricted activity is poorly understood (Betat et al., 2010), however a number of 
replacements made between motifs A and E in the A-adding enzyme of A. aeolicus interfered with 
enzymatic activity (Tomita et al., 2004). 
1.3.1.2 The carboxy-terminal portion 
Much less is known about the less well conserved C-terminal portion of the various tRNA 
nucleotidyltransferases, however, this region of the protein must play an important role in CCA addition 
as a deletion of the last two α-helices in the E. coli CCA-adding enzyme abolishes both AMP addition and 
CMP addition (Zhu and Deutscher, 1987). It was first proposed that the body and tail domains are 
involved in tRNA binding (Li et al., 2002), and the crystal structure of the A. aeolicus A-adding enzyme 
with tRNA bound supports this (Tomita et al., 2004). In addition, domain swapping experiments 
between bacterial poly(A) polymerase and the CCA-adding enzyme showed that the specificities of the 
two enzymes were dependent on their C-terminal regions with the C-terminus of the CCA-adding 
enzyme playing an anchoring role to limit polymerization to three nucleotides (Betat et al., 2004). In 
addition, the C-terminal portion of the E.coli CCA-adding enzyme has a Ni2+-dependent phosphatase 
activity, a 2'-nucleotidase phosphodiesterase activity, and a metal-independent 2',3'-cyclic activity which 
may act in concert with the CCA-adding activity to repair the 3ʹ ends of tRNAs (Yakunin et al., 2004). This 
C-terminal HD domain is conserved among other bacterial CCA-adding enzymes (Yakunin et al., 2004) 
but is not apparent in any of the eukaryotic CCA-adding enzymes. This does not exclude the possibility 
that the C-terminal regions of eukaryotic CCA-adding enzymes may have as yet uncharacterized 
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functions particularly since the CCA-adding enzymes in eukaryotes tend to be larger than those in 
bacteria. While the E. coli enzyme has 414 amino acids, the mature functional domains of the 
Kluyveromyces lactis, Saccharomyces cerevisiae, Candida glabrata and Arabidopsis thaliana proteins are 
486, 529, 533 and 542 amino acids in length, respectively. In contrast, the mature human protein 
contains only 405 amino acids. 
1.3.2 Localization, activity and stability 
Protein synthesis in eukaryotic organisms is compartmentalized and takes place in the cytosol, 
mitochondria and plastids. Although prokaryotic-type ribosomes are used in mitochondrial and plastid 
protein synthesis and eukaryotic-type ribosomes are used in cytosolic protein synthesis, some features 
of translation are conserved in these multiple locations. One of these features is the need for a 
complete CCA sequence on tRNAs that can function in protein synthesis. This requires that tRNA 
nucleotidyltransferase be present in each of these intracellular locations as, in general, eukaryotic tRNA 
genes do not code for the 3’-terminal CCA sequence (Jühling et al., 2009). Given that in the eukaryotes 
characterized to date (Chen et al., 1992, Reichert et al., 2001, Nagaike et al., 2001, Keady et al., 2002, 
Shanmugam et al., 1996, Deng et al., 2000, Hanic-Joyce and Joyce, 2002), there is a single gene coding 
for tRNA nucleotidyltransferase, this means that the gene generates products belonging to the class of 
proteins known as sorting enzymes (Zoladek et al., 1995) where the gene products are distributed to 
more than one cellular destination. This distribution may be defined by the use of different 
transcription, e.g., (Chen et al., 1992) or translation (Wolfe et al., 1994) start sites, post-transcriptional 
processing (Keady et al., 2002), post-translational modifications (Zehorai et al., 2010) or a combination 
of these (Martin and Hopper, 1994). In addition to classical amino-terminal targeting signals (Kunze and 
Berger, 2015), specific cis elements within the protein itself also have been shown to be involved in 
targeting, e.g., nuclear import and cytoplasmic retention/nuclear export sequences in Mod5p (Tolerico 
et al., 1999). 
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In addition to its role in tRNA maturation in the cytosol, mitochondria and plastids where 
protein synthesis takes place, CCA addition also may be required in the nucleus where addition of the 
CCA sequence and aminoacylation appear necessary for the export of some, but not all, tRNAs (Sarkar et 
al., 1999, Steiner-Mosonyi and Mangroo, 2004). Also, crystallographic data demonstrate interactions 
between the 3ʹ-CCA overhang of tRNAs and residues of the exportin Los1/Xpot component of the 
nuclear export machinery (Cook et al., 2009). In spite of the importance of the CCA sequence in 
nucleocytoplasmic trafficking of tRNAs, the mechanism for sending tRNA nucleotidyltransferase into the 
nucleus remains unknown. Understanding this process is important as nucleocytoplasmic shuttling of 
tRNAs has been implicated in the regulation of processes as diverse as protein synthesis (Hopper, 2013), 
the cell cycle (Ghavidel et al., 2007), and response to nutrient availability (Whitney et al., 2007). Given 
that tRNAs may undergo retrograde transport into the nucleus under specific stress conditions (Murthi 
et al., 2010, Hurto et al., 2007, Shaheen and Hopper, 2005, Pierce et al., 2010) and that tRNA 
nucleotidyltransferase functions both in the cytosol and the nucleus, we expect that tRNA 
nucleotidyltransferase localization also may be regulated. The importance of cytosolic tRNA 
nucleotidyltransferase was highlighted by studies in yeast showing that artificially increasing the nuclear 
pool of tRNA nucleotidyltransferase while decreasing the cytoplasmic pool resulted in cells that 
accumulated end-shortened tRNAs and grew slowly (Wolfe et al., 1996). Moreover, even in E. coli where 
all of the tRNA genes encode a complete CCA sequence, cells grow less well in the absence of tRNA 
nucleotidyltransferase suggesting a repair function for this enzyme (Zhu and Deutscher, 1987) in this 
organism. Evidence also shows that tRNA nucleotidyltransferase has the ability to add a CCACCA 
sequence to the ends of unstable mature tRNAs (Wilusz et al., 2011, Kuhn et al., 2015). In doing so, it 
serves as a universal quality control mechanism for controlling tRNA levels and preventing errors in 
translation (Wilusz et al., 2011). While the oxidative-stress activated nuclease angiogenin can remove 
the CCA sequence from tRNAs when cells are exposed to stress and reduce energy expenditure through 
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protein synthesis, tRNA nucleotidyltransferase can repair this damage and reactivate translation 
providing a mechanism to dynamically repress and reactivate translation at low metabolic costs (Czech 
et al., 2013). 
1.4 Outline and scope of the thesis 
Given its central importance in cell viability (required for eukaryotic protein synthesis), its 
complicated and intriguing catalytic activity (it requires three different substrates and adds a specific 
nucleotide sequence without utilizing a nucleic acid template) and its intracellular localization in 
eukaryotic cells (distributed between the nucleus, cytosol, mitochondria and plastids), tRNA 
nucleotidyltransferase represents a rare example of a single protein that can be studied to explore the 
complex roles that localization, activity, structure and stability play on protein function in the cell. 
This study was initiated to explore the interplay between protein structure, stability, activity and 
localization in the context of tRNA nucleotidyltransferase. Previously, the mature domain of the 
Arabidopsis enzyme (far from the amino-terminal targeting signal) had been shown to have a major 
impact on the distribution of tRNA nucleotidyltransferase within the cell (Schmidt von Braun et al., 
2007). Specifically adding the mature domain (in addition to the amino-terminal targeting signals) of 
tRNA nucleotidyltransferase to a reporter protein shifted targeting away from mitochondria and toward 
plastids. These data indicate that the regulation of dual localization involves not only the N-terminal 
signals, but also additional factors within the protein (folding competence, regions interacting with 
substrates or trans-acting targeting factors). 
In Chapter 2 of the thesis, the enzymatic and physicochemical properties of tRNA 
nucleotidyltransferase and two variants are explored to correlate the properties of the enzyme with the 
intracellular distribution of the protein. Two sets of amino acid substitutions, Mat-Mu1 at amino acids 
399-420 in the body domain and Mat-Mu2 at the extreme C-terminus of the protein were introduced 
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and the effects on protein structure, stability, activity and localization were monitored. The data show 
that changes in the body and tail domains of the Arabidopsis tRNA nucleotidyltransferase can alter the 
stability of the protein and reduce catalytic activity in vitro. In both cases, the distribution of the 
modified protein was shifted from mitochondrial targeting toward plastid targeting in protoplasts. 
Studies with a tightly folded Titin domain attached to tRNA nucleotidyltransferase also showed that 
plastid import was preferred over mitochondria import suggesting that the altered localization is 
dependent on the altered stability of tRNA nucleotidyltransferase and not on its reduced activity. This 
has been published as Leibovitch et al.  (2013). 
In Chapter 3, the specific amino acids in Mat-Mu1 responsible for the alterations in structure 
and enzyme activity were defined. Mat-Mu1 first was divided into two regions (Mat-Mu1A and Mat-
Mu1B) and using the same combination of biophysical and biochemical techniques as used previously, 
the amino acid substitutions linked to reduced enzyme activity were mapped to Mat-Mu1B. 
Subsequently, single point mutations were introduced into this domain and the lysine at position 418 
was shown to be most responsible for tRNA binding. If targeting is dependent on substrate binding then 
this substitution should be informative. In contrast, if changes in structure or interactions with another 
trans-acting factor either in the cytosol or at the membrane are important for targeting then the amino 
acid substitutions in Mat-Mu1A which affect structure but not activity should be informative.  This work 
will be submitted for publication when the localization experiments have been completed in the 
laboratory of Dr. Enrico Schleiff, Goethe University. 
In Chapter 4, a second model organism, Saccharomyces cerevisiae, is used to explore how a 
single amino acid substitution can alter enzyme structure, activity and stability. Previously, it was shown  
(Shan et al., 2008) that changing a single residue (glutamate 189) in motif C in the Saccharomyces 
cerevisiae tRNA nucleotidyltransferase alters the activity and thermostability of this enzyme such that a 
temperature-sensitive (ts) phenotype results. Here, a combination of random and site-directed 
13 
 
mutagenesis, genetic, biophysical (e.g., fluorescence and circular dichroism spectroscopy and thermal 
denaturation) and biochemical techniques (including enzyme assays) are used to explore further the role 
of this amino acid (in the context of motif C) in enzyme structure, stability and activity to explore the 
cause of the temperature-sensitive phenotype and to elucidate the function of motif C in tRNA 
nucleotidyltransferase structure and activity. A suppressor mutation changing arginine at position 64 to 
tryptophan did not increase thermostability but did restore enzyme activity such that cells grew at the 
restrictive temperature. This suggests that the temperature-sensitive phenotype is the result of a 
hypomorphic effect reflecting enzyme activity and not stability, i.e., the ts phenotype arises not because 
tRNA nucleotidyltransferase is unstable at the restrictive temperature, but because its reduced activity 
(which is sufficient for growth at the permissive temperature) does not meet the needs of the cell at the 
elevated temperature. These data also demonstrate the critical role motif C residue 189 actually plays in 
the organization of the head and neck regions of the enzyme's active site. Furthermore, the suppressor 
mutation suggests a possible interaction between motifs A and C. This work has been published as 
Goring et al. (2013). 
In Chapter 5, based on what was learned from the studies on the Arabidopsis and yeast 
enzymes, the effects of amino acid substitutions on the structure, stability and activity of the human 
tRNA nucleotidyltransferase were explored. In a recent study (Chakraborty et al., 2014), patients with 
congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay 
(SIFD) were shown to carry mutations leading to partial loss of function of TRNT1, the human tRNA 
nucleotidyltransferase. Five of the mutations were found in the well characterized motifs A-E of class II 
tRNA nucleotidyltransferases while two were found within the less well conserved C-terminal body and 
tail portions of the enzyme. Here, the same combination of biophysical and biochemical techniques used 
with the Arabidopsis and yeast enzymes was used to explore the variant human tRNA 
nucleotidyltransferases. Many of the variants showed the same general characteristics.  For example, all 
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of the variants showed similar secondary and tertiary structures and all variants (except for K416E) 
showed reduced thermal stability. All of the variants showed levels of in vitro enzyme activity similar to 
those of the native enzyme except for the I326T and K416E variants. This is intriguing as these two 
changes are in the C-terminal portion of the protein while the others are in the more conserved catalytic 
domains. A more detailed kinetic analysis revealed that while the I326T variant showed a ten-fold drop 
in turnover number and no change in KM for tRNA, the K416E variant showed no real change in turnover 
number but at least a seven-fold increase in KM for tRNA. Finally, both the I326T and K416E variants 
showed altered quaternary structures as compared to the native enzyme with the I326T variant showing 
an increased ratio of monomer to dimer while the K416E variant showed an increased ratio of dimer to 
monomer as compared to the active enzyme. Taken together all of these data suggest that while point 
mutations leading to changes in the catalytic domains primarily alter stability which may lead to less 
functional protein and the disease phenotype, changes made at the C-terminus of the protein affect 
both activity and binding of the tRNA substrate which contribute to impaired function of the tRNA 
nucleotidyltransferase leading to the disease phenotype. Additionally, the altered quaternary structures 
seen with the I326T and K416E variants may result in mislocation of the enzyme. Altogether, these data 
suggest that the complex phenotype seen in SIFD patients may result from different defects in tRNA 
nucleotidyltransferase which affect its structure, stability, activity, location or various combinations of 
some or all of these. This work will be submitted for publication when the in vivo localization 
experiments in mammalian cell lines have been completed in the laboratories of our collaborators at the 






1.5 Objectives of the thesis 
The overall key objectives of this thesis are: 
(I) To characterize what properties of Arabidopsis tRNA nucleotidyltransferase influence its intracellular 
distribution. 
(II) To define more precisely the role of specific amino acids in a region of the Arabidopsis tRNA 
nucleotidyltransferase where amino acid changes were shown to alter localization. 
(III) To address the role of glutamate 189 in yeast tRNA nucleotidyltransferase structure and function 
and to investigate whether defects in thermal stability or activity or both are responsible for the 
temperature-sensitive phenotype. 
(d) To explore the effects on tRNA nucleotidyltransferase structure, stability and activity of seven amino 



















2.0 The folding capacity of the mature domain of the dual-targeted plant tRNA nucleotidyltransferase 
influences organelle selection 
2.1 Preface 
The work presented in Chapter 2 was publish in: Leibovitch M., Bublack D., Hanic-Joyce P.J., 
Tillmann B., Flinner N., Amsel D., Scharf  D., Mirus O., Joyce  P.B.M., and  Schleiff E. (2013). The folding 
capacity of the mature domain of the dual-targeted plant tRNA nucleotidyltransferase dictates the 
organelle selection. Biochem J. 453(3):401–412. Paul Joyce and Enrico Schleiff designed the experiments 
and drafted the manuscript. Matthew Leibovitch performed the biophysical and biochemical 
characterization and Enrico Schleiff was involved in their analysis; Pamela Hanic-Joyce performed the 
yeast complementation experiments; Daniela Bublak, Bodo Tillmann and Dieter Scharf performed the in 
vivo import studies; Nadine Flinner, Daniel Amsel and Oliver Mirus performed the bioinformatic analysis. 
All authors contributed during manuscript preparation and approved the content. 
2.2 Abstract of Manuscript 
tRNA-NTs (tRNA nucleotidyltransferases) are required for the maturation or repair of tRNAs by 
ensuring that they have an intact cytidine-cytidine-adenosine sequence at their 3'-termini. Therefore 
this enzymatic activity is found in all cellular compartments, namely the nucleus, cytoplasm, plastids and 
mitochondria, in which tRNA synthesis or translation occurs. A single gene codes for tRNA-NT in plants, 
suggesting a complex targeting mechanism. Consistent with this, distinct signals have been proposed for 
plastidic, mitochondrial and nuclear targeting. Our previous research has shown that in addition to N-
terminal targeting information, the mature domain of the protein itself modifies targeting to 
mitochondria and plastids. This suggests the existence of an as yet unknown determinate for the 
distribution of dual-targeted proteins between these two organelles. In the present study, we explore 
the enzymatic and physicochemical properties of tRNA-NT variants to correlate the properties of the 
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enzyme with the intracellular distribution of the protein. We show that alteration of tRNA-NT stability 
influences its intracellular distribution due to variations in organelle import capacities. Hence the fate of 
the protein is determined not only by the transit peptide sequence, but also by the physicochemical 
properties of the mature protein. 
2.3 Introduction 
Protein synthesis in plants is compartmentalized and takes place in the cytosol, plastids, and 
mitochondria. Although eukaryotic-type ribosomes are used in the cytosol and prokaryotic-type 
ribosomes are used in plastids and mitochondria, some features of the translational machinery are 
conserved. The requirement for tRNAs for translation represents one of these universal features. 
Whether the tRNAs are encoded by the nuclear genome, or by the plastidic or mitochondrial genomes 
(Jühling et al., 2009), they must be processed and modified (Phizicky and Hopper, 2010) to function in 
protein synthesis. One essential modification is the addition of the 3’-terminal cytidine–cytidine–
adenosine (CCA) sequence which is required for aminoacylation (Xiong and Steitz, 2006, Betat et al., 
2010). As no plant tRNA genes encode this sequence (Jühling et al., 2009), it must be added post-
transcriptionally. The CCA adding enzymes found in plants belong to the class II tRNA 
nucleotidyltransferase (tRNA-NT) family. They are composed of four regions, the N-terminal head 
domain, the neck domain, the body region and the C-terminal tail (Fig. 2.1A) (Toh et al., 2009).  
A tRNA-NT enzyme is required in the translationally active compartments, namely the cytosol, 
mitochondrion and, in plants, the plastids. Moreover, there also are nuclear pools of tRNA-NT thought 
to be involved in the maturation of cytosolic tRNAs in yeast and mammals (Phizicky and Hopper, 2010). 
This nuclear CCA addition may serve as a quality control point prior to the export of mature tRNAs to the 
cytosol e.g. Zasloff, (1983), Zasloff et al., (1982). The nuclear localization of tRNA-NT also might reflect a 
function of this enzyme as a nucleus/cytosol-shuttling protein involved in tRNA transport (Feng and 
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Hopper, 2002). In the cytosol tRNA-NT is thought to catalyze the repair of damaged CCA sequences 
(Lizano et al., 2008) but may have an additional role in quality control. Recent studies indicate that 
tRNA-NT may recognize tRNAs with flexible acceptor stems and guanosines at the first and second 
positions and add a CCACCA sequence to their 3’-termini thereby facilitating their entry into the rapid 
tRNA decay pathway (Wilusz et al., 2011).  
To distribute tRNA-NT between organelles and the cytosol, multiple isoforms of the protein are 
synthesized from a single gene in fungi (Chen et al., 1992, Deng et al., 2000, Hanic-Joyce and Joyce, 
2002), mammals (Reichert et al., 2001, Nagaike et al., 2001), and plants (Shanmugam et al., 1996, 
Schmidt von Braun et al., 2007). As such these tRNA-NTs are representative of a group of enzymes 
designated sorting isozymes (Gillman et al., 1991), whose prevalence is greater than initially expected 
e.g. Carrie et al., (2009). Other prominent examples of sorting isozymes include other nuclear-encoded 
tRNA modifying enzymes (Martin and Hopper, 1994) and the aminoacyl-tRNA synthetases (Duchêne et 
al., 2005). Typically, these sorting isozymes are generated by alternative use of multiple transcription 
start sites and multiple in-frame start codons which give rise to long variants with amino-terminal 
mitochondrial and/or plastid transit peptides and shorter variants with cytosolic and/or nuclear 




Figure 2.1 A. thaliana tRNA-NT and variants 
(A) The X-ray structure of Thermotoga maritima CCA (PDB code 3H37 (Toh et al., 2009) is shown in 
ribbon representation with a tRNA (from Aquifex aeolicus PDB code 1VFG (Tomita et al., 2004) 
positioned based on the structural alignment of 1VFG with 3H37 (as shown in Supplementary Figure 
S2.2). The position of the T-arm and the acceptor arm are indicated. Regions in the tRNA and protein not 
solved in the corresponding crystal structures are indicated by magenta dots. In the structure the 
positions of Mat-Mu1 and Mat-Mu2 (dark blue) and the recognized parts of the PFAM domains are 
indicated (red, PolyA_pol; yellow, PolyA_polRNAbd; blue, tRNA_NucTran2_2/HD). The use of 3H37 for 
visualization of the A. thaliana protein motifs was justified by fold recognition (Supplementary Table 
S2.3). (B) The various versions of tRNA-NT used in the present study are depicted as coloured bars 
showing the mature domain translated from the third methionine residue in red, the additional region 
translated from the second methionine residue in orange and the additional region translated from the 
first methionine residue in yellow. Mat-Mu1 and Mat-Mu2 where amino acid substitutions were made 
are shown in green and blue, respectively. Coloured regions are not drawn to scale. The amino acid 




We previously demonstrated that different isoforms of A. thaliana tRNA-NT can be synthesized 
either with or without an N-terminal region containing the mitochondrial and plastid targeting 
information and that differential use of the first two in-frame ATGs could give rise to two sizes of transit 
peptides of differing intracellular distributions in onion cells (Schmidt von Braun et al., 2007). While 
proteins with the longer N-terminal signal were targeted to both mitochondria and plastids, proteins 
with the shorter N-terminal signal were preferentially targeted to plastids. A similar pattern of 
localization had been observed for the dual-targeted glutathione reductase (Rudhe et al., 2002). These 
observations, however, might reflect that the signal for efficient plastid translocation can be shorter 
than the minimal length required for mitochondrial import (Ruprecht et al., 2010, Bionda et al., 2010). 
Remarkably, in addition to a requirement for the N-terminal domain for mitochondrial and plastid 
import, the mature domain of Arabidopsis tRNA-NT also influenced the distribution of this protein. The 
presence of the mature domain in addition to the N-terminal region shifted the localization of the linked 
GFP reporter away from plastids and toward mitochondria (Schmidt von Braun et al., 2007). Intriguingly, 
a variant of the mature domain bearing amino-acid substitutions within its C-terminal region lost this 
preference for mitochondrial targeting and was directed to plastids (Schmidt von Braun et al., 2007). 
Given recent observations of unfolding and plastid import (Bionda et al., 2010), the distinct translocation 
behavior of the protein might reflect a difference in stability between the native and variant mature 
domains.  
To address how the physicochemical properties of the mature domain affect the targeting of 
Arabidopsis tRNA-NT to mitochondria and plastids we analyzed the structure, stability and tRNA-binding 
of the native and variant proteins in the context of intracellular localization. We show that for tRNA-NT, 
targeting is influenced by changes in protein stability. Further, by using the tRNA-NT N-terminal 
targeting signal fused to Titin-I27 or GFP, we show that the distribution of proteins in the cell is defined 
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in part by the portion of the protein following the targeting signal and not just only by the targeting 
signal. 
2.4 Materials and Methods 
2.4.1 Plasmid construction  
For the generation of GFP fusion proteins with the C-terminal KAKRQRIE sequence of the 
Arabidopsis tRNA-NT converted into EAEEQEIE, PCR amplification was carried out using primer 1 (Table 
S2.1) and the appropriate second primer and template as described previously (Sikorski and Hieter, 
1989). The resulting product was digested with BclI and inserted into the BamHI site of 
pBIN35S35SEmGFP. For protein production in E. coli, the appropriate clones (Sikorski and Hieter, 1989) 
were amplified by PCR using combinations of primers 2–6 (Table S2.1): primer 2 (ATG1) or primer 3 
(ATG3) and primer 4 (native C-terminus) or primer 5 (changes KAKRQRIE to EAEEQEIE) or primer 6 
(removes IKAKRQRIE). The resulting products were digested with BclI and SalI and cloned into a modified 
pGEX-2T vector (Mumberg et al., 1995) digested with BamHI and SalI. Expression clones containing the 
EDTEGE and EFSMEME sequences were generated by moving a Bpu1102I fragment containing these 
mutations (Sikorski and Hieter, 1989) into Bpu1102I-digested pGEX-2T containing the appropriate 
Arabidopsis insert. For expression in yeast, tRNA-NT–GFP fusion sequences were excised as XbaI 
fragments from the appropriate pBIN35SEmGFP derivatives and inserted into XbaI-digested pG131-2, a 
pRS313 (Sikorski and Hieter, 1989) derivative in which the KpnI–SacI multiple cloning region was 
replaced by the SacI–KpnI fragment of p426GPD (Mumberg et al., 1995) containing the TDH3 promoter 
and CYC1 terminator. Constructs were confirmed by sequence analysis (BioS&T or McGill University and 





2.4.2 Plasmid shuffling 
Plasmids expressing various tRNA-NT–GFP fusion proteins were transformed (Schiestl and Gietz, 
1989) into strain SCDT8 (MATα leu2-3,112trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 cca1::TRP1) bearing 
a derivative of pRS316 (Sikorski and Hieter, 1989) containing the wild-type CCA1 gene of S. cerevisiae 
with selection on SC medium minus uracil and histidine (Sherman, 2002). For plasmid shuffling, patches 
of two representative transformants were replica-plated from SC medium minus uracil and histidine, to 
YPD medium (Sherman, 2002), incubated 1 day at 23⁰C, replica-plated to 5-FOA medium (Boeke et al., 
1984) supplemented with 30 mg/l leucine, lysine and tyrosine and 20 mg/l adenine, histidine and 
tryptophan, with or without FOA and incubated for 3 days at 23⁰C. FOA-resistant cells then were replica-
plated to YPD or YPG plates and incubated at 23⁰C for 3 or 4 days respectively. 
2.4.3 Expression and purification of tRNA nucleotidyltransferase 
Proteins were expressed in E. coli BL21(DE3) (Shan et al., 2008) except that cells were induced 
with 0.02% w/v D-lactose and 0.5 mM IPTG at 19⁰C for 16-20 hours. Cells were harvested by 
centrifugation, stored at -80⁰C for a minimum of 1 hour, frozen pellets were thawed on ice and 
resuspended in cold lysis buffer (PBS plus 1 mM EDTA) at 2 ml/g of cell pellet prior to lysis in a French 
Pressure Cell press (Thermospectonic). Cleared lysate was cycled through glutathione Sepharose fast 
flow 4B resin (GE Healthcare or Gold Biotechnology USA) overnight (4⁰C, 1ml/min). The column was 
washed and the protein eluted with 15 mM reduced glutathione, 50 mM Tris-HCl (pH: 8.3), 140 mM 
NaCl and 2.5 mM CaCl2. Fractions of interest were digested (5 units/mg) with thrombin (2 188 NIH 
units/mg, GE Healthcare) while being dialyzed overnight (8 kDa dialysis bag) at 4⁰C in 50 mM Tris-HCl 
(pH 8.3), 140 mM NaCl and 2.5 mM CaCl2 to eliminate glutathione. Protein was passed 3x through a 
glutathione Sepharose fast flow 4B column to remove the GST tag and dialysed against PBS (50 kDa 
dialysis bag) to remove remaining thrombin and to exchange buffer.  
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2.4.4 Biophysical characterization of tRNA nucleotidyltransferase 
2.4.4.1 UV-visible spectroscopy  
The UV-visible spectra (200-400 nm) were collected using the Varian Cary 100 Bio UV-Visible 
Spectrophotometer using a 1.0 cm quartz cuvette. The approximate amount of tRNA in any sample was 
calculated using the extinction coefficient of 2.22 x 10-2 ml·μg-1cm-1 at OD260 for tRNA. To remove nucleic 
acid that co-purified with the proteins of interest, RNaseA (>60 Kunitz units/mg protein, BioShop Canada 
Inc. Burlington, ON) was added (30 ng RNaseA/ml protein solution). The RNaseA was removed by 
extensive dialysis against PBS as described above and the efficient removal was confirmed by the 
stability of an added radiolabeled tRNA template. 
2.4.4.2 CD-spectroscopy  
Far UV CD spectra (185-280 nm) were recorded on a Jasco-815 CD- spectropolarimeter under a 
constant nitrogen flow in a 0.1 or 0.2 cm cell, using a protein concentration of 0.1-0.3 mg/ml in PBS (pH 
7.4), accumulated over five scans and buffer corrected for those signals. A bandwidth of 1 nm, a 
response time of 0.25 seconds, a data pitch of 0.2 nm, and a scanning speed of 20 nm/min was used. 
Prior to measurements, samples were centrifuged (5 min. 4⁰C). The data obtained were smoothed using 
the Spectra Analysis program (Jasco). The CD spectrum for tRNA was recorded as for the protein.  
2.4.4.3 Thermal denaturation  
Thermal denaturation was monitored by CD in a 0.2 cm cell using protein concentrations of 0.1-0.3 
mg/ml in phosphate buffer (pH 7.4). The Variable Temperature program (Jasco) was used (222 nm, 
standard sensitivity) with standard settings and a data pitch of 0.2°C. The rate was 25°C/h with start and 




2.4.4.4 Fluorescence measurements  
Intrinsic fluorescence of the proteins (1.2 μM or 0.8 μM) was measured in PBS (pH 7.4) and 10% 
glycerol using the Varian Cary Eclipse Fluorescence Spectrophotometer with a 1 cm path length. After 
excitation at 280 nm or 295 nm, emission spectra were recorded in the range of 310-400 nm with a scan 
rate of 10 nm/s and excitation and emission bandwidths of 5 nm. Emission spectra at room temperature 
were averaged over 10 scans with a 1.0 nm data sampling interval and voltage was set to 600 volts. 
Protein concentrations were determined by OD280 and samples were centrifuged for five minutes at 4⁰C 
before use. All spectra were baseline-corrected and the data obtained were smoothed using the moving 
average smoothing function (Varian). Baker’s yeast tRNA (Roche), extensively purified by phenol 
extraction and ethanol precipitation was used in fluorescence quenching experiments. Protein 
(concentrations ranging between 1.0-2.6 μM) was placed in a 1 cm cell and titrated with increasing 
amounts of tRNA at room temperature. All measurements were taken at 295 nm as described above. 
UV-visible spectral scans (200-400 nm) were taken after each tRNA addition to take into account any 
inner filter effect (Shan et al., 2008). 
2.4.5 Enzyme activity assays 
Plasmids G73 and pmBsDCCA were kindly provided by Dr. Alan Weiner (University of Washington) and 
digested with restriction enzymes to generate the tRNA-N, tRNA-NC, and tRNA-NCC templates by run-off 
transcription. Each transcription reaction (100 μl) contained 1X transcription buffer (Fermentas), 500 μM 
ATP, CTP and UTP, 50 μM GTP, approximately 50 μCi [α-32P] GTP (10 μCi/μl, 3000 Ci/mmol, Perkin 
Elmer), 13 μg of linearized DNA template, 60 units of T7 RNA polymerase (Fermentas), and nuclease-free 
water. Each reaction was incubated at 37°C for three hours, phenol extracted, ethanol precipitated and 
resuspended in 10 μl of nuclease-free dH2O. To these samples, 10 μl Peattie’s loading buffer (Peattie, 
1979) was added and samples electrophoresed for 90 minutes on a 7 M urea, 20% acrylamide gel. 
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Radioactive bands were identified by autoradiography, purified (Rubin, 1973) and resuspended in a final 
volume of 100-150 μl of nuclease free dH2O. Standard enzyme assays (Cudny et al., 1978) were carried 
out in a final volume of 10 μl enzyme reaction mixture which contained 100 mM glycine buffer (pH 9), 
10 mM MgCl2, 1 mM ATP, 0.4 mM CTP, 1 μl of the appropriate [α-32P] GTP transcribed tRNA after gel 
extraction, and the amount of protein as indicated. Assays were performed for the times indicated and 
stopped by adding 10 μl of loading buffer containing 7M urea (Peattie, 1979). Enzyme kinetic assays 
were performed in 50 μl containing a fixed amount of [α-32P] GTP transcribed tRNA-NCC template and 
increasing amounts (0.1 μM to 42 μM) of purified baker's yeast tRNA (Roche). After addition of the 
appropriate amount of enzyme (5-10 ng), 10 μl aliquots of the reaction mixture were removed at 0.5, 1, 
2, 5 and 10 minutes and placed in 10 μl of loading buffer (Peattie, 1979) to stop the reaction. All samples 
were stored on ice and heated to 70oC for 10 minutes before being loaded onto 7M urea/20% 
polyacrylamide gels and separated for 12-16 hours at 1950 V. Transcripts were detected using the 
Typhoon™ TRIO Variable Mode Imager (GE Healthcare) and band intensities measured using the 
ImageQuantTL 1D version 7.0 (GE Healthcare).   
2.4.6 Analysis of in vivo localization of the proteins. 
The isolation of Solanum lycopersicum var. Moneymaker leaf mesophyll protoplasts as well as 
the polyethylene glycol (PEG) mediated transformation was carried out as described (Mishra et al., 
2002). For each transformation 20 μg plasmid DNA was used for 105 protoplasts. If necessary the final 
amount of DNA was adjusted by addition of the vector pRT-Neo which encodes neomycin 
phosphotransferase only. Incubation was performed in light for 15h at 26°C. The intracellular GFP 
localization was analyzed using a Leica SP5 confocal laser scanning microscope (Leica, Germany). GFP 
and chlorophyll were excited at 488 nm and their fluorescence emission recorded at 495-535 and 660-
710 nm, respectively.  
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2.4.7 Bioinformatic analysis and assignment of A. thaliana to the PDB structures  
Annotated bacterial and eukaryotic tRNA-NT sequences were downloaded from the refSeq 
database and aligned with MAFFT (Katoh et al., 2005, Katoh and Toh, 2008, Katoh and Toh, 2010). The 
alignment was used to build pHMMs with hmmer (http://hmmer.janelia.org/) for the neck and the 
body/tail domains of bacterial and eukaryotic proteins, resulting in four pHMMs. The nr-database 
(http://www.ncbi.nlm.nih.gov/) was searched with the four Pfams (Punta et al., 2012). pHMMs 
[PF01743 (head), PF12627 (neck), PF13735 (body/tail) and PF01966 (body/tail)] for all available tRNA-
NTs and sequences, which matched at least two pHMMs for different domains, were accepted. Poly(A) 
sequences were eliminated by CLANS analysis (Figure S2.1). Organisms for which the complete genome 
sequence was not available (http://www.ncbi. nlm.nih.gov/RefSeq) were excluded. Proteins derived 
from the same gene locus are treated as a single sequence.  
 The tRNA-NT sequences were collected from the nr-database using Blast (Altschul et al., 1997) 
resulting in a dataset with 971 sequences, which was subsequently reduced with cd-hit (Li and Godzik, 
2006) to a maximal sequence identity of 70% leaving 409 sequences in the dataset. These sequences 
were aligned with MAFFT v6.811b (Katoh et al., 2005, Katoh and Toh, 2008, Katoh and Toh, 2010). This 
MSA (multiple sequence alignment) was compared with the alignment generated by the fold recognition 
server HHpred (Soding et al., 2005) in order to validate the results and mark reliable regions. The server 
recommended the structure of Thermotoga maritima as the best hit, the structure of Geobacillus 
stearothermophilus as second best hit and the structure of the A-adding enzyme with bound tRNA of 
Aquifex aeolicus as the third hit as possible templates. This result was confirmed by another fold 
recognition server (Table S2.3). The predicted position for Mat-Mu1 and -Mu2 is the same for all three 





2.5.1 The structural properties of native and variant tRNA nucleotidyltransferase  
Our previous studies of a tRNA–NT-Mat-Mu1 variant, bearing modifications within the body 
domain of tRNA-NT (Fig. 2.1, Fig. S2.2), demonstrated that properties of this domain influence the 
intracellular distribution of this protein. To analyze the effect of changing another region within the 
mature domain we generated a variant, Mat-Mu2, bearing alterations at the extreme C-terminus of the 
tail domain (Fig. 2.1B, Fig. S2.3). Both Mat-Mu1 and Mat-Mu2 variants were expressed in E. coli, purified 
and the GST tag was removed yielding proteins of high purity (Fig. S2.3).  
To address the hypothesis that protein stability influences intracellular distribution we analyzed 
the structural integrity of both variants by CD spectroscopy. For the native and Mat-Mu2 variant we 
observed comparable CD spectra, while for the Mat-Mu1 variant the CD spectrum suggested a 
significant reduction of secondary structure (Fig. 2.2A). However, the UV-visible absorption spectra of 
the native and Mat-Mu1 variant, but not of the Mat-Mu2 variant showed a significant absorption at 260 
nm (Fig. S2.4). Given that nucleic acids and nucleotides absorb strongly at this wavelength and that 
tRNAs have a positive CD-signal with peak intensity around 220 nm (Fig. S2.4), we hypothesized that the 
native and Mat-Mu1 variants had retained E. coli RNAs and specifically tRNAs. Consistent with tRNA 
association with these proteins, dialysis using tubing with a 50 000 Dalton cut off, but not with an 8000 




Figure 2.2 tRNA is co-purified with the tRNA-NT 
(A) The CD spectra of native protein (4.24 μM, black), and Mat-Mu1 (3.04 μM, dark grey) and Mat-Mu2 
(4.01 μM, light grey) variant proteins as purified from E. coli (Supplementary Figure S2.3). (B) The CD 
spectra after removal of tRNA by extensive dialysis with RNaseA treatment for native protein (2.5 μM, 
black), or without RNAseA treatment for Mat-Mu1 (1.19 μM, dark grey), Mat-Mu2 (4.01 μM, light grey) 
and Mu1/Mu2 (2.72 μM, light grey broken line, Figure 2.1B) variant proteins. 
 
Furthermore, treatment with RNaseA followed by additional dialyses reduced the UV-visible 
absorption peak at 260 nm for both proteins (Fig. S2.4, Table S2.2). While the RNaseA treatment yielded 
an identical CD-spectrum for the native enzyme both before and after treatment (Fig. 2.2B), the CD-
spectrum for the Mat-Mu1 variant was substantially different from the CD spectrum before dialysis. 
After dialysis the Mat-Mu1 variant showed a CD-spectrum similar to the one of the native protein and 
the Mat-Mu2 variant. From the analysis of the CD-spectra we conclude that the variants are folded and 
have a primarily α-helical content as expected from the available crystal structures (Fig. 2.1A, supp. Fig. 
S2.2), although slight variations in the CD-spectra suggest that the folding is not identical. Thus, the 
mutations introduced at Mat-Mu1 and Mat-Mu2 did not alter the overall secondary structure of the 
proteins to a large extent.  
Unlike Mat-Mu1 and the native enzyme, the Mat-Mu2 variant did not show a major UV-visible 
absorption peak at 260 nm (Fig. S2.4) which suggests that regardless of what accounts for the difference 
between the native enzyme and the Mat-Mu1 variant, much less tRNA remains associated with the Mat-
Mu2 variant throughout the purification protocol. To determine whether the Mat-Mu1 and Mat-Mu2 
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modifications would be additive, synergistic or antagonistic we generated a protein containing both 
modifications. This Mu1/Mu2 variant showed a CD-spectrum that was intermediate to the other 
analyzed variants (Fig. 2.2B).   
Fluorescence spectra (Fig. S2.5A, Table 2.1) on the untreated samples revealed little red or blue 
shifting for either the Mat-Mu1 or Mat-Mu2 variant (1-4 nm), but did show a major change in 
fluorescence intensity (40-50% reduction) when compared to the native enzyme. After samples had 
been treated to remove RNA a slightly larger and more consistent blue shift (4-7 nm) but a lower 
reduction in fluorescence intensity (10-15%) was observed for both the Mat-Mu1 and Mat-Mu2 variants. 
Interestingly, the Mu1/Mu2 variant shows emission maxima nearly equal to either the Mat-Mu1 or Mat-
Mu2 variant at both wavelengths and shows a small decrease in fluorescence intensity. Fluorescence 
intensity and wavelength maxima are defined primarily at 295 nm excitation by tryptophan and at 280 
nm by both tryptophan and tyrosine. As seven of the 11 tryptophan residues contained in the 
Arabidopsis tRNA-NT are between Mat-Mu1 and Mat-Mu2 (Fig. S2.2) these changes in fluorescence 
intensity may highlight changes in the structure of the tRNA-NT in this region. Moreover, there are 
clearly differences in these signals before and after removal of RNA (compare Fig. S2.5A and S2.5B). 
2.5.2 Activity of tRNA-NT and its variants 
To determine if differences in the levels of tRNA associated with the native and variant enzymes 
reflected differences in enzyme activity we assessed the ability of the purified enzymes to support CCA 
addition in vitro. As expected, the native enzyme added a complete CCA sequence to a model tRNA 
substrate under standard assay conditions (Fig. 2.3, 100 ng protein). Although the affinity for tRNA of 
the Mat-Mu2 variant appeared to be reduced (Fig. S2.4, S2.5) we observed that this enzyme also adds a 
complete CCA sequence (Fig. 2.3, 100 ng). In contrast, the Mat-Mu1 variant and the Mat-Mu1/Mu2 
variant showed a complete loss of activity (Fig. 2.3, 100 ng). This was the reverse of what might have 
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been expected based on the absorbance peaks at 260 nm (Fig. S2.4) which suggested that tRNAs were 
associated with the Mat-Mu1 variant, but not with the Mat-Mu2 variant. However, the activity of the 
Mat-Mu2 variant is reduced when compared to the native enzyme, which becomes more obvious at 
reduced enzyme concentrations (Fig. 2.3, 20 ng protein).  
Table 2.1 Physiochemical parameters of tRNA-NT and its variants 
 
To further explore the effects on tRNA binding of altering the enzyme at Mat-Mu1 and Mat-Mu2 
we determined tRNA binding constants for the native and variant enzymes by analyzing the quenching 
of the intrinsic tryptophan fluorescence (Fig. S2.6) as we had done previously for yeast tRNA 
nucleotidyltransferase (Shan et al., 2008). We found a dissociation constant of about 0.6 μM for both 
the native and Mat-Mu1 variant proteins indicating that the alteration of amino acids in Mat-Mu1 does 
not change the ability of the protein to bind tRNA (Table 2.1). This dissociation constant is in good 
agreement with the values (0.6 to 16 μM for various tRNA substrates) reported previously for class II 
(Evans and Deutscher, 1978) and class I tRNA nucleotidyltransferases (Shi et al., 1998). The dissociation 
constant (1.8 μM) of the Mat-Mu2 variant is also well within this range but about three-fold higher than 
that of the native and Mat-Mu1 variant. Although small, this increased dissociation constant also reflects 
the reduced association of tRNA with the Mat-Mu2 variant suggested by the association of tRNA with 
protein during the purification protocol (Fig. S2.4, S2.5). Clearly though, the tRNA association with the 
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enzyme does not directly define enzyme activity as the Mat-Mu1 variant shows a similar association 
constant to that of the native enzyme but no activity, while the Mat-Mu2 variant shows an increased 
association constant and retains activity (Fig. 2.3). 
 
Figure 2.3 The enzymatic activity of native and variant tRNA-NTs 
The proteins indicated were incubated as described with a tRNA substrate for the times indicated. The 
amounts of enzyme used in the assays are indicated to the right of each assay. The reaction products 
were separated by electrophoresis on 7 M urea/20% polyacrylamide gels and visualized using the 
TyphoonTM TRIO Variable Mode Imager. The migration of different modification states is shown on the 
left. P is the active enzyme positive control (tRNA with a complete CCA sequence), N is the boiled 
enzyme negative control (original tRNA template lacking the CCA sequence) and L represents a ladder 
containing tRNA products ending at N, NC, NCC and NCCA.  
 
To more precisely link tRNA binding to enzyme activity we used a mixture of a radiolabelled 
tRNA template lacking the terminal AMP residue and the same yeast tRNAs used for fluorescence 
quenching as a substrate to define kinetic parameters for Arabidopsis tRNA nucleotidyltransferase. In 
agreement with the activity assays (Fig. 2.3), the Mat-Mu1 variant showed no activity under our assay 
conditions. In contrast, the Mat-Mu2 variant and the native enzyme showed almost identical apparent 
KM values of approximately 12 μM (Table 2.1). It is important to note that although both the association 
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constants and the kinetic parameters were calculated using a mixture of tRNAs (ending at the 
discriminator base, the first CMP, the second CMP or the terminal AMP), the apparent kinetic 
parameters were based on addition of AMP to a template lacking only the terminal AMP, so differences 
observed for the determination of the KD and KM may simply reflect this difference in template. As noted 
above (Fig. 2.3), the Mat-Mu2 variant was somewhat less active than the native enzyme. This is 
consistent with a two-fold lower apparent kcat for the Mat-Mu2 variant as compared to the native 
enzyme although the apparent KM values of these two enzymes were identical (Table 2.1). Taken 
together, all of these data indicate that tRNA binding (as measured by KD or co-purification with enzyme) 
is not strictly correlated with enzyme activity. 
To further address the role of Mat-Mu2 in enzyme activity, we generated and purified a variant 
of the tRNA-NT lacking the last nine amino acids (Mat-Δ2, Fig. 2.1B). This variant showed a reduced rate 
of CCA addition in vitro when compared to the native enzyme or the Mat-Mu2 variant (Fig. 2.3, 20 ng) 
with apparent kcat values reduced to 71% and 32% (Table 2.1), respectively. As with the Mat-Mu2 
variant, we saw a three-fold change in association constant as compared to the native enzyme, but in 
this case the change reflected a reduced KD for the variant enzyme (Fig. S2.6, Table 2.1) such that the 
difference in association constants between the Mat-Mu2 variant and the Mat-Δ2 variant is 
approximately 10 fold (Table 2.1). Intriguingly, this difference in association constants is not reflected in 
differences in apparent KM’s as the apparent KM’s for all three enzymes are within experimental error.  
To assess whether in vitro tRNA nucleotidyltransferase activities reflect in vivo activities, we 
analyzed whether tRNA-NT-GFP gene constructs could complement a null mutation in Saccharomyces 
cerevisiae. Native and mutant gene fusions, encoding tRNA-NT proteins with all three methionines 
(M(1,2,3)) or only the third methionine (M(3)) and a C-terminal fused GFP, inserted downstream of the 
TDH3 promoter in a high-copy HIS3-bearing plasmid, were introduced into a haploid strain (cca1::TRP1) 
carrying plasmid-borne yeast CCA1 and URA3 genes. Following selection of Ura+ His+ transformants, 5-
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FOA was used to select for loss of the URA3-CCA1-bearing plasmid and to assess whether variant alleles 
supported growth. As shown previously for the native enzyme (Schmidt von Braun et al., 2007), the 
M(3)-tRNA-NT-GFP construct allowed growth on glucose (Table 2.2, Fig. S2.7), confirming the 
functionality of the fusion protein in vivo. For M(1,2,3)-tRNA-NT-GFP we observed growth on 
fermentable (glucose) and non-fermentable (glycerol) carbon sources, indicating that the fusion protein 
was successfully imported into yeast mitochondria to facilitate mitochondrial protein synthesis 
consistent with earlier results for other plant proteins (Chaumont et al., 1990, Bowler et al., 1989). The 
Mat-Mu2 variants of M(3)-tRNA-NT-GFP and M(1,2,3)-tRNA-NT-GFP behaved like the native enzyme, 
while the Mat-Mu1 variants, were unable to grow on either glucose or glycerol supporting the lack of 
enzyme activity observed in vitro.  
Table 2.2 Ability of native and variant Arabidopsis tRNA-NTs to replace yeast tRNA-NT 
 
 
2.5.3 The structural stability of native and variant tRNA nucleotidyltransferases 
Next we explored whether the enzyme activity or the ability to associate with tRNA is related to 
protein stability. Following the CD-signal at 222 nm as an indication of α-helicity we observed a three-
state equilibrium for the native enzyme with transition temperatures at 316 K and 355 K, respectively. 
The first transition represents a small change of the secondary structure content, while the second 
transition reflects a full loss of secondary structure. From the unfolding trace we can conclude that the 
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intermediate state is rather stable (Fig. 2.4). The value found for the first transition is consistent with the 
one reported for the yeast tRNA nucleotidyltransferase (Shan et al., 2008).  
 
Figure 2.4 Thermal unfolding of the native and variant tRNA-NT 
The CD spectra at 20 and 90⁰C of (A) native tRNA-NT, (B) Mat-Mu1 variant, (C) Mat-Mu2 variant and (D) 
Mu1/Mu2 variant. The right-hand panels show secondary structure content in relation to the 
temperature by measuring the CD signal at 222 nm for each protein shown in the left-hand panel. The 
black lines represent the least-square fit result for a thermal transition using a two-state equation as 
described in Zoldák et al. (2004). For native enzyme, the behaviour was described with two coupled two-
state equations. The results are listed in Table 2.1. 
 
For the variants we observed a two-state transition only (Fig. 2.4 B-D). The transition 
temperature found is in the range of the first transition observed for the native protein (Table 2.1). 
Remarkably, the transition temperature for the Mat-Mu1 variant is shifted by about minus 10 K and for 
the Mu1/Mu2 variant by about minus 4 K. In contrast, for the Mat-Mu2 variant the transition 
temperature is slightly increased (plus 3 K). However, for all variants the energy required for the first 
unfolding is lower than that of the native protein and as expected the unfolding process requires less 
energy than observed for the complete unfolding of the native enzyme (Table 2.1).      
2.5.4 The cellular distribution of native and variant tRNA nucleotidyltransferases  
To see if the differences in stability affected protein distribution, we assessed the intracellular 
localization of C-terminal-GFP fusions of proteins containing all three methionines (M(1,2,3)), only the 
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first and the third methionine (M(1,3)) or the second and third methionine (M(2,3)). As a control, we 
produced the mature protein with only the third methionine (M(3)). We transformed these constructs 
into tomato protoplasts as described in Materials and Methods. Distribution was quantified in at least 
three independent experiments for each protein. Chloroplast localization was identified by overlay with 
chlorophyll fluorescence, mitochondrial localization was confirmed by MitotrackerTM staining and 
nuclear localization was confirmed by DAPI staining (exemplified in Fig. 2.5). When the GFP fluorescence 
did not overlay discretely with any of the known cellular structures the localization was annotated as 
cytosolic. With this system we can determine the distribution of the proteins in vivo and express the 
frequency of occurrence for a certain localization for each fusion protein in percentages of protoplasts in 
which this case was observed (Table 2.3, Schmidt von Braun et al., 2007). To ensure that we were 
studying the localization of the intact fusion proteins, protein from each batch of protoplasts was 
assayed with anti-GFP antibodies in order to prove protein stability and visualize potential breakdown 
products of the GFP fusion proteins (Fig. S2.8).       
When the protein lacking the first two methionines (M(3)) was used, the majority of the GFP 
fluorescence was found in the nucleus co-localizing with the DAPI fluorescence (Fig. 2.5, top row). The 
M(2,3)-tRNA-NT-Mat-Mu1-GFP and M(1,2,3)-tRNA-NT-Mat-Mu1-GFP constructs showed co-localization 
with chlorophyll fluorescence indicating that these proteins were directed to plastids (2nd and 3rd rows, 
respectively). In addition, the M(1,2,3)-tRNA-NT-Mat-Mu1-GFP also is targeted to mitochondria as 
confirmed by MitotrackerTM staining (3rd row). The M(2,3)-tRNA-NT-Mat-Mu2-GFP constructs showed a 
clear localization in the cytosol, but also a co-localization with chlorophyll fluorescence indicating that 




Figure 2.5 In vivo localization of variants of tRNA-NT 
Different constructs were generated for expression in tomato protoplasts (Table 2.3). Shown are 
examples to document the different localizations of the GFP fluorescence and the confirmation of the 
compartments targeted. Shown is the fluorescence of chlorophyll (Chl F), the GFP signal (GFP), the DAPI 
staining to visualize the nucleus (DAPI), the MitotrackerTM staining to visualize mitochondria 
(MITOTRACKER) and the overlay of all signals for protoplasts transformed with M(3)-tRNA-NT–GFP, 
M(2,3)-tRNA-NT-Mat-Mu1–GFP, M(1,2,3)-tRNA-NT-Mat-Mu1–GFP and M(2,3)-tRNA-NT-Mat-Mu2–GFP. 
The interpretation as scored in Table 2.3 is given on the right. The expression control is shown in 
Supplementary Figure S2.8. 
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Figure 2.3: Localization of tRNA-NT in protoplasts 
 
  
Any native protein containing its amino-terminal extension, regardless of whether the first, the 
second or both the first and second methionines are present, showed a GFP signal consistent with 
mitochondrial localization in almost every case (Table 2.3). We also noted, that consistent with earlier 
results in non-green tissue (Schmidt von Braun et al., 2007), the number of protoplasts showing 
chloroplast localization increased when methionine one was not present in the construct. Furthermore, 
for the native protein containing its amino-terminal extension we did not observe a significant 
population of protoplasts with nuclear or cytosolic GFP fluorescence.  
Analysis of either variant of the mature domain revealed a shift towards chloroplast localization 
such that most of the protoplasts showed GFP fluorescence co-localizing with chlorophyll fluorescence. 
In addition, we noted that few protoplasts showed GFP fluorescence co-localizing with MitotrackerTM 
fluorescence. This again parallels with the results for Mat-Mu1 in non-green tissue (Schmidt von Braun 
et al., 2007). In contrast to the earlier results for M(2,3)-tRNA-Mat-Mu1-GFP, we saw a significant 
portion of the GFP fluorescence in the nucleus (Fig. 2.5, Table 2.3). When the mature domain contained 
the Mat-Mu2 mutation, we observed chloroplast localization for each construct, but almost no 
mitochondrial or nuclear localization (Table 2.3). In contrast, when the first methionine was missing we 
observed a cytosolic distribution of the protein in all cells with a small number of protoplasts with GFP 
localization in chloroplasts.   
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2.5.5 Guidance of different marker proteins by the signal of the tRNA nucleotidyltransferase  
The difference in the distribution of the precursor proteins resulting from the changes in the 
mature domain might suggest that the stability of the precursor protein modifies its intracellular 
localization. To test this we used two defined cargo proteins, namely GFP and Titin-I27 (Titin hereafter). 
Titin has been shown to be folded in the context of a precursor protein and modifies the transport 
efficiency of short signals, while GFP does not affect protein translocation (Ruprecht et al., 2010, Bionda 
et al., 2010). When three different amino-terminal targeting signals – M(1), M(1,2), or M(2) - were fused 
to GFP, we always observed a co-localization of GFP with chloroplasts (Table 2.4), which is consistent 
with the earlier results (Schmidt von Braun et al., 2007). However, we also found for all constructs a 
large portion of protoplasts with mitochondrial localization of GFP (Table 2.4), which was not seen for 
M(2)-GFP in onion bulb scales (Schmidt von Braun et al., 2007). Similarly, we observed a localization of 
M(1)-GFP and M(2)-GFP to the nucleus (30% of all protoplasts) and a cytosolic localization of M(2)-GFP 
(45% of all protoplasts), which was not observed before (Schmidt von Braun et al., 2007).  
Table 2.4: tRNA-NT signal targeting in protoplasts 
 
The import of the precursor proteins with Titin-GFP instead of the mature domain (Fig. 2.6, 
Table 2.5) revealed a remarkable difference to the results obtained with GFP alone as cargo protein. For 
all constructs, a chloroplast, but not a mitochondrial localization of the GFP fluorescence signal was 
observed. Only for the M(1)-Titin-GFP construct did we observe any appreciable (25% of all protoplasts) 
mitochondrial localization. Remarkably, the number of protoplasts showing nuclear localization for the 
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M(1) or the M(2) guided artificial precursor was increased and the cytosolic localization in the case of 
the M(2)-containing precursor was greatly increased.  
 
Figure 2.6 In vivo localization of Titin–GFP defined by the tRNA-NT signal 
Different constructs were generated for expression in tomato protoplasts (Table 2.4). Shown are 
examples of the localization of the GFP fluorescence (left) and the overlay with the fluorescence of the 
chlorophyll (right) of protoplasts transformed with M(1,2)–Titin–GFP, M(1)–Titin–GFP and M(2)–Titin–




Table 2.5: Number of tRNA-NT paralogues in individual species in eukaryotic phyla 
 
2.6 Discussion 
2.6.1 Functional relevance of the BODY- and TAIL-domain 
The sequence of the head and neck region of class II tRNA-NTs shows high sequence similarity 
and five conserved motifs (Fig. 2.1, Fig. S2.2), which contain catalytically important residues. In contrast, 
the body and tail regions show limited sequence similarity, but the available crystal structures suggest a 
conserved fold of α-helical secondary structure (Betat et al., 2010). The modifications introduced into 
the body (Mat-Mu1) and tail (Mat-Mu2) domains are well separated from the described catalytic 
residues. While the body domain interacts with the TΨC loop and acceptor stems of tRNAs (Tomita et 
al., 2004), the tail domain is involved in interacting with the TΨC loop of tRNAs (Tomita et al., 2004, Cho 
et al., 2006). Because tRNA-NTs recognize diverse tRNAs these interactions are primarily through the 
sugar-phosphate backbone of the tRNA rather than through base-specific interactions (Tomita et al., 
2004, Cho et al., 2006). Once a tRNA has been bound at the active site, these interactions may function 
as an anchor and prevent the RNA from dislodging from the enzyme surface during CCA addition. We 
were drawn to the Mat-Mu1 and Mat-Mu2 sequences for mutagenesis as both sequence stretches are 
rich in positively charged amino acids, (i) a feature of many nuclear targeting signals (Christophe et al., 
2000) and (ii) likely targets for interaction with the sugar phosphate backbone of the tRNA during tRNA 
binding (Tomita et al., 2004). By converting the positively charged residues in these regions of the 
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protein to negatively charged residues we hoped to abolish any electrostatic interactions important to 
the function of these regions of the protein while maintaining the hydrogen bonding potential which 
would allow these regions of the protein to remain surface exposed. 
 Indeed, the two mutations altered the tRNA binding behavior. The Mat-Mu1 and the native 
protein were isolated from E. coli associated with RNA while Mat-Mu2 did not show an association 
suggesting a higher release rate for this variant (Fig. 2.2, Fig. S2.4). Further, RNA removal resulted in a 
massive CD-signal alteration for Mat-Mu1, but not for the native enzyme (Fig. 2.2). Indeed, based on the 
ratio of absorbance at 260 nm to absorbance at 280 nm (Table S2.2), the Mat-Mu1 variant and the 
native protein have approximately the same amount of tRNA associated. RNA removal resulted in a 
massive CD signal alteration for Mat-Mu1, but not for the native enzyme (Fig. 2.2). The CD signal of the 
Mat-Mu1 variant shows an approximately 3-fold increase of θMRW at 222 nm. This suggests that the 
interaction of the Mat-Mu1 variant with tRNA either alters the structure of the protein or follows a 
different mode of interaction or that the association of RNA molecules differs between the two proteins.  
A different mode of interaction would be consistent both with the observation that the RNA 
molecule can be removed by dialysis from Mat-Mu1, but not from the native enzyme, and that there is a 
more dramatic alteration of the fluorescence of the native tRNA-NT by removal of the RNA molecules 
(Table 2.1). This latter observation supports the idea that fluorescence emission spectra generally reflect 
changes of the local environments of tryptophan and tyrosine residues in a protein (Lakowicz, 2006). It 
further suggests that the Mat-Mu1 mutations change the organization of the protein in regions where 
the tryptophan residues are found, such that RNA molecules are more exposed on the surface of the 
Mat-Mu1 variant. Mat-Mu1 is positioned in a predicted helix-loop region located in space close to the 
tRNA substrate (dark blue area in Fig. 2.1) and near the beginning of the body domain of the protein 
(Fig. 2.1A, Fig. S2.2) which is thought to be involved primarily in tRNA binding and anchoring (Tomita et 
al., 2004, Cho et al., 2006). Importantly, the portion of the A. thaliana tRNA-NT that is altered to 
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generate Mat-Mu1 appears to form an additional loop in the A. thaliana protein which is not present in 
any structurally-characterized tRNA-NT. Therefore, it is difficult to directly correlate changes in this 
region with any of the known structures, however, it is possible that the Mat-Mu1 changes could extend 
the predicted helix in this region toward the tRNA substrate either changing the orientation of regions of 
the protein responsible for tRNA binding or excluding tRNA from the active site. Either of these 
possibilities could result in a change of the position of the bound tRNA such that it is not tightly bound at 
the active site and remains accessible to be dialyzed away. This latter observation is consistent with the 
loss of function of the Mat-Mu1 variant both in vivo and in vitro (Table 2.2, Fig. 2.3, Fig. S2.7). That tRNA 
can still be bound to the Mat-Mu1 variant at the body and tail domains is supported by the 
copurification of tRNA with the Mat-Mu1 variant and with the similar dissociation constants of the 
native and Mat-Mu1 variant proteins (Table 2.2).  
Unlike the Mat-Mu1 variant, the Mat-Mu2 variant shows a CD-spectrum similar to native tRNA-
NT and a more reduced fluorescence emission maximum compared to native enzyme after RNaseA 
treatment (Fig. 2.2, Fig. S2.5B, Table 2.1). This suggests that Mat-Mu2 also changes the structural 
composition of the protein, but in a different way than Mat-Mu1. Given the low degree of sequence 
similarity in this region of the protein and the fact that in most available crystal structures e.g. (Augustin 
et al., 2003) this region, although present in the analyzed construct, has not been solved it is difficult to 
precisely define a specific role for Mat-Mu2.  
Even though there is no solved tail domain with tRNA complexed to the protein there is other 
experimental evidence that can be used to interpret our observations. For example, (i) in vitro studies 
have shown that the specificities of bacterial poly(A) polymerase and tRNA-NT can be altered by 
switching their C-terminal regions (Betat et al., 2010). (ii) The C-terminal sequences can block entry of 
tRNAs lacking a CC sequence into an enzyme that catalyzes only A-addition (Tretbar et al., 2011). (iii) The 
Drosophila melanogaster tRNA-NT lacking its last 124 amino acids still retains some activity (Yang, 2008) 
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suggesting that the tail portion of the protein carries out its functions without interacting directly with 
another region of the protein. (iv) Here, we show that altering the C-terminus of tRNA-NT by adding GFP 
does not inactivate the enzyme in vivo (Table 2.2, Fig. S2.7). Taken together these data suggest that the 
C-terminal region appears to define specificity, but plays no direct role in catalysis. However, our results 
from introducing mutations to modify or delete the C-terminal nine amino acids show that modifying 
this region of the protein does reduce enzyme activity to some degree (Fig. 2.3, Table 2.1). This indicates 
that the tail domain may play some role in enzyme function (Table 2.1). If we consider that these C-
terminal nine amino acids are exposed on the surface of the protein they may represent one of perhaps 
many early interaction sites for tRNA. After binding to this site the tRNA then may be subsequently 
moved into the body region of the protein such that it is ultimately displayed appropriately at the active 
site. This hypothesis would explain why there are fewer tRNAs associated with the Mat-Mu2 or Mat-Δ2 
variants during purification and would be consistent with the increased dissociation constant of Mat-
Mu2 for tRNA (Table 2.1, Fig. S2.6, Table S2.2). Replacing a positively charged region of the protein with 
a negatively charged region would reduce the ability of that portion of the protein to bind to tRNAs. 
While it might be argued that the change in KD is not biologically relevant as the KM’s for the native 
protein and the Mat-Mu2 variant remain the same (Table 2.1), which holds true for Mat-Δ2 as well 
(Table 2.1, Fig S2.6), it is interesting to note that the KD values for the Mat-Mu2 and Mat-Δ2 variants 
differ by about 10-fold (Fig. S2.6, Table 2.1). This suggests that the mutation and deletion of this region 
of the tRNA-NT affects tRNA binding differently. In addition, while our in vitro (Fig. 2.3) and in vivo 
studies (Fig. S2.7, Table 2.2) suggest that this region of the protein can be modified such that the 
enzyme retains activity, they also indicate that altering the C-terminal nine amino acids does reduce 
activity (Table 2.1). So while this region may represent an initial interaction site it also appears to affect 
the enzymatic process.  
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The proposed structural variations are further consistent with the thermostabilities of the tRNA-
NT variants (Fig. 2.4, Table 2.1). For the native enzyme we observed a two step unfolding at 43°C and 
82°C, respectively, suggesting that the first event is an unfolding to a molten globule state with larger β-
structure content (Greenfield and Fasman, 1969) while the second represents the complete unfolding of 
the protein. For the mutants, while the transition to the molten globule state was observed we never 
witnessed the fully unfolded state. The transition of the Mat-Mu1 variant to the molten globule state 
occurs at a lower temperature than seen for the native enzyme, while it was observed at a slightly 
higher temperature for the Mat-Mu2 variant. However, the alteration of the molten globule state 
characterized by helical content is consistent with the positioning of Mat-Mu1 and Mat-Mu2 in the C-
terminal region of the protein with primarily α-helical structure (Fig. 2.1A).  
Interestingly, the structural effects of the two mutations are not additive. On the one hand, the 
wavelength of fluorescence maximum is similar to the one observed for Mat-Mu2 variant (Table 2.1) 
and after treatment the Mat-Mu1/Mu2 variant shows a CD-spectrum comparable to that of the other 
variants (Fig. 2.2). On the other hand, the reduction of the fluorescence intensity of the Mat-Mu1/Mu2 
variant by RNaseA treatment is comparable to that of the native enzyme. This restoration of 
fluorescence may represent a more “native” folding pattern in the presence of RNA. Furthermore, the 
Mat-Mu1/Mu2 variant showed an intermediate melting temperature for the molten globule state 
suggesting an additive affect from the individual changes. How the two mutations restore this 
fluorescence intensity in the presence of tRNA is unclear.  
2.6.2 The import model for the tRNA nucleotidyltransferase  
 Here we analyzed the localization of tRNA-NT variants in a tomato leaf mesophyll protoplast 
system complementing the results presented in earlier studies using onion bulb scales (Schmidt von 
Braun et al., 2007). Such complementary analysis is important because i) chloroplast-containing tissues 
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have the advantage that plastid localization of GFP fusion-proteins can be unambiguously shown 
employing the chlorophyll autoflourescence as a plastidic marker. This alleviates any problems 
associated with misleading interpretation of the localization due to problems in distinguishing between 
mitochondrial and proplastid localization in the onion bulb system (Jaedicke et al., 2011). Furthermore, 
recent results indicate that dual localization of proteins can in some cases be tissue dependent 
(Kriechbaumer et al., 2012). The in vivo localization experiments reported here further document that 
the cellular distribution of the tRNA nucleotidyltransferase is dependent on the N-terminal signal 
sequence as well as on the mature domain (Fig. 2.5, Schmidt von Braun et al., 2007) regardless of the 
tissue type used. The first five amino acids of the N-terminal signal sequence appear to be required for 
efficient translocation into mitochondria since variants lacking the first start codon show less 
mitochondrial import (Table 2.3). This effect is again reflected by the fusions between the signal 
sequences and GFP or Titin-GFP (compare M(1,2) and M(1) to M(2) in Table 2.4). This observation is 
consistent with the data for the dual-targeted zinc-metalloprotease, Zn-MP, and the dual-targeted 
mitochondrial processing peptidase subunit alpha (MPP2), for which the domain at the very N-terminus 
of the signal sequence was shown to be required for mitochondrial targeting (Bhushan et al., 2003). 
Thus, it appears to be a general scheme that the N-terminus of the signal of dual-targeted proteins is a 
determinant for mitochondrial localization.  
Interestingly, either mutation in the mature domain reduces the localization to mitochondria 
and in turn enhances the translocation into chloroplasts (Table 2.3). Only the M(2)-tRNA-NT-Mat-Mu2-
GFP construct showed a reduced organellar localization in general accompanied by a shift towards a 
cytosolic localization (Table 2.3). Correlating these results to the data from the thermal unfolding 
experiments suggests that the folding state of the mature protein has a regulatory function in the 
distribution of the tRNA nucleotidyltransferase. In contrast to the native domain, the variant domains 
unfold to the molten globule state such that the β-strand portion of the amino-terminus plays a more 
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significant role in maintaining protein structure. This suggests a connection between the stability of the 
N-terminal portion of the protein and the reduced mitochondrial import of these variants. Consistent 
with this notion, the signals fused to GFP are able to drive translocation into mitochondria, while the 
fusion with the more tightly folded Titin shifts distribution to chloroplasts (Table 2.4).  
How can this observation be translated into a functional mode of preprotein translocation? The 
molten globule state has a significant enrichment in α-sheet content (Fig. 2.4) and β-strands are located 
in the N-terminal region of the tRNA-NT (Fig. 2.1). Thus, it is likely that the mutations at the C-terminus 
stabilize the N-terminal domain by an as yet unknown mechanism. This stabilization interferes with 
mitochondrial translocation, which is comparable to the impaired mitochondrial import of the dual 
targeted yeast fumarase after cytosolic folding, for which a co-translational mode was concluded (Sass 
et al., 2003). Our results suggest a similar model in which tRNA nucleotidyltransferase is imported into 
mitochondria prior to folding either in a co-translational mechanism or post-translationally in 
association with targeting factors that keep the protein unfolded. Folding in the cytosol blocks 
mitochondrial import and redirects the protein to the nucleus or chloroplasts. Nuclear import is 
generally achieved in a folded state (Grunwald and Singer, 2012), while the translocon of the chloroplast 
was shown to provide a strong mechanical pulling force sufficient to translocate the tightly folded Titin 
domain I27 (Bionda et al., 2010). The signal sequence of the tRNA nucleotidyltransferase is most likely 
exposed even in the correctly folded state of the mature domain (Fig. 2.1) which provides another hint 
that the protein can be imported into chloroplasts after cytosolic folding. This hypothesis would also 
explain the necessity of the very N-terminus of the signal sequence for efficient translocation into 
mitochondria. In this scheme, the mitochondrial targeting factors have to be recruited to the nascent 
precursor chain at an early state of translation in order to target the translating ribosome to 
mitochondria and/or to prevent folding in the cytosol.  
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This hypothesis is consistent with the mitochondrial import of the GFP marker protein and the 
rejection of the fast and tightly folding Titin-GFP domain (Fig. 2.6, Table 2.4). In contrast, import into 
chloroplasts was not affected by the nature of the mature domain (Table 2.4). This shows that the signal 
sequence alone is not sufficient for import into mitochondria and that the folding state of the domain 
following the signal drastically influences the localization of the protein. The signal for nuclear 
localization is conferred by characteristics of the mature domain since the fusion construct between GFP 
and the mature domain that lacked an N-terminal targeting signal was mainly found in the nucleus (Fig. 
2.5, M(3)-tRNA-NT-GFP). Increased nuclear localization of the fusion constructs between the signal 
sequences and GFP or Titin-GFP (Table 2.4) is most likely the result of passive diffusion into the nucleus 
as the size of both of these fusion proteins is below the selection cut off for nuclear entry. Even strictly 
plastidic transit peptides fused to Titin-GFP are found in the nucleus when chloroplast import is impaired 
(Schmidt von Braun et al., 2007, Grebenok et al., 1997). 
2. 7 Conclusions 
We have shown that Mat-Mu1 and Mat-Mu2 alter the structure and activity of Arabidopsis 
tRNA-NT although in different ways. Mat-Mu1 eliminates enzyme activity and alters how the tRNA is 
associated with the protein. In contrast, Mat-Mu2 retains enzyme activity and tRNA binding. In addition, 
our results suggest that the translocation mode between mitochondria and chloroplasts might be 
different. Here, the translocation into mitochondria requires largely unfolded proteins, while the 
preprotein can be folded before translocation into chloroplasts. This mechanism of dual targeting of 
tRNA nucleotidyltransferase appears to be conserved in plants because for all of the plant genomes 
analyzed only one gene coding for tRNA nucleotidyltransferase was identified (Table 2.5). The second 
isoform found in Arabidopsis lyrata (gi|297813035) is lacking a major portion of its C-terminal region 
and thus most likely does not represent a functional equivalent of the tRNA-NT. The concept proposed 
here for translocation might even hold true for most of the other phylogenetic clades as multiple genes 
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are only found in stramenopiles containing complex plastids. These plastids have a translocation path 
remarkably different from those of normal plastids (Bolte et al., 2009). Thus, we propose that tRNA 
nucleotidyltransferase, like fumarase, may represent a protein which requires coupling between 























2.8 Supplementary materials 
 
Figure S2.1 CLANS analysis of the identified tRNA-NT 
The data to date have suggested that in fungi, mammals or plants there is a single gene coding for tRNA-
NT (Chen et al., 1992, Reichert et al., 2001, Shanmugam et al., 1996). To confirm this notion, the massive 
data set of available genome sequences was examined. A database with all eukaryotic class II tRNA-NTs 
was generated from the nr-database, which includes tRNA-NTs and poly(A) polymerases from bacteria 
(Yue et al., 1996). In addition to existing pHMMs from the PFAM database, pHMMs based on alignments 
of the neck and the body/tail domains were created to enhance the sensitivity for eukaryotic sequences. 
Using these pHMMs 435 eukaryotic sequences, which match at least two profiles of different domains, 
were detected. With a clustering based on sequence similarity, 49 sequences, which belong to one 
cluster and share a high-sequence similarity with an experimentally proven poly(A) polymerase of A. 
thaliana (Zimmer et al., 2009), were excluded from the dataset, leaving 386 eukaryotic tRNA-NTs, which 
are shown as a CLANS representation. Subsequently, all sequences obtained from organisms whose 
entire genome sequences are not deposited in the NCBI genome database were removed to be certain 
that all paralogues of a species were included. In most species of Viridiplantae, metazoa and fungi only 
one paralogue was found (Table 2.5 of the main text). For exceptional cases, more detailed analysis was 
performed. Remarkably, among fungi five different organisms have two paralogues, namely 
Schizosaccharomyces japonicas, Schizosaccharomyces pombe, Penicillium marneffei, Fusarium 
oxysporum and Aspergillus nidulans. The same is true for the Amoebozoa Dictyostelium discoideum and 
the Metazoa Heterocephalus glaber . Interestingly, both stramenopiles Phaeodactylum tricornutum and 
Thalassiosira pseudonana , contain two different predicted tRNA-NTs. However, to the best of our 




Table S2.1: Oligonucleotides used in the present study 
 
 
Table S2.2: Absorption ratio (A280/A260) 
 





Figure S2.2 Secondary structure prediction of the Arabidopsis tRNA-NT 
(A) The structures of Thermotoga maritime [18], Geobacillus stearothermophilus (Li et al., 2002) and 
Aquifex aeolicus (Tomita et al., 2004) are shown and the sequence parts which align to the Mat-Mu1 
and Mat-Mu2 sequence of A. thaliana are indicated (dark blue). The regions corresponding to the Pfam 
pHMMs are shown in colours [red, PolyA_pol (PF01743); yellow, polyA_polRNAbd (PF12627); and blue, 
RNA_NucTran2_2 (PF01966)/HD (PF13735)]. Additionally the structural alignment generated with Sheba 
(Jung and Lee, 2000) is shown (upper right), visualizing that the conformational space of the body and 
tail domain is larger in the crystal than for the head and neck domain. The three structures were chosen 
based on the fold recognition results presented in Table S2.3. (B) Pairwise alignment generated by the 
HHpred server for atCCA and the corresponding hits. Positions which do not occur in our MSA are 
coloured grey, and positions supported by our MSA are coloured black. Motifs A–E (Toh et al., 2009) are 





Figure S2.3 Arabidopsis thaliana tRNA-NT and its heterologous expression 
(A) The amino acid sequence of the tRNA-NT from A. thaliana is given. (B) Coomassie-Blue-stained 
SDS/PAGE of supernatant (lane 1) and pellet (lane 2) after lysis of E. coli cells overexpressing tRNA-NT, as 
well as the GST column-purified protein before (lane 3) and after (lane 4) thrombin cleavage and 






Figure S2.4 tRNA is co-purified with the tRNA-NT 
(A) The absorption spectra of the proteins used in Figure 2.2 (A) of the main text. Spectra were recorded 
before (solid lines) and after (broken lines) RNaseA treatment. The untreated native sample was diluted 
2-fold before measuring absorbance. (B) The CD signal of 1 μM tRNA is shown. 
 
 
Figure S2.5 Fluorescence emission spectra for the native and variant tRNA-NTs 
Proteins were excited at the wavelengths indicated and the fluorescence emission was measured from 
310 to 400 nm. The lines represent native (red), Mat-Mu1 (green), Mat-Mu2 (blue) and Mu1/Mu2 




Figure S2.6 The binding of tRNA to native and variant tRNA-NTs 
(A) The quenching of native fluorescence by tRNA (solid line) was analysed by the addition of 0.1, 0.2, 
0.3, 0.4, 0.5, 1.0 and 1.7 μM tRNA (left). The fluorescence intensity at 346 nm was determined and (F 0 
−F )/F 0 plotted against the tRNA concentration (right). The data were analysed by least-square fit 
analysis to (F 0 −F )/F 0 = MAX×[tRNA]/(K d +[tRNA]), and the determined KD as well as the r2 value of the 
fit is indicated. (B) The quenching of the Mat-Mu1 variant fluorescence (solid line) by tRNA was 
determined by the addition of 0.1, 0.2, 0.3, 0.4, 0.5 and 0.8 μM tRNA (left). The fluorescence intensity at 
346 nm was determined and (F 0 −F )/F 0 plotted against the tRNA concentration (right). The data were 
analysed as in (A). (C) The quenching of the Mat-Mu2 variant fluorescence (solid line) by tRNA was 
determined by the addition of 0.1, 0.3, 0.5, 0.8 and 1.6 μM tRNA (left). The fluorescence intensity at 346 
nm was determined and (F 0 −F )/F 0 plotted against the tRNA concentration (right). The data were 
analysed as in (A). (D) The quenching of the Mat-_2 variant fluorescence (solid line) by tRNA was 
determined by the addition of 0.05, 0.15, 0.35, 0.8 and 1.3 μMtRNA (left). The fluorescence intensity at 
346 nm was determined and (F 0 −F )/F 0 plotted against the tRNA concentration (right). The data were  








Figure S2.7 Enzyme kinetics of the native version and the mutants of the C-terminus 
The rate of addition of adenosine monophosphate to a fixed amount of tRNA-NCC template (v 
[pmol/sec]) by the native tRNA-NT (top), Mat-Mu2 (middle) or Mat-_2 (bottom) variant was determined 
at different tRNA concentrations (tRNA [μM]; results shown as dots). The data were analysed by a least-
squares method using the equation for Michaelis–Menten kinetics, v = V max [S]/(K m +[S]), with the 




Figure S2.8 Ability of Arabidopsis tRNA-NT–GFP gene fusions to complement a CCA1 null mutation in 
yeast 
An S. cerevisiae strain bearing a null mutation in the chromosomal CCA1 gene and plasmid-borne CCA1 
and URA3 genes was transformed with the HIS3 -bearing G131-2 plasmid alone or G131-2 derivatives 
expressing Arabidopsis tRNA-NT–GFP native or variant fusions under the control of the TDH3 promoter. 
To accomplish loss of the URA3-CCA1 bearing plasmid, two independent His+ Ura+ transformants were 
patched on SC-ura-his medium, replica-plated to YPD (glucose) medium, incubated for 24 h, and replica-
plated to medium with or without FOA. The ability of FOA-resistant yeast to grow on different carbon 




Figure S2.9 Expression of the tRNA-NT fusion constructs in protoplasts 
Protoplasts were transformed with the indicated constructs as shown in Figures 5 and 6 of the main 
text. The protoplasts were harvested, subjected to SDS/PAGE and immunodecorated with antibodies 















Chapter 3: Exploring the interplay of localization, activity, structure and stability in Arabidopsis tRNA 
nucleotidyltransferase function. 
3.1 Preface 
The work presented in Chapter 3 corresponds to the following manuscript in preparation: 
Leibovitch M., Hanic-Joyce P.J., and Joyce P.B.M. (2016). Exploring the interplay of localization, activity, 
structure and stability in Arabidopsis tRNA nucleotidyltransferase function. Target journal: Biochemical 
Journal. Paul Joyce and Matthew Leibovitch designed the experiments and drafted the manuscript. 
Matthew Leibovitch carried out the biophysical and biochemical characterization. Pamela Hanic-Joyce 
carried out the yeast complementation assays shown in Figure 3.3. Localization studies in plants will be 
performed in the lab of Enrico Schleiff, Goethe Universität, Frankfurt.  
3.2 Abstract of manuscript 
The function of any protein is defined by a combination of its structure, stability, activity and 
localization. Here, the Arabidopsis tRNA nucleotidyltransferase enzyme which functions in the cytosol, 
mitochondrion, nucleus and plastid is studied to explore the interplay of all of these factors. Previously, 
a bipartite motif (Mat-Mu1) was identified and when changed, it altered the activity, stability and 
intracellular distribution of this enzyme (Leibovitch et al., 2013). Here, the combination of site-directed 
mutagenesis, spectroscopic techniques and enzyme activity assays were used to explore the roles of 
specific amino acids within this motif. The data show that keeping either half of this bipartite motif is 
sufficient to maintain enzyme structure and stability at near native levels.  While one half of the motif 
seems to play a role in structure the other appears more important in maintaining enzyme activity. 
Specific amino acids playing a role in activity have been identified. With this more defined analysis of 





A cell is a complicated place. Growth and viability are defined at a number of levels ranging from 
the genes that any cell contains, to how those genes are expressed, to how the resulting transcriptional 
products (RNAs) are utilized and processed and ultimately to which proteins may be produced. 
However, the story does not end there. The specific function of any protein in a cell is defined by a 
combination of factors including its stability, structure, activity and localization (Whisstock and Lesk, 
2003). For example, hemoglobin can perform its function as an oxygen transporter because it has a long 
half-life (Thom et al., 2013). In contrast, other proteins such as cyclins play a role in defining the cell 
cycle because they exist only transiently (Darzynkiewicz et al., 2015). Since the time of Anfinsen, it has 
been obvious that structure defines function and proteins may be activated or inactivated by changes in 
their structure, e.g., proteolytic activation of proteases such as trypsin or chymotrypsin (Nemoda and 
Sahin-Toth, 2006). Furthermore, altered protein structure as exemplified by protein misfolding has been 
implicated in a number of diseases, e.g., cystic fibrosis, Creutzfeldt-Jakob disease, Parkinson’s disease, 
Huntington’s disease, etc. (Ramirez-Alvarado, 2008). Moreover, proteins must be directed to their 
appropriate destinations to carry out their functions. For example, when mutations in the gene coding 
for α1-antitrypsin (which normally protects against the action of proteases) cause an alteration of its 
structure such that it is not released from cells, obstructive pulmonary disease and liver disease result 
(Wang et al., 2014). Finally, the function of certain proteins may be defined by multiple activities and 
these proteins may be directed to specific destinations to carry out these different activities. For 
example, Mod5p in yeast functions to modify tRNAs in the cytosol but acts as a transcriptional regulator 
in the nucleus (Smaldino et al., 2015) and enolase not only catalyzes one of the reactions of glycolysis in 
the cytosol but also is involved in the import of tRNA into yeast mitochondria (Entelis et al., 2006).  
Here, we study tRNA nucleotidyltransferase as a model protein to understand how structure, 
stability, activity and localization may interact in defining function. This enzyme post-transcriptionally 
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adds the 3’-terminal cytidine-cytidine-adenosine sequence (Deutscher and Evans, 1977) required for 
aminoacylation to tRNAs encoded in the nuclear, mitochondrial and plastid genomes (Abe et al., 2014). 
In addition, it plays a repair function in the cytosol (Rosset and Monier, 1965), may be involved in the 
stress response targeting tRNAs for rapid decay (Wilusz et al., 2011, Kuhn et al., 2015), may serve as a 
quality-control checkpoint for nuclear export of tRNAs (Lizano et al., 2008) and may be involved in 
nucleocytosolic shuttling of tRNAs (Feng and Hopper, 2002). A single gene coding for this enzyme exists 
in most eukaryotes (Leibovitch et al., 2013) such that the product(s) of this gene must function in 
multiple cellular locations. For example, in Arabidopsis this protein functions in the nucleus, cytosol, 
mitochondria and plastids (Schmidt von Braun et al., 2007). 
A traditional understanding of protein localization relies on the interplay of targeting signals 
contained on the protein of interest, trans-acting factors (which may or may not be specific components 
of the transport machinery) that recognize these signals and a transport complex at the appropriate 
membrane. Targeting signals may be primarily amino-terminal, e.g., endoplasmic reticulum, 
mitochondrion or plastid (Kunze and Berger, 2015), carboxy-terminal, e.g., peroxisomal (Emmanouilidis 
et al., 2015) or anywhere within the protein sequence, e.g., nuclear targeting signals (Christie et al., 
2015). These targeting signals may define specific primary sequences, e.g., stretches of basic amino 
acids (Kunze and Berger, 2015), secondary structures, e.g., amino terminal α-helices(Dudek et al., 2013), 
or higher order structures, e.g., nuclear localization signals (Cokol et al., 2000) that are recognized by 
the transport machinery. Proteins may be delivered directly to the membrane (co-translational 
transport) or may be targeted post-translationally (Kunze and Berger, 2015) with the assistance of 
chaperones, e.g., Hsp70 (Deshaies et al., 1988) or accessory factors, e.g., mitochondrial import 
stimulatory factor (Hachiya et al., 1993), or importins (Christie et al., 2015). Post-translational 
modifications, e.g., phosphorylation of a targeting signal (Bauer et al., 2015), or proteolytic processing of 
a transit peptide or protein may alter targeting (Bauer et al., 2015). Also, the presence or absence of a 
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targeting signal may be defined at the level of transcription or translation (Yogev et al., 2011, Schmidt 
von Braun et al., 2007). In addition, some proteins may contain more than one sorting signal such that 
there is a delicate balance to ensure that the appropriate amount of protein is targeting to the 
appropriate destination at the appropriate time (Kunze and Berger, 2015). 
We previously showed that multiple transcripts are generated from the single Arabidopsis gene 
coding for tRNA nucleotidyltransferase indicative of protein isoforms beginning from methionines one, 
six, or 69 of the tRNA nucleotidyltransferase open reading frame (Schmidt von Braun et al., 2007). We 
showed that the first 68 amino acids were not required for enzyme activity but were both necessary and 
sufficient for mitochondrial and plastid targeting. Proteins beginning from amino acid one were targeted 
more efficiently to mitochondria than were proteins beginning from amino acid six. Intriguingly, the 
presence of the mature domain of tRNA nucleotidyltransferase in addition to the amino-terminal 
targeting sequences shifted the localization of the reporter protein GFP toward mitochondria suggesting 
that some portion of the mature domain of tRNA nucleotidyltransferase also could affect targeting 
(Schmidt von Braun et al., 2007). To address this possibility, mutations were made in the mature domain 
of the protein and shown to shift distribution from mitochondria to plastids (Schmidt von Braun et al., 
2007). To address the role of the mature domain in protein targeting and to define the role of the amino 
acids that were changed, we explored the enzymatic and physicochemical properties of tRNA 
nucleotidyltransferase variants to correlate the properties of the enzyme with the intracellular 
distribution of the protein. Our results suggested that the folding capacity of the mature domain may 
influence organelle selection and that mitochondrial targeting is impeded with a more tightly folded 
protein (Leibovitch et al., 2013). These data suggest that tRNA nucleotidyltransferase is imported most 
efficiently into mitochondria prior to folding, either through a co-translational mechanism or post-
translationally in association with targeting factors that keep the protein unfolded. The fact that there 
was no apparent change in secondary or tertiary structure as measured by circular dichroism and 
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fluorescence spectroscopy, respectively, suggests that the variant folds similarly to the native enzyme in 
vitro. In addition, the variant enzyme showed a reduced transition temperature (10°C lower than native) 
and a loss of activity below the limits of detection with our standard enzyme assay (Leibovitch et al., 
2013). This suggests that there may be a combination of structure, stability and activity involved in 
defining the targeting of this protein.   
The purpose of this study is to explore in greater detail the role of the mature domain of 
Arabidopsis tRNA nucleotidyltransferase in protein targeting. This will be done by defining the role that 
specific amino acids (Fig. 3.1) may play in protein structure, stability and activity to dissect the 
contributions of these processes in localization. One could envision that amino acid substitutions would 
alter a region of primary sequence (such as a basic stretch of amino acids characteristic of a nuclear 
localization signal) that would disrupt interaction with a membrane receptor or accessory transport 
protein (Christie et al., 2015). Altering these amino acids also could change the higher order structure of 
the protein such that it is folded into a less import competent configuration, or it is no longer able to 
interact with a receptor or accessory protein. Finally, one could envision that protein transport is 
mediated through an enzyme/substrate (e.g.,tRNA-NT/tRNA in this case) complex and that these amino 
acid changes disrupt that complex.  
To address all of these possibilities, the structure, stability and activity of the native enzyme 
(399-KDTKGKSIPPVVNHIFKFSKRK-420), the Mat-Mu1 variant (399-eDTeGeSIPVVNHIFeFSMeme-420) 
(Leibovitch et al., 2013) and seven new variants: Mat-Mu1A (eDTeGe), Mat-Mu1B (eFSMeme), 
K414EK418E (eFSMeRK), K414E (eFSMKRK), K418E (KFSMeRK), K418Q (KFSMqRK) and K420E 





Figure 3.1: Model of A. thaliana tRNA nucleotidyltransferase 
(A) The homology model of Arabidopsis thaliana tRNA nucleotidyltransferase is show in ribbon 
representation with a tRNA substrate (from Aquifex aeolicus (1VFG,(Tomita et al., 2004)). The head (red) 
and neck (green) regions are conserved among Class II tRNA nucleotidyltransferases and contain 
conserved motifs A-E. Regions that are less well conserved are grey and include the carboxy-terminal 
portion of the enzyme which includes the body and tail. (B) The mature protein used in this study starts 
from the third in frame methionine (Met69) and the head and neck regions are shown in red and green, 
respectively. The region changed to produce Mat-Mu1, between amino acids 399 and 420, is depicted 
by the thin blue and the native sequence is shown below. After the amino acids have been changed, 
Mat-Mu1A (light blue) and Mat-Mu1B (dark blue) are shown. (C) The same colour scheme is used to 
show Mat-Mu1A and Mat-Mu1B (blue) on the homology model.  
 
Neither Mat-Mu1A nor Mat-Mu1B alone show any effect on thermal stability, however, Mat-
Mu1B does affect the catalytic efficiency of the enzyme. The K418E substitution in Mat-Mu1B increases 
Km by 20 fold for tRNA suggesting that Mat-Mu1B interacts with the tRNA substrate and is required for 
catalytic function. This is particularly interesting as little is known about the function of this region in the 
body domain of the enzyme as it shows a low level of sequence conservation (Li et al., 2002, Tomita et 
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al., 2004, Kuhn et al., 2015, Toh et al., 2009, Xiong and Steitz, 2004). In contrast, no major changes in 
structure, stability or activity were associated with Mat-Mu1A. However, a protein containing 
modifications in Mat-Mu1A showed fewer proteolytic fragments than the native enzyme suggesting that 
modification of this region resulted in a conformational change that altered access to proteolytic 
processing sites. Perhaps it is this conformational change that affects mitochondrial import. These data 
suggest that while changes in Mat-Mu1A may affect mitochondrial import either by altering the folding 
of tRNA nucleotidyltransferase or by disrupting interactions with other proteins in the cell, any role for 
Mat-Mu1B in protein targeting is more likely related to its role in substrate binding.   
 
3.4 Materials and Methods 
3.4.1 Plasmid construction 
A cDNA coding for the mature domain (starting at amino acid 69) of native Arabidopsis tRNA 
nucleotidyltransferase was cloned into a modified pGEX-2T expression plasmid (Shan et al., 2007) for 
expression in E. coli or into pG131-2 for expression in yeast. QuikchangeTM mutagenesis (Stratagene) was 
performed using templates and primers as previously described (Schmidt von Braun et al., 2007) and 











Table 3.1: Oligonucleotides used in present study 
Oligonucleotide         Primer sequence (5’ ----> 3’) 
     K414E F         GTCAACCACATTTTCGAATTCTCCATGAAGAGG 
     K414E R                 CCTCTTCATGGAGAATTCGAAAATGTGGTTGAC 
     K418E F         TTTAAATTCTCCATGGAGAGGAAGACC 
     K418E R         GGTCTTCCTCTCCATGGAGAATTTAAA 
     K418Q F         CCACATTTTTAAATTCAGCATGCAGAGGAAGACCAGT 
     K418Q R         ACTGGTCTTCCTCTGCATGCTGAATTTAAAAATGTGG 
     K420E F         CCATGAAGAGGGAGACTAGTGACGCTGAAAC 
     K420E R         GTTTCAGCGTCACTAGTCTCCCTCTTCATGG 
 
3.4.2 Plasmid shuffling 
Plasmids carrying the yeast HIS3 gene and expressing various tRNA nucleotidyltransferase GFP 
fusion proteins were transformed (Schiestl and Gietz, 1989) into strain SCDT8 (MATα leu2-3,112 trp1-1 
can1-100 ura3-1 ade2-1 his3-11,15 cca1::TRP1) bearing a derivative of pRS316 (Sikorski and Hieter, 
1989) containing the wild-type CCA1 gene of Saccharomyces cerevisiae.  Cells carrying both plasmids 
were selected on SC medium minus uracil and histidine (Sherman, 2002). For plasmid shuffling, patches 
of two representative transformants were replica-plated from synthetic complete medium minus uracil 
and histidine, to YPD medium (Sherman, 2002), incubated 1 day at 23°C, and then replica plated to 5-
FOA medium (Boeke et al., 1984) supplemented with 30 mg/l leucine, lysine and tyrosine and 20 mg/l 
adenine, histidine and tryptophan, with or without 5-FOA with incubation for 3 days at 23°C. FOA-





3.4.3 Expression and purification of tRNA nucleotidyltransferase 
A 5 ml overnight culture of E.coli BL21 (DE3) carrying the plasmid of interest was diluted in 1.3 l 
of YT + ampicillin (100 μg/ml) and placed on a shaker at 37⁰C and 225 rpm for 2-3 hours until an OD600 of 
0.4-0.6 was achieved. The cells then were induced with a final concentration of 0.02% w/v of D-lactose + 
0.5 mM IPTG and returned to the shaker at 19⁰C and 193 rpm for 16-20 hours. Cells from 2.6 l were 
pelleted by centrifugation at 4⁰C in a Beckman JA-10 rotor for 15 minutes at 6 000 rpm.  Cell pellets 
were stored at -80⁰C and frozen a minimum of 1 hour before use. Cell pellets were thawed on ice and 
resuspended in 2 ml/g cold lysis buffer (PBS + 1 mM EDTA) by vortexing. The cell suspension was passed 
through a French Pressure cell press (Thermospectonic) up to four times at 1 000 psi. The resulting cell 
lysate was centrifuged at 18 000 rpm in a Beckman JA-20 rotor for 30 min at 4°C. The supernatant was 
kept and centrifuged again as above. After centrifugation, the cleared lysate was cycled through a 10 cm 
Bio-Rad column containing 1-2 ml of glutathione Sepharose fast flow 4B resin (GE Healthcare or GoldBio) 
overnight at 4⁰C at a flow rate of 1 ml/min. The column subsequently was washed with 300-500 ml of 
PBS (pH 7.4) to eliminate non-specific binding and the protein of interest was eluted with 20 ml of 
elution buffer (15 mM reduced glutathione, 50 mM Tris-HCl (pH 8.3), 140 mM NaCl and 2.5 mM CaCl2). 
Fractions (1 ml) were collected and analyzed by SDS-PAGE and fractions containing the protein of 
interest were saved. The fractions were placed in an 8 kDa dialysis bag (SpectroPor) with 50 units of 
thrombin (GE Healthcare) with dialysis against 5 l of dialysis buffer (10 mM Tris, pH 8, 140 mM NaCl, 2.5 
mM CaCl2) overnight at 4⁰C to cleave the GST tag and eliminate glutathione. After dialysis the protein 
was passed through a freshly regenerated glutathione Sepharose column to remove GST and any 
protein retaining the GST tag. The eluted protein was dialyzed overnight against 5 l of PBS at 4⁰C in a 50 
kDa dialysis bag to reduce the level of thrombin. SDS-PAGE analysis was used to ensure that the GST was 
removed from the protein solution. The protein solution then was passed once more through the 
glutathione Sepharose column if needed to ensure purity. Glycerol was added to the protein solution to 
66 
 
a final concentration of 10% and the samples stored at -80⁰C. Routinely, protein concentrations were 
determined based on the predicted molecular mass (61 943 g mol-1) and extinction coefficient at 280 nm 
(71390 M-1cm-1) for Arabidopsis tRNA nucleotidyltransferase (Gasteiger, 2006). To ensure that all 
samples were free of RNA, RNaseA (Bioshop), was added to a concentration of 30 ng/ml and dialysis was 
repeated as above in PBS (pH 7.4). 
3.4.4 Biophysical characterization of tRNA nucleotidyltransferase 
3.4.4.1 Circular dichroism Spectroscopy 
Secondary structure determination was done using circular dichroism spectroscopy. A Jasco-815 
circular dichroism spectrophotometer along with the “Spectrum Measurement” program (Jasco) was 
used. The instrument was set to scan over the region from 200 nm to 280 nm using a 0.1 or 0.2 cm cell. 
At standard sensitivity, a bandwidth of 1 nm was used, along with a response time of 0.25 seconds, data 
pitch of 0.2 nm, and a scanning speed of 20 nm/min. Data were accumulated five times at 20⁰C using a 
Pelletier water bath accessory while nitrogen was set to flow through the instrument at a constant rate 
of 3 l/min. Protein (0.1-0.4 mg/ml) from freezer stocks was used for the spectrum measurements. All 
protein samples were RNaseA treated as described previously. Prior to taking measurements, samples 
were centrifuged at 14 000 g for 5 minutes at 4⁰C. The data obtained were smoothed using the 
smoothing function in the Spectra Analysis (Jasco) program. 
3.4.4.2 Thermal denaturation monitored by circular dichroism 
Thermal denaturation was monitored by circular dichroism spectroscopy using 0.1-0.5 mg/ml 
protein. The program used was “Variable Temperature” where the signal was monitored at 222 nm at 
standard sensitivity using a bandwidth of 1 nm, response time of 0.25 seconds, and a data pitch of 0.2⁰C. 
A temperature slope of 25⁰C/hour was used while the start and end temperatures were 25⁰C and 90⁰C. 
A 0.2 cm cell was used and was sealed to limit evaporation. Prior to taking measurements, samples were 
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centrifuged and prepared as described above (3.4.4.1). Data obtained were smoothed using the 
smoothing function in the Spectra Analysis (Jasco) program. 
3.4.4.3 Tryptophan fluorescence spectroscopy 
Tertiary structure determination was done by using fluorescence spectroscopy. The instrument 
used was a Varian Cary Eclipse Fluorescence Spectrophotometer along with a Varian single cell Pelletier 
Cary accessory (water bath). The application “Scan” was used to obtain emission spectra at room 
temperature averaged over 10 scans between 310 nm to 400 nm with an excitation wavelength of 280 
nm or 295 nm. Scan speed was set to medium (600 nm/min) with a 1.0 nm data sampling interval, 5 nm 
excitation and emission slit widths, and voltage was set to medium (600 volts). A 1.0 cm cell was used 
with aliquots of 1 ml at 1.2 μM of protein determined by OD280 for the spectrum measurements. Prior to 
taking measurements, samples were RNaseA treated, dialyzed, and centrifuged as described above. The 
data obtained were smoothed using the moving average smoothing function. 
3.4.4.4 Fluorescence quenching with baker's yeast tRNA 
Fluorescence quenching experiments were done to determine apparent dissociation constants 
for proteins using tRNA as a quenching agent. The instrument used was a Varian Cary Eclipse 
Fluorescence Spectrophotometer along with a Varian single cell Pelletier Cary accessory (water bath). 
The application “Scan” was used to obtain emission spectra at room temperature averaged over 10 
scans between 310 nm to 400 nm with an excitation wavelength of 295 nm. Scan speed was set to 
medium (600 nm/min) with a 1.0 nm data sampling interval, 5 nm excitation and emission slit widths, 
and voltage was set to medium (600 volts). Baker's yeast tRNA (Roche) was extensively purified by 
phenol extraction and ethanol precipitation. A volume of 1 ml of either 2.6 μM or 1.2 μM of protein was 
placed in a 1 cm cell and titrated by adding 0.1 μM or 0.2 μM of tRNA at room temperature. Ultraviolet 
visible spectral scans were taken between titrations to take into account any inner filter effect. 
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3.4.4.5 Proteolysis with chymotrypsin 
Bovine pancreatic α-chymotrypsin (Sigma-Aldrich) at a final concentration of 0.01 units/ml was 
used to digest approximately 40 μg of protein in 1ml PBS (pH 7.4) and 10% glycerol. The proteins were 
incubated at either 15°C or 25°C and 20 μl aliquots of the digests were removed at different time 
intervals and stopped by addition of SDS-loading dye (Sambrook et al., 2008) and boiling for five 
minutes. Samples were stored on ice and visualized by SDS 13% polyacrylamide gel electrophoresis. 
3.4.5 Enzyme activity assays 
3.4.5.1 Generation of radiolabelled transcripts 
The plasmids G73 and pmBsDCCA, both generous gifts from Dr. Alan Weiner (University of 
Washington), were originally constructed by Cho et al. (Cho et al., 2003) and Oh and Pace (Oh and Pace, 
1994), respectively and contain the Bacillus subtilis tRNAAsp gene modified to produce tRNAs with 
specific 3' ends through run-off transcription. Digesting plasmid G73 with FokI results in the linearized 
template used to generate a tRNA-N product. Similarly, restriction digestion of pmBsDCCA with FokI, 
BpiI or BstOI results in tRNA-NC, tRNA-NCC and tRNA-NCCA run-off products, respectively. 
Approximately 35 μg of plasmid DNA were digested with the appropriate restriction enzyme (12 U FokI, 
40U BpiI or 40U BstOI), phenol extracted and ethanol precipitated. Each 100 μl run-off transcription 
reaction contained 20 μL of 5X transcription buffer (Thermo Scientific), 5 nmoles ATP, 50 nmoles each of 
CTP, GTP and UTP (Thermo Scientific) and 50 μCi (~16 pmoles) [α-32P] ATP (10 μCi/μL, 3000 Ci/mmol) 
(Perkin-Elmer), ~5 μg of linearized DNA template, 60 units of T7 RNA polymerase (Thermo Scientific) and 
nuclease-free water and was incubated for 2-3 hours at 37⁰C. The products were phenol extracted, 
ethanol precipitated and gel purified via polyacrylamide gel electrophoresis. The concentration of each 
runoff transcription product was determined by scintillation counting (LKB WALLAC-1217 RackBeta 
liquid scintillation counter) using a standard curve. 
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3.4.5.2 Standard activity assays 
Each 10 μl standard assay mixture (Leibovitch et al., 2013) contained 100 mM glycine buffer (pH 
9), 10 mM MgCl2, 1 mM ATP, 0.4 mM CTP, 1 μl radiolabeled template, 0.4 μl RNAsecure (25X) 
(Invitrogen) and 100 ng of protein. When proteins showed dramatically reduced activity it was necessary 
to add more protein (as indicated). The assay mixtures were heated to 65°C for 10 minutes (to activate 
the RNAsecureTM reagent) and cooled prior to adding transcript and protein. Assays were initiated with 
the addition of protein and stopped with 10 μl of Peattie's (2X) loading dye (Peattie, 1979). Samples 
were heated to 70°C and cooled prior to loading onto a 50 cm X 30 cm 7M urea 12% polyacrylamide gel 
and electrophoresed for 7-8 hours at 2000 Volts. After electrophoresis the gel was placed against a 
phosphorImager screen (GE Healthcare) for at least 30 minutes, the screen was developed and the 
transcripts detected using the Typhoon™ TRIO Variable Mode Imager (GE Healthcare). 
3.4.5.3 Standard kinetic assays 
For kinetic analysis the standard assay as described in 3.4.5.2 was used except with 10-500 ng 
protein and increasing amounts of purified Baker's yeast tRNA (0.25 μg - 50 μg). Each assay tube 
contained enough reagent for six individual assays. At each time point, 10 μl of the assay mixture was 
removed and treated as described (section 3.4.5.2). The ratio of reactant to product (tRNA-NCC/tRNA-
NCCA or tRNA-NC/tRNA-NCC) was measured by densitometry and initial rates were determined for 
varied amounts of tRNA substrate. 
3.4.6 Homology modeling of Arabidopsis tRNA nucleotidyltransferase 
The homology model of Arabidopsis tRNA nucleotidyltransferase was derived from four 
available crystal structures of Class II tRNA nucleotidyltransferases: CCA-adding enzymes from 
Thermotoga maritima (Toh et al., 2009), Homo sapiens (Kuhn et al., 2015), Bacillus stearothermophilus 
(Li et al., 2002) and the A adding enzyme from Aquifex aeolicus (Tomita et al., 2004). Their PDB numbers 
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are 3H37, 4X4W, 1MIV and 1VFG, respectively. The primary and secondary structures of the above 
resolved crystals were aligned using MODELLER v.9.13 (Ben Webb). The homology model was generated 
using MODELLER (Ben Webb) incorporating the tRNA substrate from Aquifex aeolicus (1VFG) and both 
catalytic magnesium ions and ATP from Thermotoga maritima (3H37). The homology model with the 
lowest energy level was submitted to MolProbity server (http://molprobity.biochem.duke.edu/) where 
atom-contact and geometry were analyzed (191.51/1000 atom clashes) which was carried over from the 
available crystal structures. The final homology model  was aligned with PDB files 3H37, 1VFG, 4X4W 
and 1MIV using conserved Motifs A and D generating RMS values of < 0.710 using PyMol (Schrödinger).  
3.5 Results 
3.5.1 Activity of tRNA nucleotidyltransferase and variants 
Preliminary enzyme assays (Fig. 3.2) revealed activity for the native enzyme and no measurable 
activity for the Mat-Mu1 variant consistent with what we had seen previously (Leibovitch et al., 2013). 
In addition, these assays indicated that the Mat-Mu1A variant reduces activity only to a small degree 







Figure 3.2: Activity assays with A. thaliana tRNA nucleotidyltransferases 
The proteins indicated were incubated as described with a tRNA substrate for 2, 10, 30 or 60 minutes as 
indicated by numbers 1-4 respectively. The amount of enzyme used in each of the assays was 1 ng. The 
reaction products were separated by electrophoresis on 7 M urea/12% polyacrylamide gels and 
visualized using the Typhoon™ TRIO Variable Mode Imager. P is the active enzyme positive control (tRNA 
with a complete CCA sequence), N is the boiled enzyme negative control (original tRNA template lacking 
the CCA sequence).  
 
This is consistent with the in vivo data from yeast showing that the Mat-Mu1A variant is viable 
but the Mat-Mu1B variant is not (Fig. 3.3). To determine which portions of Mat-Mu1B are needed for 
activity, specific amino acids were changed. A loss of activity is observed for the K414EK418E double 
variant, and the K418E single variant (Fig. 3.2). In contrast, the K414E and K420E changes show only a 
minor loss of activity indicating that K418E plays the largest role in reducing enzyme activity. 
Interestingly, yeast cells expressing the cytosolic forms (starting from ATG3 and lacking the first 
68 amino acids) of any of these variants (K414EK418E, K418E, K414E or K420E) were viable (Fig. 3.3), 
however, when the same variants were expressed from ATG1 and contained the 68 amino acid amino-
terminal targeting signal, cells containing the K414EK418E and K418E variants showed limited growth on 
both fermentable (glucose) and non-fermentable (glycerol) carbon sources while cells containing the 
K414E and K420E variants showed growth on both carbon sources (Fig. 3.3). To further address the role 
of K418 in enzyme activity, a glutamine was introduced at this position and activity was retained (Fig. 
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3.2). As expected, cells expressing the K418Q variant (from ATG1 or ATG3) which retained a higher level 
of activity in vitro showed growth in vivo on both carbon sources (Fig. 3.3).   
 
 
Figure 3.3: Viability Yeast assays of A. thaliana tRNA nucleotidyltransferases 
An S. cerevisiae strain bearing a null mutation in the chromosomal CCA1 gene and plasmid-borne CCA1 
and URA3 genes was transformed with the HIS3 -bearing G131-2 plasmid alone or G131-2 derivatives 
expressing Arabidopsis tRNA-NT–GFP native or variant fusions under the control of the TDH3 promoter. 
To accomplish loss of the URA3-CCA1 bearing plasmid, two independent His+ Ura+ transformants were 
patched on SC-ura-his medium, replica-plated to YPD (glucose) medium, incubated for 24 h, and replica-
plated to medium with or without FOA. The ability of FOA-resistant yeast to grow on different carbon 




To determine which kinetic parameters were affected by these amino acid substitutions, kcat and 
KM values for AMP addition to tRNA lacking only the terminal AMP residue and for CMP and AMP 
addition to tRNA lacking the terminal CMP and AMP residues were determined. Using Michaelis-Menten 
kinetics as a model, we were able to determine apparent KM and kcat values using a fixed amount of 
radiolabelled tRNA template and increasing amounts of purified baker's yeast tRNA. Sample data for the 
native enzyme and the Mat-MU1, Mat-Mu1A and Mat-Mu1B variants are shown (Fig. 3.4). In agreement 
with the activity assays, the native and Mat-Mu1A enzymes show comparable KM values of 
approximately 500 μM for ATP, 50 μM for CTP and a turnover of 4 s-1 (Table. 3.2). There also is a small 
(approximately two-fold) increase in apparent KM for tRNA binding such that all of these data are 
consistent with the preliminary activity assays (Fig. 3.2) and what was observed in yeast (Fig. 3.3). In 
contrast, although the KM values for ATP and CTP are similar to the native enzyme for the Mat-Mu1B 
variant, there is a twenty fold increase in apparent KM for tRNA binding and a sixteen fold decrease in 
turnover number (Table. 3.2). These data reflect the in vivo viability (Fig. 3.3) and in vitro (Fig. 3.2) 
activity assays.  
The more detailed analysis of Mat-Mu1B shows that the K414E and K418Q variants demonstrate 
an approximately two-fold increase in KM as compared to the native enzyme while the K414EK418E 
double variant and the K418E and K420E single variants showed increases in KM's for tRNA of 
approximately four-fold, ten-fold and five-fold, respectively. In addition, while the K414EK418E, K414E 
and K418E variants showed decreases in kcat of approximately 20-fold, four-fold and five-fold, 
respectively, the K418Q variant shows no difference in kcat and the kcat for the K420E variant increases by 
50%. While these data are consistent with the decreases in activity seen in the preliminary in vitro 




Figure 3.4: Binding and kinetics of A. thaliana tRNA nucleotidyltransferases 
(A) The rate of addition of ATP to fixed amounts of tRNA-NCC template by a fixed amount of enzyme 
with increasing amounts of tRNA was determined and plotted. The data were analyzed by a least-
squares method using the equation for Michaelis–Menten kinetics, v =Vmax [S]/(Km+[S]), with the 
results shown as the line. (B)  The quenching of Mat-Mu1A or Mat-Mu1B fluorescence by tRNA (solid 
line) was analysed as previously described (Leibovitch et al., 2013). The data were analysed by least-
square fit analysis to (F0 −F )/F0 = MAX×[tRNA]/(KD+[tRNA]), and the determined KD as well as the r2 value 
of the fit is indicated for all proteins.  
 
Table 3.2: Binding and kinetics of tRNA nucleotidyltransferase enzymes 
Protein KD (μM) for tRNA 
KM (μM) 
tRNA 








Native 0.66 11 ± 3  4 ± 0.4  0.36 460 ± 68  48 ± 6  
Mat-Mu1A  0.91 24 ± 3  4 ± 0.3 0.17 510 ± 110  43 ± 7  
Mat-Mu1B  0.51 210 ± 47  0.25 ± 0.03  0.0012 750 ± 170  34 ± 5  
K414EK418E 0.67 42 ± 7  0.16 ± 0.01 0.0038 690 ± 200  51 ± 17  
K414E ND 27 ± 7  1.1 ± 0.2 0.041 1000 ± 350  19 ± 7  
K418E 0.18 120 ± 20  0.75 ± 0.05 0.0063 510 ± 180  27 ± 5  
K418Q ND 26 ± 7  4.3 ± 0.5 0.17 510 ± 180  35 ± 13  
K420E 0.3 49 ± 14  6.6 ± 1 0.14 470 ± 140  54 ± 17  






Fluorescence quenching experiments using baker’s yeast tRNA were performed for proteins 
with Mat-Mu1A or Mat-Mu1B to obtain apparent binding constants (KDapp) for tRNA of 0.91 μM and 0.51 
μM, respectively (Fig. 3.4, Table. 3.2). These values are in good agreement with the values previously 
obtained for the native (0.66 μM) and Mat-Mu1 (0.56 μM) variant (Leibovitch et al., 2013). 
3.5.2 Structure and stability 
Our previous studies showed that both the native and Mat-Mu1 enzymes showed comparable 
circular dichroism and fluorescence spectra revealing no significant changes in secondary or tertiary 
structure (Leibovitch et al., 2013). All variants tested here (Mat-Mu1A, Mat-Mu1B, K414EK418E, K414E, 
K418E, K418Q, K420E) showed comparable CD (Fig. 3.5) and fluorescence (Fig. 3.6) spectra with the 
native enzyme as expected. 
 
Figure 3.5: Secondary structure comparisons of A. thaliana tRNA nucleotidyltransferases 
The CD spectra of proteins purified from E. coli were recorded at 20°C. All samples were RNaseA treated 







Figure 3.6: Intrinsic fluorescence of A. thaliana tRNA nucleotidyltransferases 
Approximately 1.2 uM of each protein was excited at 295 nm and the fluorescence emission was 
monitored from 310 to 400 nm. All samples were RNaseA treated with extensive dialysis in PBS (pH 7.4) 
to remove RNA and glycerol. 
 
Circular dichroism spectroscopy also was used to assess thermal stability by monitoring the CD 
signal at 222 nm. Previously, it was demonstrated that the native enzyme undergoes a three state 
equilibrium with two transition states at 42°C and 80°C respectively and that the Mat-Mu1 variant 
displays an ambiguous two state equilibrium with a single transition state suggesting a difference in 
thermal stability between the two proteins (Leibovitch et al., 2013). Here, a closer look at the Mat-Mu1 
variant showed that it also undergoes a three state equilibrium (Fig. 3.7) with its first transition state at 
10°C lower than the native enzyme (Fig. 3.7) and its second transition state about 12°C lower than the 
native enzyme (Fig. 3.7). To see if there is any connection between thermal stability and loss of activity, 
the thermal stability was assessed for each of the new variants. Surprisingly, all of the new variants 
except for Mat-Mu1A show a clear three state equilibrium with two transition states (Fig. 3.7). The Tm 
at the first transition state in each case was near that of the native enzyme with the Mat-Mu1B variant 
showing the largest decrease of only 4.5°C (Fig. 3.7). Almost all of the new variants showed a second 
transition state at approximately 80°C like the native enzyme except for the Mat-Mu1B and K414EK418E 
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variants which showed a second transition state at similar temperatures as the Mat-Mu1 variant (Fig. 
3.7). 
Figure 3.7: Thermal unfolding of A. thaliana tRNA nucleotidyltransferases 
(A) Ellipticity at 222 nm was monitored between 25°C and 90°C for each of the protein samples 
illustrating a two or three state unfolding pattern for the enzymes. (B) Thermal denaturation of the first 
transition state was monitored as previously described. The fraction of protein unfolded was defined by 
the equation F = 1/ΔθT x θ - θi/ΔθT where F is the fraction of protein unfolded, θ is ellipticity measured 
in mdeg, and ΔθT is the total change in ellipticity between the initial and final temperatures of interest; 
ΔθT= θf -θi. θi is the ellipticity value at the start temperature of interest (25°C), and θf is the final 
ellipticity value at the end temperature of interest (50°C).  (C) Thermal denaturation of the second 
transition was monitored as previously described. Fraction of protein unfolded was defined by the 
equation in (B) except that the value at the starting temperature is 50°C and the final temperature is 
90°C.   
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To explore further whether any of the amino acid substitutions altered the structure of the 
protein limited proteolysis with chymotrypsin was used. While the native protein and Mat-Mu1B variant 
show similar cleavage products of 45 kDa, 40 kDa, 37 kDa, 33 kDa and 27 kDa after the first five minutes, 
Mat-Mu1A lacks the 27 kDa cleavage products (Fig. 3.8). 
 
Figure 3.8: Limited proteolysis of A. thaliana tRNA nucleotidyltransferases with α-chymotrypsin 
The native (A), Mat-Mu1A (B) and Mat-Mu1B (C) proteins were incubated with α-chymotrypsin in PBS 
(pH 7.4) and 10% glycerol at 15°C or 25°C and aliquots removed at the time points indicated. Lane 1 is 
the molecular weight ladder (Pierce unstained protein molecular weight marker 26610), Lane 2 is the 
protein sample prior to proteolysis and lanes 3-9 are protein samples after 5 minute, 15 minute, 30 




Any protein’s function is dependent on the interplay of its structure, stability, activity and 
localization. Here, a specific region of the Arabidopsis tRNA nucleotidyltransferase (amino acids 399-420 
in the body domain) is studied to understand how it affects structure, stability, and activity to explore 
how changes in this region alter localization. This protein functions in the nucleus, cytosol, mitochondria 
and plastids of plant cells and all isoforms are encoded by a single nuclear gene (Schmidt von Braun et 
al., 2007). Simply the presence of the mature domain of the protein has been shown to alter the 
targeting of a reporter protein (Schmidt von Braun et al., 2007) and amino acid substitutions in the 
mature domain of the protein far from the amino-terminal targeting signal likewise have been shown to 
shift distribution from mitochondria to plastids and the nucleocytosol (Leibovitch et al., 2013).  
Protein targeting is defined by a combination of factors ranging from the import competence 
and folding of the protein, e.g., proteins are transported co-translationally across the endoplasmic 
reticular membrane such that they only fold upon entry (reviewed by Leslie, 2005) to the targeting 
signals contained on the protein of interest (Lange et al., 2007, Kunze and Berger, 2015) to the transport 
machinery that must recognize these signals (Kimoto et al., 2015, Saitoh et al., 2007, Radons, 2016). 
Proteins must adopt an import competent structure (Bauer et al., 2015) and fold such that targeting 
signals are accessible and arranged in a specific manner to allow chaperones (Deshaies et al., 1988) 
and/or accessory proteins (Hachiya et al., 1993) and the import machinery to interact with them. 
Proteins targeted to multiple locations must have an even more complex arrangement of interactions 
(e.g., signal competition, splice variants, protease cleavage and co-translocation piggyback transport) to 
enable appropriate targeting to the appropriate destination (Porter et al., 2015). 
Two regions of the Arabidopsis thaliana tRNA nucleotidyltransferase showed primary sequence 
characteristics (stretches of basic amino acids) typical of nuclear localization signals (Cokol et al., 2000) 
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and were surface exposed based on modelling of the available related crystal structures suggesting that 
they might function as nuclear localization signals. Surprisingly, modifications in these regions of the 
protein: amino acids 399-420 in the body of the protein (Mat-Mu1) and amino acids 535-540 at the C-
terminus of the protein (Mat-Mu2) both affected targeting, but not as expected. In both cases, nuclear 
localization was actually improved when the positively charged amino acids in these positions were 
converted to negative charges (Leibovitch et al., 2013). Specifically, in proteins modified at Mat-Mu1 
and containing amino acids six to 68 of the amino-terminal targeting signal, protoplasts showing nuclear 
localization increased from 9% to 31% suggesting that this change increased nuclear localization. When 
the same protein starting from the first in frame start codon was used, the number of cells showing 
nuclear localization increased marginally from 3% to 5% and only when the second start codon was 
removed did nuclear localization decrease (dropping from 11% to 7% of protoplasts showing nuclear 
localization). In all of these cases, there was a decrease in mitochondrial targeting and a concomitant 
increase in plastid targeting (Leibovitch et al., 2013). These data suggested that the distribution of this 
protein was not simply defined by the presence of the amino-terminal targeting sequence and that the 
region of the protein containing Mat-Mu1 may play some role in protein localization. While the Mat-
Mu1 variant showed no detectable structural changes, it did show a reduced transition temperature 
(10⁰C lower than native) and a loss of activity below the limits of detection with the standard enzyme 
assay (Leibovitch et al., 2013). This suggested that there may be a role for protein folding/stability or 
activity (but seemingly not structure) in defining the localization of this protein. To further explore the 
roles of specific amino acids in the Mat-Mu1 region of tRNA nucleotidyltransferase in structure, stability, 
activity and localization, site-directed mutagenesis was used to introduce a number of discrete amino 





3.6.1 The roles of Mat-Mu1A and Mat-Mu1B 
In the Mat-Mu1 variant, each lysine in the stretch of amino acids from 399-420 was changed to 
a glutamic acid and the single arginine was converted to methionine resulting in two stretches of three 
negative charges separated by nine amino acids (Fig. 3.1). Here, this region was divided into two parts 
where one of these stretches of positively charged amino acids was changed to negative charges 
generating either Mat-Mu1A (amino acids 399-404, now containing three negative charges) or Mat-
Mu1B (amino acids 414-420, now containing three negative charges). Based on the model of Arabidopsis 
tRNA nucleotidyltransferase (Fig. 3.1), Mat-Mu1A and Mat-Mu1B are both surface exposed and are 
positioned on opposite faces of the protein. Mat-Mu1B is predicted to be located near the acceptor 
stem and TѰC stem and loop of the tRNA substrate while Mat-Mu1A is located on the other side of the 
protein away from the tRNA substrate (Fig. 3.1). This suggests that Mat-Mu1B may interact with the 
tRNA substrate such that changes here may alter the enzyme’s activity while Mat-Mu1A seems less 




Figure 3.9: Conservation and location of Mat-Mu1  
(A) Sequence alignment of the Arabidopsis Mat-Mu1B region based on modeling with the available 
crystal structures of Class II tRNA nucleotidyltransferases from Bacillus stearothermophilus, Aquifex 
aeolicus, Thermotoga maritima and Homo sapiens. In red are the amino acids most likely to interact 
with the phosphate backbone of the tRNA. (B) A close up of Mat-Mu1A (black) and Mat-Mu1B (blue) in 
the Arabidopsis homology model viewed in cartoon. The carbon backbone of the protein is green and 
the phosphate backbone of the tRNA is orange. (C) Overlay of the Arabidopsis model (green) with the 
crystal structures from Bacillus stearothermophilus (1MIW, teal), Aquifex aeolicus (1VFG, yellow), 
Thermotoga maritima (3H39, salmon) and Homo sapiens (4X4W, pink). 
 
The alignment of the Arabidopsis homology model with the Class II structures (Fig. 3.9) shows 
conservation of a loop and an alpha helix in the region of Mat-Mu1B among tRNA 
nucleotidyltransferases. In contrast, the Arabidopsis Mat-Mu1A region is found entirely in a flexible loop 






As expected from the model of the protein, changes in Mat-Mu1A, thought to be on the outside 
of the enzyme, had only minor effects on any of the kinetic parameters associated with enzyme activity 
(Table 3.2) suggesting that these mutations did not affect enzymatic activity. If these amino acids were 
not involved in enzyme activity, the question remains as to their role in protein function and how they 
may have altered protein localization. While the native enzyme and Mat-Mu1B protein showed similar 
products when subjected to limited proteolysis the Mat-Mu1A variant showed differences as compared 
to the native and Mat-Mu1B variant (Fig. 3.8). Specifically, the 27 kDa product was evident in both the 
native and Mat-Mu1B samples but was absent from the Mat-Mu1A sample (Fig. 3.8). This difference in 
profile suggests a conformational change in Mat-Mu1A that limited the accessibility of the protease to 
hydrophobic residue(s). These data are consistent with the earlier observation that the thermal 
denaturation profile for Mat-Mu1A differs from that of the native or Mat-Mu1B variant (Fig. 3.7) and 
agree well with what was originally observed with the Mat-Mu1 variant (Leibovitch et al., 2013). It is 
interesting that the Mat-Mu1A variant does not show a second transition in thermal denaturation. 
Based on FTIR experiments (data not shown), the first transition observed defines the complete 
unfolding of the protein into intermediate soluble aggregates therefore the second transition probably 
involves the unfolding of those intermediate aggregates. Even though the melting temperatures are 
comparable between the proteins (Fig 3.7), Mat-Mu1A does not appear to undergo a second transition 
suggesting that the Mat-Mu1A variant remains in a stable soluble aggregate state after the first 
transition. This again agrees well with what was observed previously for the Mat-Mu1 variant 
(Leibovitch et al., 2013). Taken together, all of these data implicate amino acid substitutions in Mat-
Mu1A as those responsible for the change in the protein that is responsible for the altered targeting. As 
was argued previously, this could suggest a more tightly folded protein which is favored for plastid 
rather than mitochondrial import (Leibovitch et al., 2013). Although these data support a structural 
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change in the protein as altering targeting, the possibility that changes in Mat-Mu1A change the 
interaction with trans-acting factors required for import either in the cytosol or at the mitochondrial or 
plastid membrane has not been eliminated. If protein import experiments show that targeting is altered 
in proteins bearing Mat-Mu1A alone then further experiments could be designed to explore this further. 
For example, specific point mutations could be introduced to see if the apparent change in structure 
remains linked to changes in targeting. If changes in sequence are not linked to changes in structure but 
localization is altered, then experiments will need to be undertaken to try to identify trans-acting factors 
that may interact with this region of the protein. The fact that the flexible loop containing Mat-Mu1A is 
not conserved in tRNA nucleotidyltransferases in general suggests that it is not important for function, 
however, its presence in plants may reflect a role in dual import between mitochondria and plastids 
such that it will only be seen in organisms where both organelles are present.  
Changing Mat-Mu1A did not block mitochondrial targeting in yeast as cells expressing this 
protein were viable both on glucose and glycerol and grew similarly to those expressing the native 
enzyme (Fig. 3.3) indicating that this sequence is not required for mitochondrial targeting at least in 
yeast, but perhaps only alters the protein’s folding to effect to some degree its mitochondrial targeting. 
In yeast, sufficient protein still enters the mitochondrion for the cells to remain viable. We have shown 
previously (Goring et al. 2013) that in yeast an enzyme expressing only about 4% of wild-type activity is 
sufficient for growth, so if only a portion of the Mat-Mu1A variant is entering the mitochondria it might 
be sufficient to show levels of growth comparable to those of the wild-type enzyme. In fact, reduced 
mitochondrial targeting might be favorable in yeast expressing this Arabidopsis protein as it contained 
the Arabidopsis amino-terminal targeting signal. Targeting all of the protein to the mitochondrion would 
not have allowed sufficient protein to stay in the nucleocytosol to keep the cells alive. Even altering the 
nucleocytosolic distribution of the yeast tRNA nucleotidyltransferase by targeting it to the nucleus 
resulted in reduced growth (Wolfe et al., 1996). The hypothesis that these changes in Mat-Mu1A result 
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in reduced mitochondrial targeting agrees well with what we saw in the Arabidopsis Mat-Mu1 variant 
and one could envision that if the protein was not being targeted efficiently to mitochondria, it could 
begin to accumulate in the cytosol and be directed to other locations, e.g., plastid and nucleus as our 
data showed (Leibovitch et al., 2013).   
3.6.1.2 Mat-Mu1B 
Based on the model that was generated (Fig. 3.1) Mat-Mu1B appears to be located near the 
tRNA binding region of the protein. An overlay of available crystal structures with the Arabidopsis 
homology model suggests that Mat-Mu1B is conserved and interacts with the tRNA substrate via serine, 
arginine or lysine residues in all proteins (Fig. 3.9). The kinetic data support this idea. The Mat-Mu1B 
variant shows large changes in both KM and kcat (Table. 3.2). In fact, most substitutions made in Mat-
Mu1B resulted in decreased catalytic efficiency (KM/kcat), particularly the single K418E substitution and 
the K414EK418E double mutant (Table. 3.2).  
The single lysine to glutamate substitution at position 418 shows native-like structure and 
thermostability suggesting that the drop in catalytic efficiency is a direct result of reduced substrate 
binding and not to a major change in the organization of active site residues. Further supporting this is 
the observation that the KM’s reported for both CTP and ATP do not change dramatically for any of the 
variants (Table. 3.2). As, ATP and CTP bind in motif D found between the head and the neck of the 
protein (Li et al., 2002, Cho et al., 2007) nearly 200 amino acids away from the region of interest, this 
suggests that the change at 418 is not transmitted through the protein as a structural change. The 
approximately 5-fold drop in kcat seen in the K418E variant likely results as the tRNA is oriented less 
precisely at the active site making catalysis less efficient. 
 These data suggest that K418 plays an important role in tRNA binding and catalysis but not in 
protein structure or stability. It was first proposed that the body and tail domains were involved in tRNA 
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binding (Li et al., 2002, Tomita et al., 2004) as crystal structures showed exclusive interactions between 
the phosphate backbone of the tRNA and the protein. Experimental evidence also showed that the C-
terminal portion of the enzyme must play an important role in catalysis as a deletion at the C-terminus 
abolished activity (Zhu and Deutscher, 1987). In addition, C-terminal domain swapping experiments 
between bacterial poly(A) polymerase and the tRNA nucleotidyltransferase showed that this region of 
the tRNA nucleotidyltransferase played an anchoring role to limit polymerization to three nucleotides 
(Betat et al., 2004). Our homology model of the Arabidopsis tRNA nucleotidyltransferase as compared to 
the available crystal structures suggests that Mat-Mu1B is near the tRNA and indicates that both K414 
and K418 directly interact with the sugar phosphate backbone of the tRNA (Fig. 3.10). Even though we 
cannot exclude the possibility of an interaction between the tRNA and residue K414, the 10 fold increase 
in KM suggests that of the residues in that motif, mainly K418 is interacting with the tRNA substrate. The 
model constructed shows a distance of 3.74 Å (Fig. 3.10) between K418 and the sugar phosphate 
backbone of the tRNA indicative of a medium to weak electrostatic interaction (Jeffrey, 1997). We 
suggest that the change at position 418 from lysine to glutamate not only eliminates this electrostatic 
interaction but actually introduces electrostatic repulsion to destabilize the tRNA:protein complex. This 
is similar to what was observed in the active site of the B. stearothermophilus tRNA 
nucleotidyltransferase for the binding of the nucleotide triphosphates in motif D. Changing the 
conserved arginine 157 to glutamate resulted in a dramatic decrease in catalytic efficiency (Cho et al., 
2007). To support the hypothesis that electrostatic repulsion between glutamate 418 and the phosphate 
backbone of the tRNA is responsible for the dramatic drop in tRNA binding and reduced catalytic 
activity, the lysine at position 418 was converted to glutamine. While the glutamine and the glutamate 
are approximately the same size, the glutamine lacks the negative charge. As predicted, the K418Q 
substitution restored activity to near native level and altered KM only two fold (Table. 3.2). Restoring the 
turnover number to native levels supports the idea that the negative charge could repel the tRNA such 
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that it was not aligned optimally at the active site. The change in KM back to the near native level further 
supports the role of the lysine at position 418 in tRNA binding.  
 
Figure 3.10: Model of A. thaliana tRNA nucleotidyltransferase depicting the amino acids in Mat-Mu1B  
(A) Amino acids 414-420 found in Mat-Mu1B (blue) are represented as sticks and are near the tRNA 
substrate (orange). (B)  A close up of a potential interaction between K418 and the sugar phosphate 
backbone of the tRNA substrate. The distance measured between K418 and the sugar phosphate 
backbone is shown in black 
 
It would be interesting to define the role of the lysine at position 420. When it is converted to 
glutamate the KM for tRNA increases by approximately four-fold but the turnover number increases by 
approximately 50% (Table. 3.2). As lysine 420 is positioned on the opposite face of the helix to lysine 
418, one could imagine that a modification at position 420 could reorient K418 thereby altering binding 
of the tRNA substrate as reflected by the four-fold increase in KM. However, if a glutamate at position 
418 pushes the tRNA substrate away from the active site such that the kcat is reduced, perhaps the 
K420E change moves the helix containing K418 such that the tRNA when bound is oriented more 
optimally in the active site thus increasing the reaction rate. This change does not alter any of the 
physicochemical properties of the protein so it is unclear as to how it increases catalytic activity. It 
would be of interest to see what affect the K418EK420E variant would have on activity. 
Although Mat-Mu1B residues seem to be involved in substrate binding, we cannot exclude that 
it may have a role in targeting that is related to substrate binding. For example in yeast, overproduction 
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of tRNA nucleotidyltransferase can suppress a defect in Los1p, the exportin used to transport tRNA from 
the nucleus to the cytosol, indicating that tRNA nucleotidyltransferase with tRNA bound can be 
efficiently exported from the nucleus (Feng and Hopper, 2002). When methotrexate is bound to 
dihydrofolate reductase, it folds into a conformation that makes it difficult to be imported into 
mitochondria (Vestweber and Schatz, 1988). Perhaps tRNA binding to tRNA nucleotidyltransferase 
makes the protein more (or less) import competent. Although this seems unlikely, this possibility could 
be addressed by in vitro import experiments in the presence and absence of added tRNA. It might also 
be possible to compare the protease sensitivity of the native and Mat-Mu1B variant tRNA 
nucleotidyltransferases in the presence and absence of tRNA. 
If the protein import experiments to be carried out in plants show that targeting is altered in 
proteins bearing Mat-Mu1B alone or in proteins with only the specific single amino acid substitutions, 
e.g., K418E, K420E, then this will suggest that this region is involved in targeting and in substrate 
binding. To determine if substrate binding can be separated from targeting, additional amino acid 
substitutions could be introduced in this region as a means to distinguish between the two processes. 
3.7 Conclusion 
These data suggest that the previously identified Mat-Mu1 sequence can be divided into two 
parts, Mat-Mu1A and Mat-Mu1B, which play roles in protein targeting and catalysis, respectively. 
Altering Mat-Mu1A causes a change in protein conformation such that it is imported less well into 
mitochondria (or more efficiently into plastids) while changes in Mat-Mu1B alter tRNA binding and 
catalysis. In fact, a single amino acid substitution K418E results in a 60-fold drop in the specificity 
constant suggesting an important role for this amino acid in enzyme activity. This provides some of the 
most detailed analysis of a region of tRNA nucleotidyltransferase where tRNA binds. Protein import 
experiments are required to confirm the hypothesis with respect to targeting. 
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Chapter 4: The ability of an arginine to tryptophan substitution in Saccharomyces cerevisiae 
tRNA nucleotidyltransferase to alleviate a temperature-sensitive phenotype suggests a role 
for motif C in active site organization  
4.1 Preface 
The work presented in Chapter 4 was publish in: Goring M. E., Leibovitch M., Gea-Mallorqui E., 
Karls S., Richard F., Hanic-Joyce P.J., and Joyce P.B.M. (2013). The ability of an arginine to tryptophan 
substitution in Saccharomyces cerevisiae tRNA nucleotidyltransferase to alleviate a temperature-
sensitive phenotype suggests a role for motif C in active site organization. Biochim Biophys Acta. 
1834(10):2097-2106. Paul Joyce designed the experiments and drafted the manuscript. Mark Goring and 
Matthew Leibovitch performed the biophysical and biochemical characterization, Pamela Hanic-Joyce 
performed the yeast studies, Shawn Karls and Francis Richard cloned and sequenced CCA1 genes from 
suppressor strains and Ester Gea-Mallorqui showed R64W suppresses the E189F temperature-sensitive 
phenotype. All authors contributed during manuscript preparation and approved the content. 
4.2 Abstract of Manuscript 
We report that the temperature-sensitive (ts) phenotype in Saccharomyces cerevisiae 
associated with a variant tRNA nucleotidyltransferase containing an amino acid substitution at position 
189 results from a reduced ability to incorporate AMP and CMP into tRNAs. We show that this defect 
can be compensated for by a second-site suppressor converting residue arginine 64 to tryptophan. The 
R64W substitution does not alter the structure or thermal stability of the enzyme dramatically but 
restores catalytic activity in vitro and suppresses the ts phenotype in vivo. R64 is found in motif A known 
to be involved in catalysis and nucleotide triphosphate binding while E189 lies within motif C previously 
thought only to connect the head and neck domains of the protein. Although mutagenesis experiments 
indicate that residues R64 and E189 do not interact directly, our data suggest a critical role for residue 
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E189 in enzyme structure and function. Both R64 and E189 may contribute to the organization of the 
catalytic domain of the enzyme. These results, along with overexpression and deletion analyses, show 
that the ts phenotype of cca1-E189F does not arise from thermal instability of the variant tRNA 
nucleotidyltransferase but instead from the inability of a partially active enzyme to support growth only 
at higher temperatures. 
4.3 Introduction 
All mature transfer RNA (tRNA) molecules contain an invariant cytidine-cytidine-adenosine (CCA) 
sequence at their 3’-ends that is required for amino acid attachment and protein synthesis. In many 
organisms this CCA sequence is not encoded by the tRNA genes so addition of CMP and AMP residues is 
catalyzed by the enzyme ATP(CTP):tRNA nucleotidyltransferase (EC 2.7.7.25). The CCA-adding enzyme 
has been the subject of considerable study because the stepwise addition of specific nucleotides occurs 
without a nucleic acid template (Betat et al., 2010, Vörtler and Mörl, 2010). CCA-adding enzymes belong 
to the nucleotidyltransferase (NT) superfamily (Holm and Sander, 1995, Aravind and Koonin, 1999) and 
share a similar structure with four domains (head, neck, body and tail indicated in Fig. 4.1A) of similar 
dimensions (Li et al., 2002, Augustin et al., 2003, Okabe et al., 2003, Xiong et al., 2003) and a conserved 
active site signature (Holm and Sander, 1995). Based on sequence similarity, the nucleotidyltransferase 
superfamily can be divided further into two classes (Yue et al., 1996). Class I enzymes (including the 
archaeal CCA-adding enzymes, eukaryotic poly (A) polymerases, DNA polymerase  and kanamycin 
nucleotidyltransferase) do not show significant overall similarity to each other outside of the shared 
active site signature. In contrast, class II enzymes (representing eubacterial and eukaryotic CCA-adding 
enzymes) share a conserved N-terminal region containing several conserved motifs (labeled A to E, Fig. 









Figure 4.1. Structure and sequence conservation of tRNA nucleotidyltransferase. Model of the overall 
structure of Saccharomyces cerevisiae tRNA nucleotidyltransferase showing the conserved head 
(purple), neck (green), body (cyano), and tail (sand) domains. E189 (red), R64 (blue), and the catalytic 
residues; Asp 81 (yellow) and Asp 83 (yellow), are also shown. Phyre2 intensive modelling was used to 
generate the model based on the known crystal structure of the Bacillus stearothermophilus tRNA 
nucleotidyltransferase (Li et al., 2002). (B) The head and neck regions of Saccharomyces cerevisiae tRNA 
nucleotidyltransferase modeled on the Bacillus stearothermophilus structure showing the positions of 
Arg 64 and Glu 189 relative to conserved motifs A (red), B (orange), C (yellow), D (green), and E (blue). 
The rest of the enzyme is colored sand.  Key residues are also shown including the catalytic aspartic 
acids 81 and 83.  Arg 71 and Asp 72 are part of the conserved GGxVRD sequence involved in binding the 
triphosphate motif of NTP substrates (Li et al., 2002). Phyre2 intensive modelling was used to generate 
the model. (C) ClustalW (Torres et al., 2010) alignment of the head and neck regions of tRNA 
nucleotidyltransferases. The yeast enzyme and four other class II tRNA nucleotidyltransferases (Aquifex 
aeolicus (Tomita et al., 2004), Thermotoga maritime (Toh et al., 2009), Bacillus stearothermophilus (Li et 
al., 2002), human (Augustin et al., 2003)) for which crystal structures have been solved are shown.  
Motifs A-E first identified in the Bacillus stearothermophilus enzyme (Li et al., 2002) are boxed and 
labeled.  Residues R64 and E189 in the yeast enzyme are in bold. (*) amino acid identity, (:) strongly 
conserved amino acid, (.) weakly conserved amino acid. 
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Examination of solved crystal structures (Augustin et al., 2003) and co-crystal structures of class 
II tRNA nucleotidyltransferases complexed with one (Li et al., 2002, Toh et al., 2009) or more (Tomita et 
al., 2004, Tomita et al., 2006) substrates revealed roles for residues in these conserved motifs.  Motif A 
(found in all nucleotidyltransferases) includes a highly conserved GGxVRD sequence (where x is any 
amino acid) and the two metal-binding carboxylates, DxD, involved in catalysis and the binding of 
incoming nucleotide triphosphates (Li et al., 2002, Betat et al., 2010, Steitz, 1998). This conserved motif 
is found as part of a consensus five-stranded antiparallel β-sheet flanked by two α-helices common to all 
tRNA nucleotidyltransferases (Li et al., 2002, Augustin et al., 2003, Okabe et al., 2003). Motif B plays a 
critical role in ribose recognition with the conserved RRD sequence recognizing the 2’ hydroxyl group of 
the ribose in each incoming ribonucleotide triphosphate (Li et al., 2002, Cho et al., 2007).  Motif A and 
motif B are separated by a sequence which may contain a highly flexible loop that is important in the 
addition of the terminal A residue but not in the addition of the two C residues (Just et al., 2008, 
Neuenfeldt et al., 2008). Motif C, found at the C-terminal end of the head domain, shows little sequence 
conservation and is thought to act only as a connection between the head and neck domains of the 
protein (Li et al., 2002). Motif D in the neck domain, contains the conserved EDxxR sequence which acts 
as an amino-acid based template for CCA addition by forming the nucleotide binding pocket for each 
incoming CTP or ATP, while discriminating against GTP and UTP through the generation of specific 
Watson-Crick-like hydrogen bonds with the incoming nucleotides (Li et al., 2002, Cho et al., 2007, Xiong 
and Steitz, 2006, Lizano et al., 2008). Motif E may help to stabilize a helix-turn structure in motif D (Li et 
al., 2002) and/or interact with the growing 3’ end of the tRNA substrate (Cho et al., 2007).  In contrast to 
the conserved N-terminal region, sequences of the C-terminal portion of Class II enzymes bear little 
sequence conservation and are thought to be involved in RNA substrate selection through interactions 
with the T stem and loop (Tomita et al., 2004, Betat et al., 2004).  As first demonstrated in Aquifex 
aeolicus (Tomita and Weiner, 2001) certain bacteria accomplish CCA addition by using two tRNA 
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nucleotidyltransferases with partial activity, a CC-adding enzyme and an A-adding enzyme.  Recently, 
Tretbar et al., (2011) demonstrated that a deletion in the C-terminal region of an A-adding enzyme 
conferred CCA-adding activity and proposed that the C-terminal region acts to physically constrain and 
position the tRNA substrate. 
In Saccharomyces cerevisiae there is a single gene, CCA1, coding for tRNA 
nucleotidyltransferase.  The essential role for this gene was demonstrated by Aebi et al., (1990) who 
isolated a temperature-sensitive (ts) allele, ts352.  When cells bearing this mutation are shifted to the 
non-permissive temperature of 37oC there is an abrupt cessation of protein synthesis attributed to a 
reduction in the pool of functional tRNAs (Peltz et al., 1992).  We (Shan et al., 2008) previously 
determined that the ts352 mutation results from a glutamate to lysine substitution at position 189 
(E189K), which is located in motif C (Fig. 4.1).  Based on the available crystal structures of other class II 
tRNA nucleotidyltransferases, E189 is predicted to be near the end of a β-strand such that it could 
interact with the adjacent α-helix to support a β-turn near the junction of the head and neck domains.  
We also studied the effect of the E189K substitution and showed reduced activity at both the permissive 
and non-permissive temperatures in vitro and a 6oC reduction in melting temperature as measured by 
circular dichroism spectroscopy (Shan et al., 2008).  Studies of additional E189 variants (E189F, E189Q, 
E189H) revealed a range of structural and catalytic effects in vitro and a variety of growth phenotypes. 
The E189F variant was similar to E189K and showed reduced activity (approximately 25 fold less than 
native enzyme) and thermal stability and both mutants exhibited a temperature-sensitive phenotype.  
The E189Q variant showed a 2.5-fold drop in activity, no change in thermal stability in vitro and mutants 
exhibited a 75% reduction in growth rate at 37oC.  The most interesting variant, E189H, exhibited no 
detectible change in thermal stability but showed a 13-fold reduction in activity and conferred a 
temperature-sensitive phenotype.  This result did not support the classical notion that the temperature-
sensitive phenotype was caused by thermolability of the gene product (Tan et al., 2009, Poultney et al., 
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2011).  Taken together these results suggested that the size of the residue at position 189 was important 
to enzyme activity and that larger residues were deleterious.  Therefore, we (Shan et al., 2008) proposed 
that the E189F substitution altered the organization of the head and neck domains generally by 
disrupting (through lost hydrogen-bonding potential or through steric hindrance) a turn connecting a β-
strand and an α-helix in the region of the yeast enzyme corresponding to motif C in the Bacillus 
stearothermophilus enzyme (Li et al., 2002).  Motif C is a region with little sequence conservation and is 
thought to provide only a linking role in the organization of the head and neck regions of tRNA 
nucleotidyltransferase.  However, given the important catalytic residues in the head and neck regions of 
the protein it would not be surprising if altering the local arrangement of this region could affect enzyme 
activity. How the E189F substitution affected interactions with any or all of the tRNA 
nucleotidyltransferase substrates, i.e., tRNA, CTP, or ATP remains largely unexplored.  Moreover, the 
wide range of effects conferred by E189 substitutions did not distinguish between whether the 
temperature-sensitive phenotypes were caused by reduced thermal stability of the variant proteins or 
by partial defects in enzyme activity which only affected growth at higher temperatures. 
To further address the role of glutamate 189 in yeast tRNA nucleotidyltransferase structure and 
function and to investigate whether defects in thermal stability or activity or both were responsible for 
the temperature-sensitive phenotype, we used UV mutagenesis to generate an intragenic suppressor 
(cca1-E189F,R64W) of the rarely reverting cca1-E189F allele.  By comparing the sequence of the yeast 
enzyme to that of the Bacillus stearothermophilus protein for which a crystal structure is available (Li et 
al., 2002), we suggest that R64 of the yeast enzyme is found in a position corresponding to the end of a 
β-strand at the start of motif A (Fig. 4.1B, C).  While the R64W substitution alone does not affect enzyme 
activity or stability, it restores the E189F protein to an active conformation without restoring thermal 
stability, suggesting an important structural association between residue 64 in motif A and residue E189 
in motif C. The protein encoded by the cca1-E189F,R64W allele retains the reduced melting temperature 
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exhibited by the cca1-E189F variant but shows increased activity at the permissive temperature 
suggesting that it is the reduced activity of the cca1-E189F variant and not its altered stability that 
confers temperature-sensitivity. We also show that the temperature-sensitive phenotype can be 
suppressed in vivo by overexpressing the cca1-E189F variant from a heterologous promoter and that 
diploids bearing the cca1-E189K mutation in trans to a cca1 null allele exhibit more extreme heat 
sensitivity than cca1-E189K/cca1-E189K diploids.  We conclude that although the cca1-E189F mutation 
produces a classical temperature-sensitive phenotype, this mutation is actually hypomorphic and 
renders the gene product partially inactive at all temperatures.  This reduction in enzyme activity, 
however, is deleterious only at the high temperature. 
4.4 Materials and Methods 
4.4.1 Strains 
Yeast strains 352-1A, E189F, NT33-5, YPH500, BY4743 are as described (Aebi et al., 1990, Shan et 
al., 2008, Shanmugam et al., 1996, Brachmann et al., 1998), respectively.  Strain SCDT8 (MATα 
cca1::TRP1 leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15) is a derivative of W303-1B (R. 
Rothstein) and carries a pRS316 derivative containing CCA1 and URA3 genes.  Yeast strain NT1-34 (MATa 
ura3 leu2-3,112 lys2 his3 ade2 cca1-E189K) was a product of a cross between W303-1A (R. Rothstein) 
and 352-1A.  Diploid yeast strains (relevant genotypes cca1-E189K/cca1-E189K and cca1-
E189K/cca1::TRP1 are the results of matings between haploid strains (NT1-34 with NT33-5 and NT1-34 
with SCDT8, respectively) with selection of diploids on SC medium minus Lys and Trp.  Diploidy was 
confirmed by formation of asci on sporulation medium.  E.coli strains XL2-Blue and BL21 (DE3) were 





4.4.2 Plasmid Construction   
Standard molecular biology techniques were employed throughout (Ausubel, 1989).  The open 
reading frame (ORF) of the CCA1 gene was amplified by polymerase chain reaction using primers 
MUTCCA5-4 and MUTCCA3 (Table 4.1) and digested with BamHI and SalI for insertion into a modified 
pGEX-2T (GE Healthcare) vector (Shan et al., 2008) for expression in E. coli.  Plasmid A163-2 was 
constructed by transferring the SacI-KpnI expression cassette of p415-ADH (Mumberg et al., 1995) into 
SacI-KpnI digested pRS316 (Sikorski and Hieter, 1989).  Plasmid SCR9-1 containing the 5’-noncoding 
region and ORF of CCA1 fused to the CYC terminator was constructed as follows: oligonucleotides 
SCCAPR5 and SCCAAM3 (Table 4.1) and Pfu polymerase were used to amplify the target region from the 
genomic DNA of strain BY4743.  The PCR product was digested with SacI and SalI and inserted into 
similarly digested pA163-2.  For expression of Cca1p from the TDH3 or ADH1 promoters, 
oligonucleotides SCCCA1GFPATG3 and SCCAAM3 (Table 4.1) were used to amplify the CCA1 open 
reading frame without the mitochondrial targeting signal from template SCR9-1.  The PCR product was 
digest with BamHI and SalI and ligated to similarly digested p426GPD (Mumberg et al., 1995) or A163-2.  
Plasmid SCR9-1 was used as template in QuikChangeTM (Stratagene) site-directed mutagenesis reactions 
utilizing Pfu polymerase.  Oligonucleotide pairs are listed in Table 4.1.  Oligonucleotides were purchased 
from Biocorp Inc. (Montreal, QC).  All plasmid constructs were confirmed by sequence analysis (McGill 
University and Génome Québec Innovation Centre). 
4.4.3 UV mutagenesis 
Strain E189F (Shan et al., 2008) was chosen for UV mutagenesis as it is less likely to revert than 
strain E189K (with the sequence AAA at codon 189).  Moreover, any single point mutation at the 
phenylalanine codon 189 (TTT) is likely (seven out of nine possible substitutions) to result in the 
introduction of another large hydrophobic amino acid, which, based on our previously-proposed size-
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constraint model (Shan et al., 2008), would result in loss of enzyme activity and thereby further 
decrease the possibility of isolating revertants.  UV mutagenesis was a modification of(Lawrence, (1991).  
In brief, cells were exposed to 50 J/m2 UV light (254 nm) in 0.9% phosphate buffered saline with a 
Stratalinker® UV Crosslinker Model 1800 (Stratagene), pelleted by centrifugation, resuspended in 100 μl 
phosphate buffered saline, and spread onto YPD plates.  All manipulations were carried out under dim 
red light.  The plates then were incubated in the dark at 37oC.  Temperature-resistant colonies were 
patched onto YPD, incubated at room temperature, and replica plated to 37oC to confirm loss of the 
temperature-sensitive phenotype. 
4.4.4 Growth assays 
Transformation of yeast strain E189F (Shan et al., 2008) was by the method of Schiestl and 
Gietz, (1989) with selection on synthetic complete medium lacking uracil (Sherman, 2002) at 22oC.  Two 
independent transformants were replica-plated to the same medium and incubated at 22oC or 37oC to 
assess temperature sensitivity.  







R64W3  CCGCCCGTGATCCAAAGAGTCAATGGTTCAGGCTTATTGTGGTAC 
R64E5  CCTGAGCCATTGACTCTCGAGATCACGGGCGGATGGG 
R64E3 CCCATCCGCCCGTGATCTCGAGAGTCAATGGCTCAGG 
SCQCE189R5  CATTCATAAAGGTGAAGTACGAGATTTCACCAAGAGAGG 




MUTCCA5-4  ACTAGTGGATCCATGACGAA 
MUTCCA3 ATCGATGTCGACTACTACAG  
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4.4.5 Heterologous protein expression and purification 
The procedure was modified from that of Shan et al. (2008) with minor modifications.  Protein 
expression was induced in 1.3 l of E. coli BL21 (DE3) cells by adding IPTG to a final concentration of 0.5 
mM or 1 mM with growth at 18°C for 16-20 hours.  After lysis and centrifugation, the cleared lysate was 
loaded onto a Glutathione Fast Flow 4B (GE Healthcare) column and the GST-tagged protein eluted using 
elution/cleavage buffer (50 mM Tris-HCl, 140 mM NaCl, 15 mM glutathione, 2.5 mM CaCl2, pH 8.0).  
Cleavage by thrombin (Amersham Biosciences, 1 unit/g protein) was carried out overnight at 4°C with 
dialysis against Tris-HCl/NaCl buffer (50 mM Tris-HCl, 140 mM NaCl, pH 8.0).  After cleavage had been 
verified, additional dialyses were used to remove the glutathione and GST tag and to change the buffer 
to PBS (pH 7.3).  The samples then were loaded again onto the Glutathione Fast Flow 4B column to 
remove any remaining GST tag and glycerol was added to the pooled proteins to a final concentration of 
10% (v/v) before storage at -80°C.  
4.4.6 Enzyme Assays 
Plasmids G73 and pmBSDCCA were constructed by Cho et al. (2002) and Oh and Pace (1994) 
respectively and generously provided by Dr. Alan Weiner (University of Washington).  By digesting with 
the appropriate restriction enzymes, these plasmids generated templates ending in the discriminator 
base (N), the antepenultimate base (C), the penultimate base (C) or the 3’ terminal base (A) of a tRNA 
with a complete CCA sequence.  Each run-off transcription reaction (100 μl) contained 20 μl of 5x 
transcription buffer (Fermentas), 5 μl of 10 mM UTP, 5 μl of 10 mM CTP, 5 μl of 10 mM ATP, 5 μl of 1 
mM GTP, 50 μCi [α32P] GTP (10 μCi/μl, 3000 Ci/mmol, Perkin Elmer), at least 1 μg of linearized DNA 
template, 60 units of T7 RNA polymerase (Fermentas) and RNase-free water.  After incubation at 37°C 
for 3 hours, each reaction was phenol extracted, ethanol precipitated and resuspended in nuclease-free 
water for purification after electrophoresis and exercised from a 7M urea, 20% acrylamide gel.  Enzyme 
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assays were modified from Cudny et al., (1978) with each 10 μl reaction mixture containing 100 mM 
glycine buffer (pH 9), 10 mM MgCl2, 1 mM ATP, 0.4 mM CTP, 1 μl of the appropriate [α-32P] GTP-labelled 
transcript after gel extraction, and the quantity of enzyme indicated.  Standard assays were performed 
for 2 minutes at 22oC and 37 oC.  Reactions were terminated by adding 10 μl of 2X loading buffer 
containing 7M urea (Peattie 1979) with heating at 70oC for 10 min and the reaction products 
characterized after electrophoresis on 7M urea/20% polyacrylamide gels with detection by 
autoradiography or using the Typhoon™ TRIO Variable Mode Imager (GE Healthcare). 
4.4.7 Circular Dichroism Spectroscopy 
Circular dichroism studies were performed on all proteins, in the 200-280 nm far-UV region, at 
22°C using a JASCO 815 spectropolarimeter.  A Jasco-815 circular dichroism spectrophotometer along 
with the Variable Temperature program (Jasco) was used to measure CD signals.  At standard sensitivity, 
a bandwidth of 1 nm was used, along with a response time of 0.25 seconds, data pitch of 0.2 nm and a 
0.2 cm cell.  Temperature was regulated using a Pelletier water bath accessory while nitrogen was set to 
flow through the instrument at a constant rate of 3 l/min.  Aliquots of 0.5 ml at 0.85 μM (0.061 mg/ml) 
of protein were used for the measurements.  For scans a scan speed of 20 nm/min was used.  Five 
accumulations were collected.  The 1 x PBS buffer (pH 7.3) was scanned under identical conditions in 
order to establish the base line and was subtracted from each spectrum in order to reveal the protein 
spectrum alone.  For thermal experiments a temperature slope of 30°C/hour was used.  The cell was 
stoppered to limit evaporation.  The data obtained were smoothed using the smoothing function in the 







4.5.1 Identification of a mutation in the CCA1 gene that suppresses the temperature-sensitive 
phenotype 
To isolate suppressors of the temperature-sensitive cca1-E189F mutation, cells were UV 
irradiated (54-60% cell survival) to generate cells which could grow at the non-permissive temperature 
(37oC).  Of the cells that grew at the non-permissive temperature (0.0003%), the CCA1 open reading 
frame was amplified by polymerase chain reaction and the products were sequenced.  Multiple clones 
(approximately 25%) showed, alone or in combination with another mutation, the same CGG to TGG 
transition resulting in an arginine to tryptophan substitution at position 64 in the gene product.  To 
confirm that this single mutation was sufficient to suppress the temperature-sensitive phenotype, this 
nucleotide change was introduced by site-directed mutagenesis into the cca1-E189F allele on plasmid 





Figure 4.2. Growth of yeast expressing native and variant tRNA nucleotidyltransferases. Yeast strain 
E189F was transformed with plasmids coding for the tRNA nucleotidyltransferase proteins indicated and 
two independent transformants were replica-plated to SC medium lacking uracil and incubated at 22oC 
or 37oC to assess temperature sensitivity. 
 
4.5.2 Effect of the R64W substitution on tRNA nucleotidyltransferase activity  
Native and variant proteins were produced in E. coli as GST fusion proteins, the GST-tags 
removed and the proteins purified to near homogeneity (Fig. S4.1). As the cca1-E189F,R64W mutant 
was able to grow at the non-permissive temperature, we expected to see an increased level of enzyme 
activity as compared to the cca1-E189F mutant.  Indeed, when provided with a template lacking the CCA 
sequence, the cca1-E189F,R64W mutant showed enzyme activity near native levels at both the 
permissive and non-permissive temperatures with reduced efficiency in incorporation of AMP at the 
third position (Fig. 4.3A).  In contrast, the cca1-E189F variant showed reduced activity with little or no 
full extension at both the permissive and non-permissive temperatures within 30 min incubation period 




Figure 4.3. Nucleotide addition by tRNA nucleotidyltransferase variants. (A) The enzymes indicated (5 
ng) were incubated with a tRNA template ending at the discriminator base for 2 or 30 min at the 
temperatures shown and the products separated by polyacrylamide gel electrophoresis. P, positive 
control (active enzyme generating a product containing a complete CCA sequence), N, negative control 
(boiled enzyme leaving a product lacking the CCA sequence). (B) The enzymes (2 ng) indicated were 
incubated for 2 or 30 min at the temperatures shown and the products separated by polyacrylamide gel 
electrophoresis. Controls as in panel A. (C) The reactions were carried out to completion at 22oC with 
the tRNA template ending at the discriminator base and the nucleotides indicated and the products 
separated by polyacrylamide gel electrophoresis. Controls as in panel A. 
did not eliminate enzyme activity indicating that an arginine to tryptophan substitution at position 64 
does not dramatically affect enzyme activity.  These data also confirm the observation that, with 
increased exposure to 37oC, the activity of the native enzyme is reduced in vitro (Shan et al., 2008).  To 
address differences in AMP incorporation observed at the third position we repeated the reactions using 
a template lacking only the terminal adenosine (Fig. 4.3B).  Supporting what we already had observed, 
we noted that at the permissive temperature the E189F variant added AMP inefficiently, while the 
R64W and R64WE189F variants showed an intermediate level of ATP incorporation as compared to the 
native enzyme (Fig. 4.3B).  When the reactions were performed at 37oC the native enzyme added AMP 
efficiently, while the E189F variant again was unable to add to the third position and the R64W and 
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R64WE189F variants showed an intermediate level of incorporation (Fig. 4.3B).  These results show that 
while the E189F variant has little or no activity, the R64WE189F suppressor has restored enzyme activity 
to a level similar to that of the R64W variant and intermediate between that of the native enzyme and 
the E189F variant.  Furthermore, the R64W change also restores activity to near native levels at the non-
permissive temperature for the E189K variant (data not shown).   
To detect differences in the ability to discriminate between ATP and CTP, we carried out end-
point analyses at 22oC to measure the incorporation of either AMP or CMP (Fig. 4.3C).  As was expected, 
the native enzyme showed low levels of misincorporation of AMP (at the first position) or CMP (at the 
third position).  The E189F variant showed a low level of AMP incorporation at the first position and little 
or no addition of either AMP or CMP at the third position reflecting this enzyme’s reduced activity.  
Intriguing results were obtained for the R64W and R64WE189F variants indicating that AMP is 
misincorporated at both the first and the second positions and CMP is misincorporated at the third 
position more frequently than for the native enzyme (Fig. 4.3C).   
4.5.3 Effects of the R64W substitution on tRNA nucleotidyltransferase structure and thermal stability 
To determine what effect the R64W suppressor mutation had on enzyme structure and thermal 
stability we used circular dichroism and fluorescence spectroscopy.  The circular dichroism spectra were 
similar for all proteins at 22oC (Fig. 4.4) and showed the characteristic peak minima at 208 nm and 222 
nm expected for proteins with α-helical character as seen previously for E189F and other E189 variants 
(Shan et al., 2008).  These data were supported by fluorescence experiments where the wavelength of 
fluorescence intensity maximum at 22oC differed by less than 3 nm between any of the proteins (data 
not shown).  The thermal stability of the native and variant enzymes was monitored using circular 




Figure 4.4. Circular dichroism spectra for native and variant tRNA nucleotidyltransferases. All spectra 
were recorded at 22 oC with proteins at ~1 μM.  native _._._., R64W ……, R64WE189F - - -, E189F ______. 
 Using either melting temperature (Tm) or percent remaining α-helicity at 37oC, the values for the 
R64WE189F variant were in good agreement with the E189F variant while the R64W variant showed 
values more similar to those of the native enzyme (Fig. 4.5, Table 4.2).  Although the changes in Tm are 
small (maximum of 4.5oC), the differences are reproducible (standard deviation ± 1oC or less in each 
case) with the native enzyme and the R64W variant being more similar to each other (Tm of ~40-42oC), 
while E189F and R64WE189F are more similar to each other and show a Tm of ~38oC and reduced 
remaining α-helicity.  The results for the native enzyme and the E189F variant are in good agreement (± 




Figure 4.5. Representative thermal denaturation curves of native and variant tRNA 
nucleotidyltransferases.  Signal intensity at 222 nm was monitored between 20°C and 50°C for proteins 
at ~1 μM. native _._._., R64W ……, R64WE189F - - -, E189F ______.  Fraction of protein unfolded was defined 
by the equation F = 1/ΔθT x θ - θi/ΔθT where F is the fraction of protein unfolded, θ is ellipticity 
measured in mdeg, and ΔθT is the total change in ellipticity between the initial and final temperatures of 
interest; ΔθT= θf -θi. θi is the ellipticity value at the start temperature of interest (20°C), and θf is the 
final ellipticity value at the end temperature of interest (50°C).   
 
TABLE 4.2.  Biophysical characteristics of native and variant tRNA nucleotidyltransferases 
 
Protein Mean Tm (oC) Remaining α-helicity at 37oC (%) 
native 41.8 ± 0.8 83.0 
E189F 37.4 ± 0.9 59.7 
R64W 39.5± 0.7 82.9 
R64WE189F 38.6 ± 1.1 61.4 
Each experiment was performed at least twice and the data represent the mean and standard deviation 
from the mean. Tm is defined as the temperature at which the fraction of unfolded protein is 50% and 
remaining α-helicity is defined as the θ222 at 37°C as compared to 22°C multiplied by 100%. 
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4.5.4 Roles of R64 and E189 
To further explore the roles of positions 64 and 189, we produced several additional amino acid 
substitutions at these two positions and tested the abilities of these variant proteins, expressed from 
plasmid-borne genes, to suppress the ts phenotype of cca1-E189F (Fig. 4.2). As we have shown 
previously, transformants expressing the E189F and E189K variant proteins were unable to grow at the 
non-permissive temperature.  In contrast, transformants expressing the R64W variant, the R64WE189F 
variant, or the native enzyme all grew at the non-permissive temperature.  These data are consistent 
with the comparable levels of CCA-adding activity obtained for these variants in vitro (Fig. 4.3).  We then 
reversed the residues normally found at positions 64 and 189 in the native enzyme to produce a plasmid 
expressing an R64EE189R variant enzyme and these transformants did not grow at the non-permissive 
temperature.  While the R64E substitution alone allowed for growth at the non-permissive temperature, 
expression of the R64EE189K or R64EE189F double substitution variants yielded a temperature-sensitive 
phenotype.  In contrast, the expression of the R64W substitution in combination with either the E189K 
or E189F change conferred growth at 37⁰C.  Finally, expression of the single E189R amino acid 
substitution variant also did not suppress the temperature-sensitive phenotype.   
4.4.5 The cca1-E189F and cca1-E189K mutations are hypomorphic in vivo  
As the cca1-E189F variant protein showed reduced activity at the permissive and non-permissive 
temperatures, and the R64W substitution restored activity in vitro at both temperatures without 
significantly affecting the overall structure or stability of the protein, we reasoned that the cca1-E189F 
mutation was hypomorphic rather than conditional.  To address this hypothesis we overexpressed the 
mutant protein via heterologous promoters and showed that the temperature-sensitive phenotype of 
cca1-E189F could be suppressed (Fig. 4.6A).  Therefore, increasing the amount of the partially active 
enzyme was sufficient to restore growth at the non-permissive temperature.  We also confirmed the 
hypomorphic nature of the first-isolated ts allele, cca1-E189K (ts352), by comparing the growth of cca1-
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E189K/cca1-E189K diploids to cca1-E189K/cca1::TRP1 diploids.  While neither of these strains grew at 
37°C, the cca1-E189K/cca1::TRP1 was uniquely sensitive to the lower temperature of 30°C (Fig. 4.6B).   
 
Figure 4.6. Growth of yeast expressing varying amounts of tRNA nucleotidyltransferase. (A) The native 
or E189F variant of tRNA nucleotidyltransferase was expressed from the promoters indicated in yeast 
strain E189F and incubated at 22oC or 37oC on SC medium lacking uracil to assess temperature 
sensitivity. (B) Diploid yeast strains (relevant genotypes shown) were replica plated to YPD medium and 
incubated at the temperatures indicated.   
4.6 Discussions 
4.6.1 The R64W substitution restores tRNA nucleotidyltransferase activity 
Our previous work (Shan et al., 2008) showed that substitutions at position 189 conferred a wide range 
of phenotypes and suggested a key role for E189 in enzyme structure and function. To further address 
the role of glutamate 189 in tRNA nucleotidyltransferase activity, we subjected strain E189F to UV 
mutagenesis and 25% of the resulting temperature-resistant isolates showed a CGG to TGG transition at 
codon 64 (resulting in an arginine to tryptophan substitution) in addition to the original E189F 
substitution.  Introducing a plasmid-borne copy of this gene into the temperature-sensitive strain E189F 
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resulted in suppression of the temperature-sensitive phenotype (Fig. 4.2) indicating that this mutation 
alone defined the suppressor.  To assess how the R64W substitution alone or in combination with E189F 
affected CCA addition in vitro, we tested variant proteins for the ability to add CMP and/or AMP to tRNA 
substrate templates.  When a tRNA template ending at the discriminator base (Fig. 4.3A) was used, the 
native enzyme exhibited complete CCA addition at both the permissive and non-permissive 
temperatures.  In contrast, the E189F variant showed little or no complete CCA addition at either the 
permissive or non-permissive temperature.  This observation was in good agreement with our earlier 
results (Shan et al., 2008), although those assays had measured nucleotide incorporation as acid-
precipitable counts and therefore, did not assess specific addition at each of the 3 positions in the CCA 
sequence.  It has been shown (Peltz et al., 1992, Aebi et al., 1990) that tRNAs generated at the non-
permissive temperature by the cca1-E189K strain lack a complete 3’ terminus, suggesting that it is the 
reduced ability to incorporate nucleotides and not misincorporation that defines the phenotype.  The 
presence of multiple species in the E189F samples indicates either incomplete CCA addition or 
misincorporation of nucleotides at the antepenultimate or penultimate positions, which could block 
further extension.  The latter possibility seems unlikely because increasing the incubation time at the 
permissive temperature (compare 2 min with 30 min) increases the amount of the extended products 
with a concomitant reduction in the intermediate species (Fig. 4.3B). The data suggest that the loss of 
efficiency of E189F is not linked to reduced specificity in nucleotide selection but instead is due to a 
lower nucleotide addition rate. When the reactions were repeated in the presence of ATP alone, some 
AMP was incorporated into the template at the antepenultimate position to block further extension 
particularly in the case of the native and E189F variant (Fig 4.3C). Intriguingly, both the R64W variant 
and the R64W/E189F variant were able to incorporate a second AMP (Fig. 4.3C) suggesting that the 
R64W substitution does have an effect on nucleotide selection. However, these data combined with our 
earlier observation of decreased incorporation of AMP as measured by acid-precipitable counts (Shan et 
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al., 2008) support the idea that the phenotype observed in the E189F variant reflects reduced enzyme 
activity and not misincorporation into the growing tRNA. Interestingly, the enzymes showing complete 
CCA addition also are able to incorporate CMP instead of the 3ʹ-terminal AMP when provided with CTP 
alone (Fig. 4.3C). Although CMP addition may be the default addition reaction for many class II tRNA 
nucleotidyltransferases (Hoffmeier et al., 2010), when the enzyme is given both ATP and CTP, AMP 
incorporation is favored at the third position (Fig. 4.3C, compare ATP + CTP lanes with CTP lanes). In any 
event, addition of CMP to the final position by the E189F variant is greatly reduced. These data indicate 
that at both the permissive and non-permissive temperatures the rate of nucleotide addition of the CCA 
sequence is reduced in the E189F variant. This suggests that the reduction in enzyme activity is not due 
to the inability of the enzyme to recognize one or the other nucleotide, but instead is due to a reduced 
ability to add nucleotides to the tRNA substrate. This implicates changes either in substrate binding 
(affinity and/or positioning) or in the organization of the catalytic residues at the active site, in the loss 
of activity. 
Interestingly, both the R64W and R64WE189F variants show some loss of efficiency in terms of 
nucleotide selectivity at all positions (Fig. 4.3C).  Based on the available crystal structure of the Bacillus 
stearothermophilus tRNA nucleotidyltransferase (Li et al., 2002) we expect residue R64 to be in motif A 
which contains both the highly conserved GGxVRD sequence and the two carboxylate residues 
important for catalysis in nucleotidyltransferases (Li et al., 2002, Hoffmeier et al., 2010).  Position 64 is 
expected to be in the first β-strand in the nucleotidyltransferase catalytic domain (Hoffmeier et al., 
2010) while the two catalytic carboxylates are in the adjacent β-strand (Li et al., 2002).  Converting 
arginine at this position to tryptophan restores activity to the E189F variant, and has only a limited 




4.6.2 The R64W substitution does not dramatically alter tRNA nucleotidyltransferase structure 
To assess the structural effects of the R64W and E189F substitutions, we used circular dichroism 
spectroscopy to detect changes in the secondary structure of the proteins.  The CD spectra were similar 
for all of the proteins at 22oC (Fig. 4.4) and showed characteristic peak minima at 208 nm and 222 nm 
that were indicative of high α-helical character.  These results supported the fluorescence data (data not 
shown) and indicated that the proteins shared similar secondary structures confirming what we had 
seen previously for native enzyme and E189F, E189K, E189H and E189Q variants (Shan et al., 2008).  
4.6.3 The R64W substitution does not dramatically alter thermal stability 
Given that the R64W amino acid substitution restored enzyme activity and eliminated the 
temperature-sensitive phenotype in cells carrying the cca1-E189F mutation, we wanted to determine 
whether the R64W substitution restored thermal stability to the E189F variant. To assess thermal 
stability we followed the CD signal at 222 nm which is indicative of the α-helical content of the protein.  
All of the proteins showed similar two-state thermal denaturation curves (Fig. 4.5) but exhibited 
different Tms (Table 4.2).  In analyzing these curves we found that the R64W substitution did not alter 
dramatically the thermal stability or percent remaining α-helicity of either the native protein or the 
E189F variant (Table 4.2), i.e., both the E189F and R64WE189F variants had reduced values when 
compared to the R64W and native proteins.  Taken together these results suggest that the R64W 
substitution does not alter the structure or the stability of either the native or E189F variant to any 
major degree.  Furthermore, it is clear that suppression of temperature-sensitivity does not correlate 
with increased thermal stability.  Previously, we showed that the E189H variant showed a Tm, percent 
remaining α-helicity and thermal denaturation curve in good agreement with those of the native 
enzyme, but yet displayed a temperature-sensitive phenotype (Shan et al., 2008).  Here we show that 
R64WE189F and E189F also have comparable thermal stability parameters, yet R64WE189F suppresses 
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the temperature-sensitive phenotype while E189F does not, unless it is over-expressed from the ADH1 
or TDH3 promoter (Fig. 4.6A).  Consequently, the suppression of the temperature-sensitive phenotype is 
not expected to correlate with any differences in denatured protein level caused by the observed 
differences in thermal stability.  However, the suppression of the temperature-sensitive phenotype 
correlates well with near-native levels of activity, while temperature-sensitivity correlates with, and 
appears to be characterized by, low specific activity. Moreover, in further support of these observations 
we have shown that generating the R64WE189K variant restores activity of the E189K variant to near 
native levels (data not shown).  Finally, even with thermal stability parameters effectively identical to 
those of the native enzyme, but with an intermediate level of activity (~40% of native), the E189Q 
variant displays an intermediate temperature-sensitive phenotype (Shan et al., 2008).  Taken together 
these observations suggest that the differences in thermal stability of the variant proteins that we have 
characterized appear not to play a major role in the development of the temperature-sensitive 
phenotype or its subsequent.  If protein stability is not the criterion that defines the temperature-
sensitive phenotype then how does the R64W mutation restore enzyme activity and suppress the 
temperature-sensitive phenotype? 
4.6.4 The R64W substitution suppresses the temperature-sensitive phenotype 
To explore the role of R64W in the suppression of the temperature-sensitive phenotype, we 
generated other variant alleles and tested their ability to alleviate the temperature-sensitivity of the 
cca1-E189F mutation (Fig. 4.2).  Based on the available crystal structures of class II tRNA 
nucleotidyltransferases, it is possible to generate a model of the yeast enzyme which posits an 
electrostatic interaction between R64 and E189 important for enzyme structure or function.  This model 
was supported by our initial observations that enzyme activity was reduced when position 189 was 
changed to either a positively charged or hydrophobic residue (potentially disrupting this interaction).  
Moreover, the ability of the R64W substitution to suppress the temperature-sensitive phenotype 
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conferred by the cca1-E189F mutation suggested that this proposed electrostatic interaction was 
replaced by a hydrophobic interaction.  However, this model does not stand up to scrutiny as 
transformants carrying plasmid borne cca1-R64W or cca1-R64W,E189K alleles are temperature resistant 
(Fig. 4.2).  The change from R64 to W64 would have disrupted the predicted electrostatic interaction in 
the native enzyme, and would not have allowed for a hydrophobic interaction in the E189K 
temperature-sensitive variant.  As we had shown that a hydrophobic residue and a positively charged 
residue could be tolerated at position 64 we also investigated how a negative charge at this position 
would affect activity.  Transformants bearing the plasmid borne cca1-R64E allele grew at the non-
permissive temperature (Fig. 4.2), thereby allowing us to explore whether we could replace the 
proposed E189 to R64 salt bridge with an R189 to E64 salt bridge.  We found that cells transformed with 
plasmids bearing cca1-E189R, cca1-R64EE189R, cca1-R64EE189F, or cca1-R64EE189K alleles were 
unable to grow at 37oC (Fig. 4.2), indicating that the R64E substitution cannot suppress temperature-
sensitivity.  
The data presented here are more consistent with the structural model for E189 that we 
proposed initially (Shan et al., 2008).  Our model showed E189 positioned at a turn between a β-strand 
and an α-helix in the head and neck region of the protein and we suggested that replacement of the 
glutamate residue at position 189 by larger residues would alter the organization of this turn and 
thereby affect enzyme activity. Our observation that a plasmid-borne cca1-E189R allele could not 
suppress the temperature-sensitive phenotype of the cca1-E189F mutation, supports this model since 
arginine has a Van der Waals’ volume of 148 Å3 (Martin and Keller, 1996) which is larger than the 
previously studied E189K and E189F substitutions that conferred a ts phenotype.  An interesting 
question remains as to how an alteration at position 64 can restore activity and alleviate the 
temperature-sensitive phenotype.  Our data indicate that there is no essential direct electrostatic or 
hydrophobic interaction between amino acid 64 and amino acid 189.  Therefore, we propose that the 
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change in structure conferred by E189 substitutions is compensated for by a second minor alteration in 
structure conferred by R64W.  The R64W substitution alone does not alter the structure of the protein 
sufficiently to abrogate enzyme activity (Fig. 4.3) and clearly, charge is not essential at position 64 as in 
addition to the native arginine, both tryptophan and glutamate substitutions are tolerated at this 
position to generate an active enzyme.  Moreover, some variability in the relative Van der Waals’ 
volumes (Martin and Keller, 1996) is also acceptable at this position (148 Å3 for arginine, 163 Å3 for 
tryptophan, but only 109 Å3 for glutamate).  The importance of a larger amino acid residue at this 
position may be reflected by the fact that although tryptophan, arginine and glutamate generate a 
functional enzyme, the position corresponding to residue 64 in the Saccharomyces cerevisiae protein is 
usually occupied by either an arginine or a tyrosine (Van der Waals’ volume 141Ǻ3) in many other tRNA 
nucleotidyltransferases, including those for which crystal structures have been solved (Fig. 4.1).  
Moreover, only the amino acid with the largest Van der Waals’ volume (tryptophan) is able to suppress 
the temperature-sensitive phenotype (Fig. 4.2).  Based on computer modeling and crystal structures of 
the related eubacterial enzyme, we predict that position 64 in the yeast enzyme is within the 
catalytically important motif A (Li et al., 2002) and in the first β-strand of the nucleotidyltransferase 
catalytic domain (Hoffmeier et al., 2010). A glutamate substitution at this position would be expected to 
alter the organization of the β-strand in a minor manner and this is supported both by the ability of the 
cca1-R64E allele and the inability of cca1-R64E,E189F, cca1-R64E,E189K, or cca1-R64E,E189R alleles to 
complement the temperature-sensitivity of cca1-E189F. In contrast, we suggest that the larger and more 
hydrophobic tryptophan substitution at position 64 is able to alter the organization of this β-strand in 
such a way that the deleterious effects of the E189F substitution are suppressed.  Regardless of the 
changes in this β-sheet, they do not measurably affect the thermal denaturation of the native or variant 
enzymes when loss of α-helical structure is the criterion by which structure is measured. We propose 
that the substitutions at position 189 result in minor conformational changes in the active site of the 
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enzyme which reduce enzyme activity.  These conformational changes may modify the orientation of 
the catalytically important β-sheet, or the organization in space of the flanking motifs; A, B, D, and E.  
The result of this may be to reduce either the amount of the tRNA and/or the nucleotide triphosphate 
substrates that are bound or their orientation relative to the catalytic residues. We propose that 
changes at position 189 result in a minor conformational change in the protein that alters the ability of 
the tRNA substrate to bind to the enzyme. This alteration could affect either the amount or the 
orientation of the tRNA that is bound, but in any case reduces enzyme activity. Subsequently, 
introducing the R64W substitution in motif A, known to be directly involved in catalysis and nucleotide 
triphosphate binding, may subtly adapt the organization of the active site to restore enzyme activity at 
the expense of some fidelity. This may be achieved by reorganizing the β-sheet to recover substrate 
binding, or by reorganizing catalytic residues.  In fact, we do see some loss in nucleotide selectivity with 
both the R64W and R64WE189F variants. These data demonstrate the critical role motif C residue 189 
has in the organization of the head and neck regions of the enzyme’s active site. 
4.6.5 The temperature-sensitive cca1 alleles are hypomorphic  
From our data it is clear that the temperature-sensitive phenotype of E189F results not from 
decreased thermal stability of the mutant protein but primarily from a partial loss of tRNA 
nucleotidyltransferase activity that affects cell growth only at higher temperatures.  Furthermore, this 
temperature-sensitive phenotype can be suppressed by restoring the activity of the tRNA 
nucleotidyltransferase but not necessarily its thermal stability. The loss of temperature-sensitivity 
conferred by overexpression of the cca1-E189F allele (Fig. 4.6A) and the more extreme temperature-
sensitivity (no growth at 30oC) exhibited by cca1-E189K/cca1::TRP1 diploids (Fig. 4.6B) support our 
conclusion that the ts cca1 mutations are hypomorphic. Furthermore, the ability of the R64W 
substitution to suppress the deleterious effects of the E189F and E189K substitutions by restoring the 
activity of the tRNA nucleotidyltransferase but not its thermal stability supports the conclusion that the 
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substitutions at E189 cause partial loss of activity at both permissive and non-permissive temperatures. 
While temperature-sensitive (ts) mutants of yeast were first defined by their inability to form colonies at 
36oC but to grow “normally, or nearly so,” at 23oC (Richards, 1974), in the intervening years, this 
phenotype has been attributed to a variant gene product that is functional at one temperature 
(permissive) but which is rendered non-functional at a higher (non-permissive) temperature (Tan et al., 
2009, Poultney et al., 2011).  It is generally assumed that at the permissive temperature the activity of 
the mutant protein is similar to wild-type (Hartwell, 1967).  The simple idea that a ts phenotype arises 
because a gene product is functional at the permissive temperature but not functional at the non-
permissive temperature is clearly an oversimplification.   
We suggest here that the ts phenotype arises not because tRNA nucleotidyltransferase is 
unstable at the non-permissive temperature, but because its inherent reduced activity (which is 
sufficient for growth at the permissive temperature) does not meet the needs of the cell at the non-
permissive temperature. This phenotype may result simply because the defective enzyme cannot 
generate functional tRNAs at a sufficient rate for protein synthesis at the non-permissive temperature or 
it may involve other differences in cells grown at higher temperatures. For example, CCA1 transcript 
levels are decreased at the higher temperature (Chakshusmathi et al., 2004).  Moreover, in response to 
stress, tRNA transcription is also down-regulated and endonucleolytic cleavage of cytoplasmic tRNAs 
increases (Castells-Roca et al., 2011). Our observations are in good agreement with data indicating that 
rather than producing a thermolabile protein, the widely used cdc13-1 mutation produces a gene 
product that is impaired for function even at the permissive temperature of 23oC (Thompson and 
Parker, 2009). These authors propose that the growth phenotype results from an additive effect of this 
partial-loss-of-function mutation (whose effect is present at all temperatures) combined with some 
additional aspects of telomere metabolism that are affected by high temperatures and not simply from 
a temperature-dependent impairment of a single gene.  Moreover, Paschini et al. (2012) point out that 
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other cellular pathways could be affected by higher temperatures and could make a specific 
hypomorphic mutation generate a temperature-sensitive phenotype.  Based on the results presented 
here, we would argue that this is indeed the case with processes such as mRNA stability and protein 
synthesis, both of which are affected by tRNA nucleotidyltransferase activity (Peltz et al., 1992). 
Interestingly, certain null mutations, including genes involved in RNA metabolism, e.g., GLE2 (Paschini et 
al., 2012), LRP1 (Miao et al., 2006) and telomeres, e.g., HPR1 (Mitchell et al., 2003); protein folding and 
degradation, e.g., RPN9 (Jimeno et al., 2002), BUL1 (Takeuchi and Toh-e, 2001), YDJ1 (Yashiroda et al., 
1996), CKS1 (Caplan and Douglas, 1991); and assembly and structure of multiprotein complexes, e.g., 
FMC1 (Kaiser et al., 1999), NUP84 (Lefebvre-Legendre et al., 2001), SNF1 (Rout et al., 2000), generate ts 
phenotypes.  This also suggests that a loss of protein function may manifest itself only at the non-
permissive temperature due to some change in the intracellular conditions at the higher temperature. 
Moreover, aneuploids often exhibit a temperature-sensitive phenotype (Tachibana et al., 2007, Hanic-
Joyce, 1985). Torres et al. (2007, 2008) suggest that, at higher temperatures, imbalanced 
stoichiometries for members of multiprotein complexes cause proteotoxic stress which, depending on 
the genes involved, can lead to a temperature-sensitive phenotype. Data are accumulating to indicate 
that a temperature-sensitive phenotype is not always indicative of a thermolabile gene product.  Further 
research will elucidate what additional factors are involved in generating the ts phenotype in cells with 









4.7 Supplementary Figures 
 
Figure S2.1. Quality of proteins used in this study. Proteins were separated by SDS-PAGE and stained 
with Coomassie blue. Ladder, PageRulerTM unstained Broad Range Protein Ladder #SM1881, native 












Chapter 5: Establishing the link between human tRNA nucleotidyltransferase and congenital 
sideroblastic anemia with B-cell immunodeﬁciency, periodic fevers and developmental delay (SIFD) 
5.1 Preface 
 The work presented in Chapter 5 corresponds to the following manuscript in preparation: Leibovitch M. 
et al. (2016). Finding the link between human tRNA nucleotidyltransferase and congenital 
sideroblastic anemia with B-cell immunodeﬁciency, periodic fevers and developmental delay (SIFD). 
Paul Joyce and Matthew Leibovitch designed the experiments and drafted the manuscript. Matthew 
Leibovitch carried out all studies described here. Experiments using human cell lines to complete this 
study will be performed by our collaborators at the Children’s Hospital of Eastern Ontario.   
5.2 Abstract of manuscript 
Recently (Chakraborty et al., 2014), seven alleles of the TRNT1 gene (p.T154I, p.M158V, p.L166S, 
p.R190I, p.L166S, p.I223T, p.I326T, and p.K416E) were identified in patients with congenital sideroblastic 
anemia with B-cell immunodeﬁciency, periodic fevers and developmental delay (SIFD). The TRNT1 gene 
encodes tRNA nucleotidyltransferase which is essential for protein synthesis as it plays a vital role in 
tRNA maturation. Five of the seven alleles defined amino acid substitutions in the well-characterized 
motifs A-E of class II tRNA nucleotidyltransferases, while two were located in the less well conserved 
body and tail domains (Li et al., 2002). We define here the biophysical and biochemical characteristics of 
the variant proteins to relate changes in tRNA nucleotidyltransferase to the SIFD phenotypes that result. 
Our data suggest that the SIFD phenotype is linked to poor stability of the T154I, L166S and I223T 
variant proteins, and to a combination of both reduced stability and catalytic function in both the 
M158V and R190I variants. Our results also show mutations mapped to the body and tail domains of the 
protein are interesting. In the case of the I326T variant, the substitution leads to a loss of stability, 
reduced catalytic activity, lower affinity for the tRNA substrate and a loss of quaternary structure. In 
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contrast, the K416E substitution results in poor binding and affinity for the tRNA substrate. Together 
these data suggest that the complex phenotype seen in SIFD patients may result from different defects 
in tRNA nucleotidyltransferase which affect some or all facets of its structure, stability, activity, and 
location. 
5.3 Introduction 
Sideroblastic anemias are a diverse group of diseases defined by the presence of ring 
sideroblasts (erythroid precursors with perinuclear mitochondrial iron deposition) in bone marrow 
(Wiseman et al., 2013). While in some instances anemia is the only symptom of the disease, in other 
cases clinical features may be much broader and include neuromuscular and metabolic phenotypes 
(Fleming, 2011). Several defective genes responsible for sideroblastic anemia have been identified and 
they map into three main groups: those involved in heme production, those involved in Fe-S cluster 
biogenesis and transport, and those involved in mitochondrial protein synthesis (Iolascon, 2014). These 
genes may be encoded in either the nuclear or the mitochondrial genome (Fleming, 2011). Recently 
(Wiseman et al., 2013), a clinical subgroup was identified with congenital sideroblastic anemia with B-
cell immunodeﬁciency, periodic fevers and developmental delay (SIFD). As the name suggests, SIFD is a 
severe multiorgan syndrome with life-threatening complications such that many patients die in the first 
decade of life (DeLuca et al., 2016).  
When whole exome sequencing and descent mapping techniques were used on SIFD patients, 
an autosomal recessive mode of inheritance was detected and the causative gene responsible for this 
syndrome was identified as TRNT1 (Chakraborty et al., 2014). This nuclear gene codes for ATP(CTP):tRNA 
nucleotidyltransferase (TRNT1), the enzyme responsible for the addition of the conserved cytidine-
cytidine-adenosine (CCA) sequence to the 3' end of both nuclear and mitochondrially-encoded transfer 
RNAs (tRNAs). The identified mutations result in partial loss of function of TRNT1 and lead to metabolic 
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defects in both the mitochondria and cytosol, which can account for the phenotypic pleiotropy observed 
in human patients (Chakraborty et al., 2014).  
Exome sequence analysis revealed three frameshift alleles, three splicing variants, and seven 
unique missense TRNT1 alleles characterized here as p.T154I, p.M158V, p.L166S, p.R190I, p.I223T, 
p.I326T, and p.K416E (Chakraborty et al., 2014). Five of these seven alleles define amino acid 
substitutions found in the well-characterized motifs A-E (Li et al., 2002) located in the conserved head 
and neck portions of class II tRNA nucleotidyltransferases (Yue et al., 1996) (Fig. 5.1). None of these 
mutations map to conserved Motif A which plays a key role in catalysis by coordinating two catalytic 
magnesium ions and binding the triphosphate moiety of each nucleotide triphosphate (Joyce and Steitz, 
1994, Steitz, 1998). However, both the T154I and M158V substitutions map to Motif B which functions 
by discriminating between deoxyribonucleotides and ribonucleotides at the active site (Li et al., 2002). 
The L166S substitution is found in the less well conserved Motif C which acts as a connection point 
between the head and neck region of the protein (Li et al., 2002) but may also act as a flexible spring 
element modulating the relative orientation of the head and body domains to help accommodate the 
growing 3’ end of the tRNA substrate (Ernst et al., 2015). The R190I substitution is found in Motif D 
which is responsible for forming a binding pocket to accommodate incoming CTP or ATP (Li et al., 2002) 
and discriminates against UTP and GTP binding (Yue et al., 1996, Shi et al., 1998, Cho et al., 2007). In 
contrast, the I223T substitution is found in the less well conserved spacer between motifs D and E and 
the I326T and K416E substitutions were found in the poorly conserved body and tail portions of the 
protein, respectively (Fig. 5.1). While one can imagine how mutations in the conserved catalytic portions 
of the protein might result in structural changes that lead to changes in stability or activity resulting in 
the SIFD phenotype, it is more difficult to understand how mutations in the less well conserved portions 




Figure 5.1: Human tRNA nucleotidyltransferase (Kuhn et al., 2015) 
The human tRNA nucleotidyltransferase (PDB 4X4W) protein was remodelled with two magnesium ions 
(grey balls) and ATP (PDB 3H39, Toh et al., 2009) and a tRNA (orange) (PDB 1VFG,Tomita et al., 2004) at 
the active site. The head (blue), neck (salmon), body and tail (green) domains are visualized showing the 
polypeptide backbone (cartoon). The ATP substrate is shown in stick (blue) and mutations mapped to 
the human tRNA nucleotidyltransferase protein are represented in pink. 
 
The ATP(CTP):tRNA nucleotidyltransferase is an enzyme with multiple functions in addition to its 
role in adding the CCA sequence required for aminoacylation. The tRNA nucleotidyltransferase enzyme 
also may play a repair function in the cytosol (Rosset and Monier, 1965), be involved in tRNA quality 
control (Kuhn et al, 2015), in the stress response for targeting tRNAs for decay (Wilusz et al., 2011) and 
in nucleocytosolic shuttling of tRNAs (Feng and Hopper, 2002). Given all of these possible roles in the 
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cell and the multiple locations where the enzyme must function, it is not surprising that changes in tRNA 
nucleotidyltransferase structure, stability, activity or localization could lead to the phenotypes observed.     
In this study, we show that there are no measurable changes in the secondary and tertiary 
structures of any of the variants, however single amino acid substitutions at T154I, M158V, L166S, 
R190I, I223T or I326T all lead to a decrease in stability. Surprisingly, all changes made in the conserved 
head and neck regions of the protein (motifs A-E) responsible for catalytic function, had no major effect 
on activity for the tRNA, ATP and CTP substrates. In contrast, both I326T and K416E showed changes 
catalytically with a 10-fold drop in activity and poor binding of the tRNA substrate. When activity assays 
were repeated with a modified mini-tRNA substrate, the native and T154I, M158V, L166S, I223T variants 
showed comparable activity while under these conditions the R190I, I326T and K416E variants showed 
less activity. Here, we also show that in vitro all of the proteins except for the I326T variant form a 
homodimer stabilized by a disulfide bond. Collectively, these data suggest that changes made in the 
head and neck portions lead to altered stability and changes in the body and tail affect tRNA binding, 
activity and dimerization. Ultimately, an understanding of how these changes affect tRNA 
nucleotidyltransferase function may aid in developing treatments for SIFD. 
5.4 Materials and methods 
5.4.1 Plasmids and cloning 
The cDNAs coding for the native and variant human tRNA nucleotidyltransferases in pTrueORF 
(Origene) (Chakraborty et al., 2014) were used as templates for the polymerase chain reaction. The 
open reading frame for the native or mutant cDNA was amplified by PCR as follows: 200 μmoles of 
dNTPS, 5X Phusion HF buffer (New England Biolabs), 0.25 units of Phusion DNA Polymerase, 25 pmoles 
of primers and 25 pmoles of template as described previously (Leibovitch et al., 2013) with an annealing 
temperature of 51°C. The primers used are 5’-ATCCCATATGAAGTTGCAGTCTCCCG-3’ (start codon 
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underlined) and 5’-ATGTCTGGATCCTTAGGTCTTCTTTATGTAACTCAG-3’ (stop codon underlined). The 
resulting PCR products were digested with BamHI and NdeI and ligated into pET-15b digested with the 
same enzymes.  
The G73 and pmBsDCCA plasmids, both generous gifts from Dr. Alan Weiner (University of 
Washington), were originally constructed by Cho et al. (Cho et al., 2003) and Oh and Pace (1994), 
respectively and both contain the Bacillus subtilis tRNAAsp gene modified to produce specific 3' ends 
after restriction digestion and in vitro transcription. Plasmids pMG73 and pMpmBsDCCA expressing 
mini-tRNA templates containing only the TψC stem and loop and the aminoacyl stem of the tRNAAsp 
were generated from G73 and pmBsDCCA by removing 31 nucleotides including the DHU, anticodon and 
variable stems and loops from the tRNAAsp gene by using QuikChangeTM mutagenesis to amplifying only a 
portion of the gene of interest. The following primers were used:  
5’-GCGGGTTCGAGTCCCGTCCGG-3’ and 5’-CCGGACCTATAGTGAGTCGTATTAGGGGATCC -3’ and the 
resulting products were ligated and transformed into E.coli XL2 cells.  
The identity of each product was confirmed by sequence analysis (McGill University and Génome 
Québec Innovation Centre). 
5.4.2 Expression and purification of tRNA nucleotidyltransferase 
E.coli BL21 (DE3) carrying the plasmid of interest was grown in 10 ml of YT + ampicillin (100 
μg/ml) medium at 37⁰C and 225 rpm for 16-18 hours. Cultures were transferred in 5 ml aliquots into 
flasks containing 1.3 l of YT + ampicillin (100 μg/ml) medium and returned to the shaker at 37⁰C and 225 
rpm for 2-3 hours until an OD600 of 0.4-0.8 was achieved. The cells then were induced with a final 
concentration of 0.5 mM IPTG and returned to the shaker at 19⁰C and 193 rpm for 16-20 hours. Cells 
were collected by centrifugation at 4⁰C in a Beckman JA-10 rotor for 15 minutes at 6 000 rpm. Cell 
pellets were stored at -80⁰C for a minimum of 1 hour before used.  
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Frozen cell pellets were thawed on ice while being resuspended in cold lysis buffer (PBS + 1 mM 
EDTA) at approximately 2 ml/g of pellet. The resuspended cell suspension was passed through a French 
Pressure cell press (Thermospectonic) three to four times at 1000 psi. The resulting cell lysate was 
centrifuged at 18 000 rpm in a Beckman JA-20 rotor once for 30 min at 4⁰C. The cleared lysate was kept 
and centrifuged once more as above before being passed two to four times through a 10 cm Bio-Rad 
column containing 2-3 ml of NTA-Ni resin (Novagen). The column was washed first with 50-100 ml of 
PBS (pH 7.5) + 10% glycerol and then with 50-100 ml 10 mM imidazole in PBS (pH 7.5) + 10% glycerol to 
eliminate non-specific binding. Bound protein was eluted stepwise with 6-8 ml each of 50 mM, 100 mM, 
150 mM and 250 mM imidazole in PBS (pH 7.5) + 10% glycerol. Fractions were analyzed by SDS-PAGE 
and appropriate fractions were pooled, transferred to a 50 kDa dialysis bag (SpectroPor) and dialysed 
against 1-2 l of PBS (pH 7.5) + 10% glycerol for 1-2 hours at 4⁰C. Dialysis was repeated as above for 3-5 
hours and then overnight. The protein was removed from the dialysis bag and stored at -80⁰C in 
aliquots.  
 Protein concentrations were determined by Bradford assay (Bradford, 1976) and based on the 
molar extinction coefficient (38515 M-1cm-1) at 280 nm for tRNA nucleotidyltransferase (Gasteiger, 
2006). Absorption readings were determined in a 1.0 cm quartz cell using the Varian Cary 100 Bio UV-
Visible Spectrophotometer. All samples were treated with a final concentration of 20 ng/ml RNAseA 
(Bioshop) and dialyzed extensively in PBS (pH 7.5) to remove any nucleic acid associated with the 
protein. 
5.4.3 Biophysical characterization of tRNA nucleotidyltransferase 
5.4.3.1 Circular dichroism spectroscopy 
Secondary structure determination was done by using circular dichroism spectroscopy. Protein 
samples, prepared as described above (section 5.4.2), were diluted in PBS to approximately 0.4 mg/ml 
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and placed in a 0.2 cm cell cuvette. Prior to taking measurements, samples were centrifuged at 14 000 x 
g for 5 minutes at 4⁰C. A Jasco-815 circular dichroism spectrophotometer along with the “Spectrum 
Measurement” program (Jasco) was used and was set to scan over the region of 200 nm to 260 nm. At 
standard sensitivity, a bandwidth of 1 nm was used, along with a response time of 0.25 seconds, data 
pitch of 0.2 nm, and a scanning speed of 20 nm/min. Data were accumulated five times at 20°C using a 
Pelletier water bath accessory while nitrogen was set to flow through the instrument at a constant rate 
of 3 l/min. The data obtained were smoothed using the smoothing function in the Spectra Analysis 
(Jasco) program. 
5.4.3.2 Thermal denaturation monitored by circular dichroism 
Temperature denaturation was monitored by circular dichroism for each protein. A sample of 
approximately 0.5 mg/ml was prepared as described above (section 5.4.2). The program used was 
“Variable Temperature” where the signal was monitored at 222 nm at standard sensitivity using a 
bandwidth of 1 nm, response time of 0.25 seconds, and a data pitch of 0.2°C. A temperature slope of 
30°C/hour was used while the start and end temperatures were 20°C and 60°C. A 0.2 cm cell was used 
and was sealed to limit evaporation. Data obtained were smoothed using the smoothing function in the 
Spectra Analysis (Jasco) program. 
5.4.3.3 Tryptophan fluorescence spectroscopy 
Tertiary structure determination was done by using fluorescence spectroscopy. The instrument 
used was a Varian Cary Eclipse Fluorescence Spectrophotometer along with a Varian single cell Pelletier 
Cary accessory (water bath). The application “Scan” was used to obtain emission spectra at room 
temperature averaged over 10 scans between 310 nm to 400 nm with an excitation wavelength of 280 
nm or 295 nm. Scan speed was set to medium (600 nm/min) with a 1.0 nm data sampling interval, 5 nm 
excitation and emission slit widths, and voltage was set to medium (600 Volts). Samples (1 ml) were 
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prepared as described above (section 5.4.2) and diluted to a final concentration of 2.2 μM determined 
by OD280 (38 515 M-1cm-1 molar extinction coefficient) for the spectrum measurements and placed in a 1 
cm cuvette. The data obtained were smoothed using the moving average smoothing function (Cary 
Eclipse software, Agilent). 
5.4.3.4 Gel filtration chromatography 
The quaternary structure and the binding capacity of the tRNA substrate of tRNA 
nucleotidyltransferase was assessed by gel filtration chromatography using a Superdex 200 10/300 GL 
column (GE Healthcare Life Sciences). The flow rate was set to 0.65 ml/min and samples were monitored 
by absorption at 280 nm. The column was equilibrated with at least two volumes of 50 mM Tris-HCl (pH 
7.6) and 100 mM NaCl prior to sample injection. All protein samples 500 μl (0.3-1 mg/ml) were 
centrifuged for five minutes at 4⁰C prior to injection. RNA-free samples were prepared as described 
above (section 5.4.2). To see the effect of RNA on the proteins, the RNaseA treatment was not used and 
6 μM purified baker’s yeast tRNA (Roche) was added with preincubation for 1 h at 4⁰C prior to injection.  
When needed, samples were preincubated with reducing agent (2 mM TCEP, Sigma-Aldrich) for 1 hour 
at 4⁰C prior to injection.  Bio-Rad Molecular weight standard (151-1901) was used to generate 
calibration curve and assign the molecular weight of each species (see S5.1). 
Equations: 
[Dimeric protein] = (Absorbance at 1250 seconds)(extinction coefficient of protein at 280 nm over 
extinction coefficient of tRNA and protein at 280 nm)/((Extinction coefficient of protein)x(pathlength)) 
[Total protein] = (Absorbance at 1475 seconds + Absorbance at 1350 seconds of RNaseA treated sample) 
/((Extinction coefficient of protein)x(pathlength)) 
[Total tRNA] = (Absorbance at 1250 seconds + Absorbance at 1350 seconds + (absorbance at 1475 
seconds - absorbance at 1475 seconds of RNaseA treated sample) + ( absorbance at 1700 seconds - 
absorbance at 1700 seconds for RNaseA treated sample ))x(extinction coefficient of tRNA at 280 nm 
over extinction coefficient of tRNA and protein at 280 nm)/(Extinction coefficient of tRNA)x(pathlength) 
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[tRNA complexed/protein complexed] = (Absorbance at 1250 seconds + Absorbance at 1350 
seconds)x(extinction coefficient of tRNA at 280 nm over extinction coefficient of tRNA and protein at 
280 nm)/(Extinction coefficient of tRNA)x(pathlength) 
kd=(Free protein)x(Free Ligand)/ (Bound complex) 
kd = ((Total protein) – (protein-tRNA complex))x((Total tRNA – protein-tRNA complexed))/ ((protein-tRNA 
complex)) 
 
5.4.4 Enzyme activity assays 
5.4.4.1 Run-off Transcription and purification of transcripts 
Each 100 μl run-off transcription reaction contained 20 μL of 5X transcription buffer (Thermo 
Scientific), 5 nmoles ATP, 50 nmoles each of CTP, GTP and UTP (Thermo Scientific) and 50 μCi (~16 
pmoles) [α-32P] ATP (10 μCi/μl, 3000 Ci/mmol) (Perkin-Elmer), ~5 μg of linearized DNA template, 60 units 
of T7 RNA polymerase (Thermo Scientific) and nuclease-free water and was incubated for 2-3 hours at 
37⁰C. The products were phenol extracted, ethanol precipitated and gel purified via polyacrylamide gel 
electrophoresis. The concentration of each runoff transcription product was determined by scintillation 
counting (LKB WALLAC-1217 RackBeta liquid scintillation counter) using a standard curved. 
5.4.4.2 Standard Activity Assays 
Each standard assay mixture contained 100 mM glycine buffer (pH 9), 6 mM MgCl2, 1.2 mM ATP, 
0.1 mM CTP, 10-20 ng of the [α-32P] ATP labelled tRNA transcript and 0.1-100 ng of protein (modified 
from Leibovitch et al., 2013). Assays were initiated with the addition of protein and stopped with 10 μl 
of Peattie's (2X) loading dye (Peattie, 1979) after two minutes. Samples were heated to 70°C and cooled 
prior to loading onto a 50 cm x 32 cm 7M urea 12% acrylamide gel and electrophoresed for 7-8 hours at 
2000 Volts. The gel was place against a phosphorImager screen (GE Healthcare) for at least 30 minutes, 
the screen was developed and transcripts were detected using the Typhoon™ TRIO Variable Mode 




5.4.4.3 Standard Kinetics Assays 
For kinetic analyses, the standard assay as described in 5.4.4.2 was used except with a maximum 
of 1 ng of protein and increasing amounts of tRNAAsp. Each assay tube contained enough reagents for 
two to three individual assays. At each time point, 10 μl of the assay mixture was removed and treated 
as described (section 5.4.4.2). The ratio of reactant to product (tRNA-NCC/tRNA-NCCA or tRNA-
NC/tRNA-NCC) was measure by densitometry and initial rates were determined for varied amounts of 
tRNA substrate. Similarly, the assays were repeated with varying amounts of ATP or CTP with a fixed 
amount of tRNAAsp lacking the terminal CMP residue and/or AMP residue. 
5.4.5 Homology Modeling of Human tRNA nucleotidyltransferase 
 The homology model of human tRNA nucleotidyltransferase with bound magnesium ions, ATP 
and tRNA was derived from the Homo sapiens (PDB 4X4W) (Kuhn et al., 2015), Thermotoga maritima 
(PDB 3H39) (Toh et al., 2009) and Aquifex aeolicus (PDB 1VFG) (Tomita et al., 2004) crystal structures of 
Class II tRNA nucleotidyltransferases. The primary and secondary structures of these proteins were 
aligned using MODELLER v.9.13 (Ben Webb). The homology model was generated using MODELLER (Ben 
Webb) incorporating the Thermotoga martima tRNAPhe substrate modeled at the Aquifex aeolicus active 
site and both catalytic magnesium ions and ATP from Thermotoga maritima crystal structure into the 
human enzyme. The homology model with the lowest energy level was viewed by PyMol (Schrödinger).  
5.5 Results 
5.5.1 Biophysical characterization of the tRNA nucleotidyltransferase variants 
Seven different disease-causing mutations have been mapped to TRNT1.  These mutations result 
in the following amino acid substitutions: T154I or M158V in motif B, L166S in motif C, R190I in motif D, 
I223T between motifs D and E, and I326T or K416E in the more carboxy-terminal portion of the protein 
(Fig 5.1).  To link these mutations to the disease phenotype, it is important to define how these amino 
130 
 
acid changes affect protein structure, stability, activity and location. Here, any changes in structure, 
stability and activity will be explored. To determine whether any of the seven single amino acid 
substitutions alter the secondary structure or melting temperature of tRNA nucleotidyltransferase, we 
used circular dichroism (CD) spectroscopy. The spectrum of the native enzyme has the characteristic 
peak minima at 208 nm and 222 nm expected for a protein with primarily α-helical character (Fig. 5.2). 
This was as expected based on the available crystal structures of the native enzyme (Augustin et al., 
2003, Kuhn et al., 2015). The circular dichroism spectra of all variants showed excellent agreement with 
the spectrum of the native enzyme indicating that no single amino acid substitution dramatically altered 
the secondary structure of this protein (Fig. 5.2).  
 
Figure 5.2: Secondary structure comparisons of human tRNA nucleotidyltransferases 
The CD spectra of the native and variant proteins as purified from E. coli were recorded at 20⁰C. The CD 






In contrast, when the melting temperature of the native and variant enzymes was monitored by 
following the change in CD peak minimum at 222 nm with increasing temperature, all of the variants 
showed a 5-7°C decrease in melting temperature as compared to the native enzyme (Fig. 5.3) except for 
the K416E variant which showed a melting temperature similar to that of the native enzyme. 
As the mature native protein contains only four tryptophan residues (one in the region between 
conserved motifs A and B in the head domain of the protein, one in the highly conserved motif E in the 
neck domain and two in the less well conserved tail domain of the protein), fluorescence spectroscopy 
(upon excitation of tryptophan residues at 295 nm) was used to determine if any of the amino acid 
alterations resulted in changes in the tertiary structure of the protein.  
Figure 5.3: Thermal unfolding of human tRNA nucleotidyltransferases  
Signal intensity at 222 nm was monitored between 25°C and 60°C for the native and variant proteins 
after the removal of RNA by RNaseA treatment and extensive dialysis in PBS (pH 7.5).  Fraction of 
protein unfolded was defined by the equation F = 1/ΔθT x θ - θi/ΔθT where F is the fraction of protein 
unfolded, θ is ellipticity measured in mdeg, and ΔθT is the total change in ellipticity between the initial 
and final temperatures of interest; ΔθT= θf -θi. θi is the ellipticity value at the start temperature of 
interest (25°C), and θf is the final ellipticity value at the end temperature of interest (60°C).   
132 
 
The native protein gave a spectrum with a fluorescence emission maximum at 332 nm which is within 
experimental error (1-2 nm) of the fluorescence emission maxima seen for all of the variants (Fig. 5.4).  
The spectra for the T154I, M158V, L166S and I326T variants showed a 15 - 20% drop in fluorescence 
intensity at maximum (Fig. 5.4) while the I223T, R190I and K416E variants showed almost no difference 
in fluorescence intensity (~5% lower as compared to native). 
 
Figure 5.4: Fluorescence emission spectra of human tRNA nucleotidyltransferases 
Approximately 2.2 μM of each protein was excited at 295 nm and the fluorescence emission was 
measured from 310 to 400 nm. The lines represent the native and variant proteins after the removal of 
RNA by RNaseA treatment and extensive dialysis in PBS (pH 7.5). 
 
Gel filtration chromatography was used to assess the quaternary structure of the native and 
variant tRNA nucleotidyltransferases.  When the heterologously-expressed enzymes were isolated from 
E. coli, the native enzyme showed four absorbance peaks: one at 22 kDa, another at 50-52 kDa, a third 
at 78 kDa and a fourth at ~136-144 kDa (e.g., Fig. 5.5 A, 5.6 A). The T154I, M158V, L166S and R190I 
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variants showed four absorbance peaks similar to the native enzyme: one at 19-24 kDa, another at 50-
52 kDa, a third at 71-84 kDa and a fourth at 131-138 kDa (Fig. 5.5 B-E, respectively). In contrast, the 
I223T variant showed absorbance peaks at 24 kDa, 52 kDa and 162 kDa (Fig. 5.5 F), the I326T variant 
showed absorbance peaks at ~22 kDa, 56 kDa and 84 kDa, (Fig. 5.6 B) and the K416E variant showed 




Figure 5.5: Gel filtration chromatography of human tRNA nucleotidyltransferases 
A) native, B) T154I, C) M158V, D) L166S, E) R190I, and F) I223T proteins purified from E. coli and eluted 
from a Superdex 200 10/300 GL gel filtration column at 22⁰C. Molecular masses were calculated as 
described in section 5.4.3.4. 
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As we previously showed that heterologously-expressed tRNA nucleotidyltransferase isolated 
from E. coli has bacterial tRNA associated with it (Leibovitch et al., 2013), we treated the native enzyme 
and the I326T variant with RNaseA to remove any tRNA to better define what forms of the protein were 
present in each absorbance peak. If the protein migrates close to its expected molecular mass of 50 kDa 
and the 78-84 kDa peak represents the protein plus bound tRNA then we should expect that the relative 
amounts of these two peaks will change upon RNaseA treatment. This was indeed the case for both of 
the enzymes (Fig. 5.6 A-B). The shift in molecular mass after addition of RNaseA suggests that the 50 kDa 
species represents a monomer and the 78-84 kDa species represents the monomer plus tRNA.  
Interestingly, the ~140 kDa species in the native enzyme was lost upon RNaseA treatment and a new 
species at 101 kDa appeared (Fig. 5.6 A). This suggests that the ~140 kDa species represents a dimer 
with one to two tRNAs attached while the 101 kDa species represents the dimer with no tRNA 
associated with it. No species of greater than about 84 kDa is apparent in the elution profile of the I326T 
variant (Fig. 5.6 B). The disappearance of the 22 kDa peak in both spectra after RNaseA treatment 
suggests that this peak represents free tRNA (Fig. 5.6 A-B).  
To further assess the role that tRNA may play on the elution profiles of these two enzymes, the 
proteins were incubated with 6 μM of commercial baker’s yeast tRNA. This is approximately twice the 
amount of tRNA associated with the heterologously-expressed enzymes and when added it enriched 
both the 78 kDa and ~140 kDa peaks evident in the native enzyme and the 78 kDa peak (to a small 
extent) in the elution profile for the I326T variant (Fig. 5.6 A-B).  Interpretation of these data is 
complicated by the fact that the molar extinction coefficient (ε) for tRNA at 280 nm (3x105M-1.cm-1) is 
about 10 times greater than that of tRNA nucleotidyltransferase (3.8x104 M-1.cm-1) meaning that peak 
size is defined by both a contribution from the protein and from the tRNA. Using the known extinction 
coefficients and deconvoluting the absorption peaks, these data suggest that the native enzyme and the 
K416E variant exist as both monomers and dimers with the monomer predominating in each case with a 
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dimer:monomer ratio of 1:10 for the native enzyme and 1:2 for the K416E variant. These data further 
suggest that the tRNA complexes more efficiently with the native monomer (with an equal ratio of 
protein with and without bound tRNA) than with the I326T monomer (with a 1:10 ratio of protein with 
and without tRNA bound). Using the ratio of protein complex to free protein and knowing the amount of 
protein and tRNA added, apparent dissociation constants of 2.4 μM ± 0.3, 86 μM ±16 and 316 μM ± 55 
were calculated for the native enzyme, and the I326T and K416E variant enzymes, respectively. 
As the available crystal structure of the human enzyme (Augustin et al., 2003) showed a 
disulfide bond between the Cys373 residues of the two monomers, a reducing agent (2 μM TCEP) was 
added to the native enzyme and the K416E variant to see what affect it would have on the higher order 
structure (Fig. 5.6 A and C). In both cases the absorbance peaks for the higher molecular weight species 
(at ~140 kDa and 104 kDa) suggestive of dimers, disappeared and the 78 kDa and 50-52 kDa peaks 
indicative of monomers increased (Fig. 5.6 A and C). As no apparent dimer was seen in the elution 
profile of the I326T variant no reducing agent was added to that sample. Again, using the ratio of 
protein complex to free protein and knowing the amount of protein and tRNA added, an apparent 
dissociation constant of 1.8 μM ± 0.14 was calculated for the native enzyme in the presence of reducing 










Figure 5.6: Quaternary structure and tRNA binding of human tRNA nucleotidyltransferases 
The gel filtration (Superdex 200 10/300 GL) chromatograms of A) native, B) I326T, and C) K416E (C) 
proteins as purified from E. coli at 22⁰C. Proteins were monitored with co-purifed E.coli tRNA (protein 
alone), after addition of Baker’s yeast tRNA (tRNA), after RNaseA treatment (RNaseA) and in the 




To support the presence of dimers and monomers predicted from the gel filtration observations, 
a standard 13% SDS-PAGE was carried out in the absence of any reducing agent (Fig. 5.7). With the 
reducing agent (panel A), all proteins migrate at a similar molecular mass of approximately 48 kDa 
except for I223T which appears slightly larger. Mass spectrometry confirmed that all of the proteins had 
the expected molecular masses of 48.5 ± 0.1 kDa (depending on the amino acid substitution). In the 
absence of reducing agent (panel B), all of the proteins show a major band at about 48 kDa and two 
additional bands at approximately 100 kDa and 115 kDa suggestive of a protein dimer. Only I326T lacks 
these higher molecular weight species in good agreement with what was seen in the gel filtration 
chromatography. 
 
Figure 5.7: SDS-PAGE of human tRNA nucleotidyltransferases 
Approximately 4 μg of the native and variant proteins were incubated in SDS loading dye with (A) and 
without reducing agent, boiled and analyzed by SDS-PAGE. Under reducing conditions (A), protein bands 
were detected at approximately 48 kDa. Under non-reducing conditions (B), protein bands were 
detected around 48 kDa, 100 kDa and 115 kDa. Molecular weights were assessed based on the 
molecular weight markers (Pierce unstained protein molecular weight marker 26610). 
 
5.5.2 Enzymatic characterization of tRNA nucleotidyltransferase variants 
5.5.2.1 Activity 
To assess what affect the amino acid substitutions had on enzyme activity, each variant was 
assayed using increasing amounts of enzyme in the standard (Leibovitch et al., 2013) enzyme assay. 
138 
 
Initially, all enzymes were incubated with a tRNA substrate lacking only the terminal AMP residue to 
monitor the addition of AMP (Fig. 5.8 A). While all of the substrate is converted to product over the time 
frame tested at 10 ng of protein for the native and the T154I, M158V, L166S, R190I and I223T variant 
enzymes, both the I326T and K416E variants show only about 75% conversion of substrate to product 
under these conditions. If one compares relative activity to protein concentration (Fig. 5.8 A) it suggests 
that the amount of protein required to convert 50% of the substrate to product in this standard assay is 
0.4-0.5 ng of enzyme for the native and T154I, M158V, L166S, R190I and I223T variants but about 10 
times higher (~5-7 ng) for the I326T and K416E variants.    
When the same assay was repeated using a mini-tRNA containing only the TψC stem and loop 
and the aminoacyl stem of the tRNAAsp, again the native and T154I, M158V, L166S and I223T variant 
enzymes showed similar levels of activity at 10 ng protein required to convert all of the substrate to 
product while in this case the R190I, I326T and K416E variants showed less activity. In comparing 
relative activity to protein concentration, the native and T154I, M158V L166S, and I223T variant 
enzymes show similar amounts of enzyme (~20 ng) required to convert half of the substrate to product 
while the R190I, I326T and K416E variants show that more enzyme is needed (~100 ng) (Fig. 5.8 B). For 
this mini-tRNA, both the M158V and R190I variants show reduced conversion of substrate to product as 
compared to the native enzyme in contrast to what was seen for the full-length tRNA. While the R190I 
variant looks similar to the I326T and K416E variants in terms of enzyme required to convert half of the 
substrate to product (~100 ng), the M158V variant requires approximately the same amount of protein 
(~30 ng) to reach the halfway mark, but it never achieves 100% conversion of substrate to product over 
the course of the reaction (Fig. 5.8 B). 
When the proteins were incubated with tRNA lacking its terminal CMP and AMP residues to 
monitor the addition of both CTP and ATP a more complex picture results (Fig. 5.8 C). Again, at 10 ng of 
protein more than 95% of substrate is converted to product (containing both CMP and AMP) for the 
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native and T154I, M158V, L166S, R190I and I223T variants while both the I326T and K416E variants show 
less product (~75%). The analysis is more complicated in this case because of the presence of an 
intermediate substrate (that contains the CMP residue but lacks the terminal AMP residue). At 0.1 ng of 
protein for the native enzyme, 18% of the substrate was converted to the final product whereas 17% of 
the substrate was present as an intermediate species (lacking the AMP residue). Only slightly less 
activity was observed for variants T154I, M158V and L166S variants (approximately 10% final product 
with less than 10% intermediate product). In contrast, the R190I, I223T, I326T and K416E variants show 






Figure 5.8: Enzymatic activity of human tRNA nucleotidyltransferases 
The proteins indicated were incubated at 37⁰C for 2 minutes with a (A) tRNA-NCC substrate or (B) mini 
tRNA-NCC substrate or (C) tRNA-NC substrate as described in materials and methods. The amount of 
enzyme added is indicated above each assay. The reaction products were separated by electrophoresis 
on 7M urea/12% polyacrylamide gels and visualized using the Typhoon™ TRIO Variable Mode Imager. P 
is the active enzyme positive control (tRNA with a complete CCA sequence), N is the boiled enzyme 
negative control (original tRNA template lacking the CA or A sequence). Products were analyzed by 




Since the substitutions T154I and M158V are found in Motif B which plays a role in 
discriminating between the binding of ribonucleotides and deoxyribonucleotides, the native and T154I 
and M158V variant enzymes were assayed for the ability to incorporate dAMP at the terminal position 
or dCMP at the penultimate position (Fig. 5.9). At all protein concentrations tested the T154I variant 
used dCTP or dATP most effectively as a substrate and the M158V variant used dATP or dCTP least, with 
the native enzyme showing a rate of incorporation between the variants. 
 
Figure 5.9: Deoxyribonucleotide incorporation of native and variant enzymes 
The proteins indicated were incubated at 37⁰C for 2 minutes with (A) tRNA-NC substrate and dCTP or (B) 
tRNA-NCC substrate and dATP as described in materials and methods. The amount of enzyme added is 
indicated above each assay. The reaction products were separated by electrophoresis on 7M urea/12% 
polyacrylamide gels and visualized using the Typhoon™ TRIO Variable Mode Imager. Products were 
analyzed by densitometry and the percent product is listed under each assay. 
 
To determine if there was any correlation between the decrease in melting temperature seen in 
most variants and the activity levels measured, samples were checked for activity in the standard assay 
after preincubation at 37⁰C for different times. The activity measured after each preincubation was 
compared to the activity in the absence of heat treatment (Fig. 5.10). For up to 10 min of preincubation, 
the native and K416E enzymes showed approximately 100% activity while the remaining enzymes 
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showed considerably less activity (40-70%). After 20 minutes preincubation, the native enzyme retained 
~96% of its initial activity, the K416E variant retained about 90% of its activity, both the R190I and I326T 
variants retained about 50% of their activity and the T154I, M158V, L166S and I223T variants retained 
between 14% and 32% of their activity (Fig. 5.10). These data are in good agreement with what was 
seen in the thermal denaturation experiments (Fig. 5.3) and suggest a link between stability and activity. 
 
Figure 5.10: Thermal stability activity assays of human tRNA nucleotidyltransferases 
Activity, defined as AMP addition to the tRNA-NCC template in a standard assay, is measured after 
preincubation at 37⁰C for the times indicated. For the variants (I326T and K416e) with the least activity 
1ng of protein was used while in all other cases 0.1 ng of protein was used. Reaction products were 
analyzed by densitometry and rates were calculated. Percent activity is the rate of a specific protein 
after preincubation divided by the rate for the same protein in the absence of preincubation multiplied 
by 100%.   
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5.5.2.2 Kinetic analyses 
Detailed kinetics analyses were carried out on the native enzyme and L166S, I326T and K416E 
variants. To first determine the KM and kcat values for tRNA, AMP addition to a tRNA lacking only its 
terminal AMP residue was performed at varying concentrations of added baker’s yeast tRNA at 37⁰C. 
Intriguingly, the data for the native, L166S and K416E variant enzymes fit best to a sigmoidal plot (Fig. 
5.11) when the reaction rate was plotted as a function of compared to the concentration of added tRNA. 
This suggested an allosteric effect involved in tRNA binding and cooperativity constants of 2.13 ± 0.46, 
2.08 ± 0.34 and 2.50 ± 0.47 were calculated for the native, L166S and K418E variant enzymes, 
respectively (Table 5.1).  
 
Table 5.1: Kinetics of tRNA nucleotidyltransferase enzymes 
 
*NA =Not applicable  
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The potential for an allosteric interaction was suggested by the apparent dimerization described 
previously (Fig. 5.5, Fig. 5.7).  Consistent with this, the data for the I326T variant which showed no 
apparent dimer (Fig. 5.5, Fig. 5.7), fit best to a hyperbolic initial velocity versus [S] plot suggestive of 
Michaelis-Menten kinetics (Fig. 5.11).  When the kinetic data were collected at one tRNA concentration 
but with increasing concentrations of ATP or CTP the data fit best to a hyperbolic plot (Fig. 5.11) 
suggesting that tRNA binding promotes the allosteric transition.  
To dissect further how tRNA binding could be linked to an allosteric effect, detailed kinetics 
analysis were carried out using the mini-tRNA substrate lacking its terminal AMP residue. As with the 
complete tRNA, the data generated using the mini-tRNA showed a sigmoidal plot and provided a 
cooperativity coefficient of 1.85 ± 0.3 for the native enzyme (Fig. 5.11, Table 5.1). In addition, the 
turnover number (0.72 s-1 ± 0.19) was in good agreement with that seen when the tRNAAsp was used as 
substrate although the binding constant (1.14 μM ± 0.36) was about 20 fold higher. 
When the experiments were repeated in the presence of a reducing agent (Fig. 5.11), all kinetic 
data fit best to a hyperbolic plot suggestive of Michaelis-Menten kinetics. This suggests that the 
cooperativity is a consequence of the homodimer created by disulfide bond formation between 
monomers. Interestingly, KM and kcat values changed minimally between reducing and non-reducing 
conditions (Table 5.1). In either case, the KM's determined for the tRNAAsp substrate for the native, L166S 
and I326T enzymes were approximately 100 nM while the K416E variant showed a seven-fold increase 
in KM (Table 5.1). In contrast, the kcat values for the native, L166S and K416E enzymes were essentially 
identical while the I326T variant showed a ten-fold reduction in turnover number (Table 5.1). For all 
enzymes analyzed, KM values ranged between approximately 150-230 μM and 3-13 μM for ATP and CTP, 




Figure 5.11: Enzyme kinetics of human tRNA nucleotidyltransferases 
The rate AMP incorporation was plotted in the presence of increasing amounts of tRNA-NCC template A) 
native, C) L166S, D) I326T, E) K416E protein or B) native enzyme with mini-tRNA-NCC template. Assays A, 
D, and E were repeated in the presence of reducing agent. The data were analysed by a least-squares 
method using the equation for Michaelis–Menten kinetics, v =Vmax [S]/( KM+[S]) or the Hill equation for 




Mitochondrial diseases represent a large family of illnesses showing diverse phenotypes (Tonin 
and Entelis, 2014). These diseases may be defined by mutations in either the mitochondrial or nuclear 
genome. Specifically, mitochondrial diseases have been linked to mutations in tRNAs and tRNA 
modifying enzymes (Abbott et al., 2014). Recently, multiple patients showing congenital sideroblastic 
anemia with B cell immunodeficiency, period fevers and developmental delay (SIFD) have had the 
mutations responsible for this disease mapped to the TRNT1 gene (Chakraborty et al., 2014). This gene 
codes for tRNA nucleotidyltransferase which is responsible for the addition of the 3’-terminal cytidine-
cytidine-adenosine sequence to both mitochondrial and cytosolic tRNAs. The human tRNA 
nucleotidyltransferase is a Class II tRNA nucleotidyltransferase which contains five highly conserved 
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motifs (A-E) in the amino terminal half of the protein (Li et al., 2002). In contrast to the conservation in 
the head and neck regions, the remaining body and tail regions of the Class II tRNA 
nucleotidyltransferases have little primary sequence conservation (Yakunin et al., 2004), although the 
available crystal structures show these regions might be involved in tRNA binding (Tomita et al., 2004, 
Xiong and Steitz, 2004). 
The seven mutations identified in patients with SIFD (Chakraborty et al., 2014) have been 
mapped to motifs B (T154I or M158V), C (L166S), to the region between motifs C and D (R190I), to the 
main region between motifs D and E (I223T), and to the more carboxy-terminal region (I326T or K416E) 
far from the well characterized catalytic motifs. The mutations mapping to each of these distinct 
domains will be discussed individually to explore their possible effects on tRNA nucleotidyltransferase 
structure, stability, activity and localization that may be linked to the disease phenotype. 
5.6.1 Mutations found within conserved Motif B 
Motif B is responsible for ensuring that ribonucleotides and not deoxyribonucleotides are 
incorporated into the tRNA substrate (Li et al., 2002). A specific highly conserved RRD sequence has 
been shown to be required for this selectivity (Li et al., 2002). The central arginine has been shown to 
form a hydrogen bond with the hydroxyl group of an incoming ribonucleotide resulting in the preference 
for ribonucleotides over deoxyribonucleotides. An arginine to isoleucine substitution at the central 
residue of the triplet resulted in the loss of the hydrogen bonding potential and removed the selection 
of  ribonucleotides over deoxyribonucleotides for incorporation (Cho et al., 2007). In motif B of the 
human enzyme (Fig. 5.12), the residues T154 and M158 are two and six amino acids, respectively from 




Figure 5.12: Motif B and C of human tRNA nucleotidyltransferase 
(A) Conserved motifs B (blue) and C (salmon) are shown in ribbon form. Amino acids of interest are 
shown as sticks (pink) and are identified by the one letter code. (B) Alignment of Motif B and (C) Motif C. 
The alignment was performed with ClustalW with Class II tRNA nucleotidyltransferases from 
Thermotoga maritima, TM (3H39); Aquifex aeolicus, AA (1VFG); Saccharomyces cerevisiae, SC 
(NP_011095); Arabidopsis thaliana, AT (NP_173680); Lupinus albus, LA (AAB03077); Homo sapiens, HS 
(10U5_A); Bacillus stearothermophilus, BS (Q7SIB1).  Invariant amino acids are noted by (*), conserved 
amino acids are noted by (:) and similar amino acids are noted by (.).  Catalytically important residues 
are bold (black) and amino acids described here are bold and underlined (red).  
 
Although a methionine is not absolutely conserved at the position corresponding to 158 in the 
human enzyme, this position is typically a large aliphatic hydrophobic residue. Given the conservation at 
these two positions in motif B, it seems reasonable to predict that they also may be involved in 
nucleotide selection. When tested initially for activity in the standard enzyme assay for both AMP 
addition and the final CMP addition (Fig. 5.8), both variants showed activity consistent with that of the 
native enzyme although the M158V variant was slightly less active. This is surprising given that a single 
phenylalanine to alanine substitution in Motif B of the Aquifex aeolicus enzyme have been shown to 
decrease enzyme activity by about 10-fold (Tomita et al., 2004). Perhaps the substitution of a 
methionine by another aliphatic hydrophobic amino acid retains enough conservation in physical 
properties that activity is maintained. However, one would anticipate that the conversion of the 
148 
 
conserved threonine to isoleucine (from small and hydrophilic to large and hydrophobic) would have a 
more dramatic effect on activity. Activity approximately that of the native enzyme was seen when a 
mini-tRNA was used as the template for AMP addition (Fig. 5.8). This indicated that the disease 
phenotype likely does not result from a hypomorphic effect due to reduced enzyme activity as we saw 
with the temperature-sensitive phenotype in yeast (Goring et al., 2013) or as was seen for mutations in 
TRNT1 which cause retinitis pigmentosa with erythrocytic microcytosis (DeLuca et al., 2016). In the 
standard in vitro assays, the enzymes are provided with specific CTP and ATP substrates but in vivo, 
there may be competition between ATP and dATP or CTP and dCTP for binding at the active site. The 
native enzyme will select for the ribonucleotide triphosphates but the T154I and M158V variants may 
alter the nucleotide triphosphate binding region of the enzyme to allow a certain level of 
misincorporation of dATP or dCTP which would generate a population of tRNAs which would not be 
aminoacylated and which would affect the efficiency of protein synthesis. To address this possibility the 
standard in vitro assay was carried out with the tRNA-NC template in the presence of the native enzyme 
or the T154I or M158V variant but with dCTP instead of CTP as substrate, or with the tRNA-NCC 
template with dATP instead of ATP as substrate. When compared to the native enzyme the M158V 
variant was even less efficient at incorporating dCTP (Fig. 5.9 A) or dATP (Fig. 5.9 B). In contrast, the 
T154I variant showed an apparent increase in both dATP and dCTP incorporation (Fig. 5.9). These 
observations suggest that the change at position 158 from methionine to valine does reduce activity to 
extent degree when either NTPs or dNTPs are used as substrates so that this decrease in activity may be 
linked to the phenotype observed. In contrast, the T154I variant showed nucleotide incorporation equal 
to or better than that of the native enzyme most notably for AMP incorporation (Fig. 5.8) and for dAMP 
and dCMP incorporation (Fig. 5.9). Perhaps in this case, it is not the reduced incorporation of NTPs that 
leads to the phenotype but the misincorporation of dNTPs. 
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Are there other effects of these two amino acid substitutions that could lead to the disease 
phenotype? The analysis of the human crystal structure reveals that both T154 and M158 are buried 
within the protein such that one would anticipate that the resulting hydrophobic substitutions would 
not dramatically alter protein structure (Fig. 5.12). This appears to be the case as no structural change as 
measured by circular dichroism spectroscopy (Fig. 5.2), fluorescence spectroscopy (Fig. 5.4) or gel 
filtration chromatography (Fig. 5.5). However, both variants show reduced thermal stability at nearly 5°C 
below that of the native enzyme (Fig. 5.3). In good agreement with the thermal denaturation 
experiments, preincubation of these proteins at 37°C for 20 minutes results in a decrease in enzyme 
activity by about three and seven-fold for T154I and M158V, respectively as compared to the native 
enzyme (Fig. 5.10). This suggests either that some population of the protein molecules unfold 
completely at this temperature and lose activity or that all of the protein molecules unfold to some 
degree such that they have reduced activity. In human cell lines, Chakraborty et al., (2014) show that 
cells with the T154I substitution retained about two-thirds of the tRNA nucleotidyltransferase protein as 
compared to native cells as measured by Western blotting. Recently (Sasarman et al., 2015), an alanine 
to valine substitution was identified in Motif B two amino acids amino terminal to the conserved RRD 
sequence. This patient suffered a first crisis of lactic acidosis at 18 days of age, showed the 
characteristics of SIFD and died of cardiac arrest during an episode of fever and acute acidosis at 21 
months of age. Immunoblot analysis revealed about a 10-fold drop in tRNA nucleotidyltransferase in the 
variant as compared to the native enzyme. Taken together with our results, this suggests that protein 
stability may be an important parameter in defining the disease phenotype. One can speculate that the 
disease phenotype results from a combination of changes to structure, stability and activity. In the case 
of the M154V variant, there is reduced stability and loss of activity and for the T154I variant, there is 
reduced stability and increased incorporation of dNTPs as compared to the native enzyme.   
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Taking all of these data into account it is interesting that patients carrying the T154I variant are 
neither transfusion nor intravenous immunoglobulin–dependent suggesting that the T154I variant is less 
severe than the M158V variant (Chakraborty et al., 2014) even though the amino acid substitution looks 
more dramatic (hydrophilic to hydrophobic) and seems to have an effect on the discrimination between 
ATP and dATP (at least in the in vitro assay). To test the hypothesis that the level of enzyme activity is 
reduced because the M158V variant protein is less stable than native (and not because it is less active 
than native), it will be useful to check for tRNA nucleotidyltransferase protein levels in cell lines 
expressing the M158V substitution. 
5.6.2 Mutation found within conserved Motif C 
Motif C acts as a connection point between the head and neck region of tRNA 
nucleotidyltransferases (Li et al., 2002) and may act as a flexible spring element modulating the relative 
orientation of the head and body domains to help accommodate the growing 3’ end of the tRNA 
substrate (Ernst et al., 2015). Studies have shown that changing the conserved aspartate (Fig. 5.12) in 
Motif C to an alanine resulted in a 15-fold decrease in turnover for the addition of ATP to the tRNA-NCC 
template, but did not affect the binding of the tRNA substrate (Ernst et al., 2015). A similar observation 
was made in Saccharomyces cerevisiae tRNA nucleotidyltransferase when the glutamate residue 
(adjacent to the conserved aspartate) was changed to a phenylalanine or lysine resulting in a large 
decrease in activity leading to a temperature-sensitive phenotype (Shan et al., 2008). The nearly 100-
fold decrease in enzyme activity was sufficient to generate a temperature-sensitive phenotype in yeast 
indicating a hypomorphic effect resulting from this reduction in activity (Goring et al., 2013). Leucine at 
position 166 represents a conserved large aliphatic hydrophobic amino acid found in Motif C among 
Class II tRNA nucleotidyltransferases that is two amino acids amino-terminal to the important aspartic 
acid residue. It is conceivable that a change of the leucine at this position to a serine residue which is 
smaller and more hydrophilic could be linked to the phenotype. In contrast to what was observed when 
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amino acids were changed in Motif C of the yeast (Goring et al., 2013) and human (Ernst et al., 2015) 
enzymes, the ability of the L166S variant to add CTP and ATP to the 3' end of the tRNA lacking the 
terminal AMP or both CMP and AMP residues appears to be equivalent to that of the native enzyme 
(Fig. 5.8). Detailed kinetic analyses further support this observation, generating equivalent turnover 
numbers for both the L166S variant and the native enzyme (Table 5.1) with nearly equivalent binding 
constants for tRNA, ATP and CTP (Table 5.1). In fact, the turnover number for the L166S variant is two 
times greater than that of the native enzyme for AMP addition. Previous studies of variants within Motif 
C showed changes in kcat but no changes in KM values for tRNA binding (Leibovitch, in preparation, Ernst 
et al., 2015) for the variant proteins. So here while the change in turnover number is small, it may 
suggest that the L166S variant is more efficient than the native enzyme. As with the Motif B variants, 
this amino acid substitution does not suggest that a direct affect on enzyme activity is the cause of the 
observed phenotype. 
To help identify any change to the L166S variant, secondary and tertiary structure analyses using 
dichroism circular and tryptophan fluorescence spectroscopies, respectively were performed.  As in 
Motif B, negligible changes in secondary (Fig. 5.2) or tertiary (Fig. 5.4) structure were observed as 
compared to the native enzyme. Gel filtration chromatography (Fig. 5.5) and SDS-PAGE (Fig. 5.7) 
indicated that quaternary structure also was not affected. However, as observed for the Motif B 
variants, the stability of the L166S protein appears to be compromised showing about a 7°C decrease in 
Tm as compared to the native enzyme (Fig. 5.3). Pre-incubation of the L166S variant at 37°C prior to 
assaying for activity further supports the loss of thermostability. The L166S variant lost 10% of its activity 
after one minute of pre-incubation and almost half of its activity within five minutes (Fig. 5.10). Based on 
this experiment, the L166S variant is the most thermolabile as all of the other enzymes retain full 
activity after one minute and more than 80% of activity at five minutes (Fig. 5.10). Even though L166 has 
no catalytic role, it may be directly involved in stabilizing the connection between the head and the neck 
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portions of the protein (Li et al., 2002). In human cell lines (Chakraborty et al., 2014) cells with the L166S 
substitution in combination with the T154I substitution showed significantly less protein than the native 
enzyme. This destabilization of the protein may result in reduced levels in the cell. Sasarman et al., 
(2015) showed that a heterozygous tyrosine to phenylalanine substitution in Motif C in consort with a 
heterozygous alanine to valine substitution at position 148 resulted in a patient with motor 
development delay and normal cognitive development. This patient showed nearly normal levels of 
TRNT1 by immunoblotting and only moderately reduced mitochondrial protein synthesis as compared to 
the controls (Sasarman et al., 2015). This suggests that the milder form of the disease results from a 
moderate change in protein structure and function. For the L166S variant it appears that decreased 
stability leading to reduced activity and not an intrinsic reduction of activity is responsible for the SIFD 
phenotype.  
5.6.3 Mutation found between conserved Motifs C and D 
Motif D contains the well conserved (E/D)DxxR sequence that helps to accommodate incoming 
CTP or ATP substrates (Li et al., 2002). The conserved glutamate, aspartate and arginine residues 
recognize CTP or ATP by forming Watson-Crick-like base pairs with the nucleotides (Yue et al., 1996, Shi 
et al., 1998, Cho et al., 2007). In converting from CTP to ATP binding the active site of the enzyme 
rearranges to allow the appropriate interactions with the incoming ATP or CTP (Li et al., 2002). R190 is 
three residues amino-terminal of the conserved glutamate but is not generally conserved among Class II 
tRNA nucleotidyltransferases (Fig. 5.13). Interestingly, the crystal structure of human tRNA 
nucleotidyltransferase reveals that R190 forms a hydrogen bond with the conserved glutamate of the 
EDxxR motif in Motif D (Fig. 5.13). As this glutamate hydrogen bonds with the arginine residue of the 
motif to orient it for ATP or CTP binding during the rearrangement of the active site (Li et al., 2002), 
R190 also could participate in the rearrangement of the ATP/CTP binding pocket and in the binding of 
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incoming NTPs. It would be interesting to compare the crystal structures of the native and R190I 
variants in the presence of each nucleotide triphosphate to see if any differences could be observed.  
 
Figure 5.13: Motif D of human tRNA nucleotidyltransferase 
(A) Conserved motif D (salmon) is shown as a ribbon. Amino acids of interest are shown in sticks (pink or 
red) and are identified by the one letter code. (B) Alignment of Motif D. The alignment was performed 
with ClustalW with Class II tRNA nucleotidyltransferase from Thermotoga maritima, TM (3H39); Aquifex 
aeolicus, AA (1VFG); Saccharomyces cerevisiae, SC (NP_011095); Arabidopsis thaliana, AT (NP_173680); 
Lupinus albus, LA (AAB03077); Homo sapiens, HS (10U5_A); Bacillus stearothermophilus, BS (Q7SIB1).  
Invariant amino acids are noted by (*), conserved amino acid are noted by (:) and similar amino acids are 
noted by (.).  Catalytically important residues are bold (black) and amino acids of described in this study 
are bold and underlined (red).  
 
Surprisingly, replacing the arginine at position 190 with isoleucine does not appear to affect 
enzyme activity under standard assay conditions except for CMP addition at the lowest enzyme 
concentration tested (Fig. 5.8). When the activity assays were repeated with a mini-tRNA containing only 
the aminoacyl stem and the TψC stem and loop, a difference in AMP addition that was not observed 
with the full length tRNA substrate became evident. While the native and R190I enzymes added AMP at 
similar rates at the 4 ng enzyme level when using the full length tRNA as a substrate, the R190I variant 
yielded only about 20% of the activity compared with the native enzyme when the mini-tRNA substrate 
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was used (Fig. 5.8). It would be interesting to repeat the experiment with a mini-tRNA designed as a 
substrate for CMP addition to determine if the R190I substitution would reduce CMP incorporation. If 
both AMP and CMP incorporation are altered, this might suggest that the R190I substitution causes a 
change in the protein that alters mini-tRNA binding since it has fewer contact points with the enzyme 
than does the full-length tRNA. A more detailed kinetic analysis of activity with the mini-tRNA substrate 
may provide insight into this question. While the native enzyme showed an approximately 10-fold 
increase in KM for the mini-tRNA as compared to the full-length tRNA it would be interesting to 
determine the KM values for the R190I variant. Perhaps there is no apparent change in kinetic 
parameters for the native and R190I variant enzymes with the full-length tRNA because any changes 
introduced by the amino acid change are not significant enough to affect tRNA binding and catalysis. In 
contrast, the changes may lead to decreased binding and catalysis for the mini-tRNA. This may be 
physiologically relevant as some human mitochondrial tRNAs, e.g., tRNASer(AGY) have non-canonical 
structures. Recently (Sasarman et al., 2015), two patients were identified with mitochondrial 
encephalomyopathies largely due to impaired mitochondrial translation resulting from defective CCA 
addition to mitochondrial tRNASer(AGY) caused by mutations mapped to the TRNT1 gene coding for tRNA 
nucleotidyltransferase. Therefore, it is apparent that mutations which make the enzyme less able to use 
the non-standard mitochondrial tRNAs as substrates can lead to the observed phenotype.  
In terms of the biophysical characteristics of the R190I variant, structural analyses revealed 
negligible changes in secondary (Fig. 5.2), tertiary (Fig. 5.4) or quaternary (Fig. 5.5, Fig. 5.7) structure as 
compared to the native enzyme, however thermal denaturation shows the a drop of about 6°C in Tm for 
the variant as compared to the native enzyme (Fig. 5.3). The lower stability is likely a direct result of 
minor reorganization of the ATP/CTP binding pocket due to a loss of the hydrogen bond between R190 
and the catalytic glutamate at position 193. The change in hydrophobicity at position 190 also poses a 
problem since adjacent residues are polar and R190 is normally water exposed. Burying of the isoleucine 
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could cause the binding pocket to be moderately altered reducing activity at higher temperatures. A 
twenty minute incubation at 37°C shows about a 50% drop in activity confirming the loss of structure. 
The increase in hydrophobicity and loss of the hydrogen bond likely cause the isoleucine at position 190 
to be more buried, partially destabilizing the protein. Even though the altered stability is an unlikely 
explanation for reduced activity, it may participate in reducing CCA activity in the cell as this mutation in 
human cell lines results in about 30% lower protein concentrations as compared to the native enzyme 
(Chakraborty et al., 2014). In an effort to change the specificity of the motif D binding pocket, triple or 
double mutants were created in the EDxxR motif in the B. stearothermophilus tRNA 
nucleotidyltransferase with reduced activity demonstrating the importance of this region in NTP binding 
and activity (Cho et al., 2007). We hypothesize that the loss of the hydrogen bond to E193 resulting from 
the conversion of R190 to isoleucine restricts movement in Motif D altering the specificity for NTPs in 
the binding pocket of the enzyme. We propose that R190 may also directly interact with the tRNA 
substrate sugar phosphate backbone and help properly anchor the tRNA substrate via electrostatic 
interactions. Activity assays with the modified mini-tRNA suggest that activity within mitochondria might 
also be further compromised as mitochondrial tRNA may lack regions which could interact with the 
enzyme. We propose that the combination of altered specificity, activity and stability for the R190I 
variant may lead to the SIFD phenotype in humans.  
5.6.4 Mutations found within poorly characterized regions of human tRNA nucleotidyltransferase 
5.6.4.1 I223T 
Isoleucine 223 is situated in an α-helix buried deep within the neck portion of the protein 
between Motif D and Motif E (Fig. 5.14). Although much is known about the function of Motif D and 
there is some information as to the role of Motif E, the amino acids between these regions are not 
conserved among Class II tRNA nucleotidyltransferases. This specific region likely acts as a simple 
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connection between Motif D and Motif E in the neck portion of the protein. As seen for the four 
previously characterized variants there were no obvious changes in secondary (Fig. 5.2) or tertiary (Fig. 
5.4) structure for the I223T variant as compared to the native enzyme. Intriguingly, although the I223T  
 
Figure 5.14: Position of residue I223 between motifs D and E of human tRNA nucleotidyltransferase 
Human tRNA nucleotidyltransferase polypeptide backbone is shown in ribbon (salmon). Amino acid I223 
is shown in sticks (pink).   
 
variant showed no structural changes (except for a minor change in fluorescence maximum), SDS-PAGE 
showed an anomalous migration distance for this protein. Although mass spectrometry confirmed a 
mass of 48.5 kDa as expected, the protein migrated differently than all of the other proteins with an 
apparent molecular mass of about 50 kDa (Fig. 5.7 A). This may indicate that the amino acid substitution 
does somehow alter how the protein unfolds under the denaturing conditions of SDS-PAGE. Under the 
non-denaturing conditions of gel filtration chromatography (Fig. 5.5) the protein elutes with apparent 
molecular masses of 52 kDa and 162 kDa where the monomeric species (52 kDa) corresponds well with 
the apparent molecular mass of native protein but the dimeric species (162 kDa) seems much larger 
(~140 kDa for native enzyme). SDS-PAGE under non-reducing conditions also shows I223T with more 
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intense bands around 116 kDa suggesting that the substitution at position 223 may alter quaternary 
structure but not the ability to form a dimer. Perhaps this amino acid substitution causes some type of 
minor conformational change in the protein such that it does not unfold as the other proteins do under 
reducing and denaturing conditions. We have seen this type of anomalous slow migration of an 
Arabidopsis tRNA nucleotidyltransferase variant which also showed altered localization and reduced 
activity (Leibovitch et al., 2013).  
Thermal denaturation (Fig. 5.3) revealed that the Tm for this variant was about 5°C lower than 
the native enzyme in good agreement with what had been observed for the four variants described 
above. I223T showed activity similar to that of the native enzyme (Fig. 5.8) and only minor 
destabilization on preincubation at 37°C with retention of fully one third of its activity after 20 minutes 
at 37°C. Again, while reduced stability may play a role in the onset of SIFD in patients carrying this 
mutation, a role in altered protein localization cannot be excluded. The Arabidopsis tRNA 
nucleotidyltransferase showed altered migration on SDS-PAGE and reduced targeting to mitochondria in 
vivo (Leibovitch et al., 2013). Experiments with human cell lines should be able to address these 
possibilities.  
5.6.4.2 I326T and K416E 
The I326T and K416E substitutions are found within the body and tail portions of the protein 
about which not much is known (Yakunin et al., 2004). The body and tail domains of tRNA 
nucleotidyltransferase are believed to be involved in tRNA recognition and binding (Li et al., 2002). The 
body and tail regions appear to exclusively interact with the sugar-phosphate backbone of the tRNA 
substrate as determined by observations using the available crystal structures (Tomita et al., 2004, Xiong 
and Steitz, 2004). The available crystal structure of the human enzyme indicates that residue I326 is 
found in an α-helix buried in the body portion while residue K416 is found at the end of an α-helix and 
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exposed to the aqueous environment (Fig. 5.15). As had been observed for all of the previously 
characterized variants there were no major changes in secondary (Fig. 5.2) or tertiary (Fig. 5.4) structure 
for either variant as compared to the native enzyme. Thermal denaturation revealed that the Tm for the 
I326T variant was about 7°C lower than the native enzyme in good agreement with what had been 
observed for all of the variants described previously. In contrast, the K416E variant showed a Tm similar 
to that of the native enzyme (Fig. 5.3). 
 
Figure 5.15: Body and tail domains of human tRNA nucleotidyltransferase 
Human tRNA nucleotidyltransferase polypeptide backbone is shown in ribbon (green). Amino acids of 




The I326T variant does not show any apparent dimer on gel filtration chromatography (Fig. 5.6) 
while the K416E variant shows a greater ratio of dimer to monomer than does the native or any other 
variant enzyme (Fig. 5.6). As the available human crystal structure showed a C373-C373 disulfide bond 
involved in dimer formation (Augustin et al., 2003, Ernst et al., 2015) the gel filtration experiments were 
repeated in the presence of a reducing agent and as expected the dimers disappeared (Fig. 5.6). These 
observations were confirmed by SDS-PAGE in the presence and absence of a reducing agent (Fig. 5.7). 
Again all proteins except the I326T variant showed a higher molecular weight species in the absence, but 
not the presence of the reducing agent (Fig. 5.6). Given the position of the disulfide bond in the tail of 
the protein (Fig. 5.15), it could be argued that amino acid substitutions such as those at positions 326 
and 416 could cause a rearrangement of this portion of the enzyme to either decrease (in the case of 
I326T) or increase (in the case of K416E) disulfide bond formation. Given the predicted role of the tail 
portion of the protein in tRNA recognition and binding it would seem likely that rearrangements of the 
tail region also could affect tRNA binding. The I326T variant which does not form a homodimer, binds 
poorly to tRNA (Fig. 5.6 B) while the K416E variant which forms the homodimer at a much greater ratio 
than the native enzyme does not appear to bind tRNA at all (Fig. 5.6 C). The apparent KD values for tRNA 
binding to the I326T variant and the K416E variant are 40 fold and 125 fold higher than that of the 
native enzyme, respectively. A similar increase in KD was observed for a C-terminal variant of the 
Arabidopsis tRNA nucleotidyltransferase where the final four C-terminal positively charged amino acids 
were converted to negatively charged amino acids (Leibovitch et al., 2013). Experimental evidence has 
previously shown that the C-terminus may play a role in tRNA binding as swapping the tail of E. coli tRNA 
nucleotidyltransferase with that of poly (A) polymerase caused tRNA slippage which suggested that the 
function of the tail is to hold and anchor the tRNA substrate in place (Betat et al., 2004). In the case of 
the I326T variant, the substitution likely causes adjacent helices to move causing misalignment of the 
tRNA substrate with positively charged amino acids responsible for recognition and anchoring of the 
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tRNA substrate (Fig. 5.15). The lysine at position 416 however, may be directly interacting with the 
negatively charge sugar phosphate backbone of the tRNA substrate and may have a central role in tRNA 
binding. Therefore, the K416E substitution prevents direct contact with the tRNA substrate by 
electronegative repulsion via electrostatic interactions.  
Treating the native enzyme, or the I326T or K416E variant with RNAseA in the presence or 
absence of reducing agent clearly shows the relative amounts of dimer and monomer. While the I326T 
variant forms only a monomer in the presence or absence of tRNA (Fig. 5.6), the native protein is 
predominantly monomeric (Fig. 5.6) and the K416E variant exists as both a monomer and a dimer (Fig. 
5.6). Even though the dimer species is lost under reducing conditions, tRNA binding is not affected (Fig. 
5.6). Detailed kinetic analyses of the native and I326T, and K416E variant enzymes support these 
observations. Under non-reducing conditions, the native and K416E variant enzymes show cooperativity 
whereas the I326T shows none (Fig. 5.11). Under reducing conditions, apparent cooperativity was lost 
for all three proteins (Fig. 5.11).  
The physiological relevance (if any) of dimer formation remains to be determined. Since the 
cytosol is a reducing environment (Go et al., 2008), one would not expect dimerization. However, the 
mitochondrion provides an oxidizing environment where dimerization may occur. It will be useful to 
examine tRNA nucleotidyltransferase isolated from mitochondria and the cytosol to determine if these 
proteins exist in monomeric or dimeric conformations. To form this thiol linkage, the monomers must be 
in close proximity (Trivedi et al., 2009). Perhaps the relative mitochondrial tRNA nucleotidyltransferase 
concentration is greater than the cytosolic concentration. The relative amounts of dimers and 
monomers seen under the experimental conditions here suggest that protein dimerization is through 
weak interactions and is short lived. It is interesting that the K416E variant enzyme which has the 
greatest amount of dimer is also the variant with the highest Tm (Fig. 5.3) and the greatest remaining 
activity upon incubation at 37°C (Fig. 5.10). However, the I326T variant which shows the least amount of 
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dimer has neither the lowest Tm (Fig 5.3) nor the least retained activity after incubation at 37°C (Fig. 
5.10). So there is not a direct link between dimerization and protein stability.  
A detailed kinetic analysis was performed on the I326T and K416E variants to see if any of the 
features of tRNA binding or altered quaternary structure affected enzyme activity. The turnover number 
for the I326T variant is approximately 10-fold that of the native enzyme while the KM for tRNA binding 
was similar to the native enzyme (Table 5.1). In contrast, the KM for tRNA was 5-7 fold higher for the 
K416E variant as compared to the native enzyme and the turnover number was only reduced by 
approximately 50% as compared to the native enzyme (Table 5.1). In each case the KM vlaues for ATP 
and CTP remained essentially the same among the native and variant enzymes (Table 5.1). So while the 
I326T replacement dramatically reduces catalysis, it has little effect on tRNA binding at the active site. In 
contrast, the K416E change does not really alter catalysis but increases the KM for tRNA binding. These 
data suggest that in the case of the I326T variant it is not simply the poor binding of the tRNA substrate 
that is directly responsible for the 10-fold drop in turnover. There must be some other factor at play.  
As with the other variants it seems that reduced stability of the I326T variant may be linked to 
SIFD. In contrast, the K416E variant represents the only variant that has structural stability and retained 
activity comparable to the native enzyme. In this example, it is not simply a loss of stability that leads to 
the phenotype, but perhaps may reflect poor substrate binding. Again, experiments to look at the levels 
and localization of these variants may be informative as to defining how SIFD results. We previously 
have shown that altering or removing the C-terminal eight amino acids of the Arabidopsis tRNA 
nucleotidyltransferase allows the enzyme to maintain activity but alters tRNA binding by about nine-fold 
and changes the intracellular distribution of the resulting protein (Leibovitch et al., 2013). Recently 
(DeLuca et al., 2016), it has been shown that a patient suffering from retinitis pigmentosa with 
erythrocytic microcystis carries a frame shift mutation in the TRNT1 gene that removes the last seven 
amino acids of the human tRNA nucleotidyltransferase and replaces them with ten other amino acids.  
162 
 
These data point to some role for the carboxy terminus of tRNA nucleotidyltransferase in enzyme 
structure or function. Further studies are required to see if SIFD results from a combination of a change 
in activity and/or localization.     
5.7 Conclusion 
In this chapter, we suggest that the SIFD phenotype is linked to poor stability of the T154I, L166S 
and I223T variant proteins, and to a combination of both reduced stability and catalytic function in both 
the M158V and R190I variants. However, the phenotype created by the I326T variant may be related to 
a multitude of problems which include reduced stability, low catalytic activity, poor affinity for the tRNA 
substrate and inability to dimerize. In contrast, the poor affinity of the K416E variant for tRNA may lead 
to the SIFD phenotype. Localization studies in vivo are necessary to fully explore whether changes in 
higher order structure (I223T and I326T) or tRNA binding (I326T and K416E) have any influence on the 














5. 8 Supplementary figures 
 
Figure S5.1: Molecular weight standard curve  
Bio-Rad molecular weight standard (151-1901) was used to generate a calibration curve for gel filtration. 
Standards were run as described in 5.4.3.4. The distribution constants (Kd) for the standards and 
samples was calculated as follows: Kd = (Ve -V0)/Vs where the Ve is the eluted volume of sample, V0 is the 
















6.0 Conclusions and future work 
 In this study, I set out to explore how localization, activity, structure and stability all are 
intertwined in defining a protein’s function. I used tRNA nucleotidyltransferase which catalyzes an 
interesting reaction (requiring three different substrates and incorporating nucleotides without a nucleic 
acid template) and is targeted to multiple intracellular destinations (cytosol, nucleus, mitochondria and 
plastids) as my model protein. Using the Arabidopsis, yeast and human tRNA nucleotidyltransferases, I 
was able to show some common features that help to establish the interplay of all of these factors in the 
function of this enzyme.  
 In Chapters 2 and 3, we showed that stability and/or activity may play a role in defining the 
distribution of this enzyme in the cell. Modifications in the mature domain of the protein in the body 
(Mat-Mu1) and tail domains (Mat-Mu2) both altered intracellular localization while Mat-Mu1 also 
eliminated activity and altered stability. We predict that the Mat-Mu1 variant causes the protein to fold 
more tightly making mitochondrial import less energetically favorable. To explore more precisely the 
role of Mat-Mu1 we fine-structure mapped the functions of specific amino acids in this region. Three 
amino acid substitutions in Mat-Mu1A (the first half of Mat-Mu1) appear to alter the folding of the 
protein and suggest that these amino acid substitutions result in the more tightly folded protein which is 
favored for plastid rather than mitochondrial import. In contrast, amino acid substitutions in Mat-Mu1B 
(the second half of Mat-Mu1) reduced enzyme activity but had little effect on structure or stability. In 
fact, we were able to define a single amino acid substitution, K418 that likely plays a direct role in tRNA 
binding. We now are in a position to see if it is the change in folding (Mat-Mu1A) or in activity (Mat-
Mu1B) that is linked to the altered distribution of this protein. Import experiments with all of these 
variant proteins are underway in the laboratory of our collaborators and these results will be important 
to distinguish between these two possibilities. In terms of defining the specific function of this region of 
the protein in enzyme activity it would be interesting to explore more closely the role of the lysine 
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residue at position 420. Converting this lysine residue to glutamate resulted in a 50% increase in 
turnover number. Studies such as described in Chapters 2 and 3 of this thesis could be used to define 
the contribution to enzyme activity of this amino acid. For example, what effect would a K420A or 
K418EK420E double variant have on KM and kcat. 
  Although changes in motif Mat-Mu2 altered intracellular distribution of the protein, 
dramatically reducing the number of cells showing mitochondrial localization, it showed no apparent 
changes in enzyme activity or physicochemical properties. Changing the charge of Mat-Mu2 or removing 
it completely resulted in an approximately 9-fold change in dissociation constant although the catalytic 
constants for these and the native enzyme were unchanged. Given the increased importance placed on 
the carboxy-terminal portion of tRNA nucleotidyltransferases as seen here and with the human enzyme 
(K416E substitution, for example), a more detailed understanding of what is happening in this region of 
the protein is required. We can carry out similar fine structure mapping experiments with this carboxy-
terminal motif as we have done with Mat-Mu1. Given that tRNA nucleotidyltransferase is a sorting 
isozyme in most eukaryotes, it will be interesting to extrapolate from what we have seen in Arabidopsis 
to other organisms which contain both mitochondria and plastids to see if a similar mechanism of 
discrimination between organellar targeting is conserved.  
 In Chapter 4, we demonstrate that a single amino acid substitution (E189F) in motif C generates 
a temperature-sensitive phenotype not because of a loss of stability but due to a decrease in enzyme 
activity. This hypomorphic effect was suppressed by overexpression of the variant enzyme or by an 
intragenic mutation changing arginine at position 64 to tryptophan (which increased the activity of the 
E189F variant 10 fold but did not restore its stability). We show that by increasing or decreasing the 
amount of variant tRNA nucleotidyltransferases in yeast, we can modulate the hypomorphic effect and 
where the temperature-sensitive phenotype manifests itself (Fig. 4.6). It would be instructive to explore 
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the proteomes in these cells to see how yeast adapts to growth under these conditions of reduced tRNA 
nucleotidyltransferase activity given the large number of functions attributed to this enzyme. 
  In addition, we have begun to define more precisely the roles of specific amino acids in enzyme 
structure, stability and activity. Based on these experiments, we were the first to suggest that motif C 
played a role in enzyme activity (other than acting as a linker between the head and neck region of the 
protein) and that residue E189 played a function in defining this role. Our hypothesis has been 
supported by recent work suggesting that motif C plays a role in the orientation of the enzyme's head 
and body domains to accommodate the growing 3'-end of the tRNA (Ernst et al., 2015). Our suppressor 
data further suggest that there is an interaction between motif A (R64) and motif C in enzyme activity as 
the R64W change suppresses the temperature-sensitive phenotype resulting from the E189F or E189K 
change. A more detailed biochemical and physicochemical analysis should be performed to explore in 
more depth the roles of amino acids E189 and R64. For example, it would be useful to have crystal 
structures of these yeast variant enzymes. Failing generation of crystals, it would be informative to carry 
out FTIR spectroscopy on the native and variant enzymes. As the available crystal structures indicate 
that tRNA nucleotidyltransferase is primarily α-helical with a single β-sheet in the head domain (Fig. 4.1) 
and R64 is found at the end of one of the β-strands of this sheet and E189 is found at a loop connecting 
another β-strand with an α-helix, FTIR analysis (which can more specifically separate the β-sheet signal 
from that of an α-helix) would allow us to more specifically identify if changing R64 or E189 alters the 
orientation or conformation of this β-sheet.  
 It is interesting that the R64W change suppresses both the E189F and E189K substitutions, but 
that the R64E substitution (which is viable at the restrictive temperature) will not suppress an E189F, 
E189K or E189R substitution. I suggest combining R64W with other substitutions which impair catalytic 
function to assess if the enhanced activity observed is specific to changes to motif C. In this light, it 
would be interesting to define the kinetic parameters of all of these variants (for example, to determine 
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the KM for ATP, CTP or tRNA or the turnover number). This may allow us to define the role of R64 in 
motif A where the catalytic magnesium ions are bound. It may be useful that an arginine at this position 
is conserved in the yeast and human enzymes, but not in the bacterial enzymes for which crystal 
structures have been solved (Fig. 4.1). We can compare the effects of the changes in motifs A and C in 
the yeast enzyme with the corresponding changes in the human enzyme (and vice versa).  
 In a traditional sense, there has always been a direct connection between protein stability and 
activity. Here we show that is not that simple. For example, in Chapter 2 we show how changes in 
structure lead to altered stability but not to changes in activity. The fine structure mapping of Mat-Mu1 
in Chapter 3 further revealed how altered stability could be separated from altered activity. In Chapter 4 
where a yeast temperature-sensitive phenotype was explored, our data suggest that the phenotype is 
the result of a hypomorphic effecting loss of activity but not loss of stability. A suppressor mutation was 
found that restored activity but not stability. All of these observations point out how complicated it is to 
understand the properties that define a protein’s function. Given that human diseases (Chakraborty et 
al., 2014, Sasarman et al., 2015, DeLuca et al., 2016) have now been linked to mutations in the TRNT1 
gene coding for tRNA nucleotidyltransferase it has become more important to develop a detailed 
understanding of how this protein functions.   
 Our preliminary characterization of seven variant proteins first identified in patients suffering 
from SIFD (Chakraborty et al., 2014) in Chapter 5 revealed that they segregated into two groups: those 
with reduced thermostability and those with reduced activity. As we showed previously that reduced 
activity can lead to a temperature-sensitive phenotype in yeast, one can imagine that reduced activity 
could lead to a disease phenotype in humans. One also could imagine that reduced stability could either 
reduce protein function or eliminate protein molecules due to improper folding such that activity is 
reduced. Simply put in each of these cases, there is not sufficient tRNA nucleotidyltransferase activity to 
meet the needs of the cell and the disease phenotype arises. This is particularly evident in cells that 
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depend heavily on mitochondrial respiration and could also reflect improper localization of the enzyme 
which also may depend on structure or stability as we already have seen in Arabidopsis. To address 
these possibilities, we could initially correlate thermostability in vitro with protein levels in vivo. For 
example, immunoblotting as has been done with the A148V (Sasarman et al., 2015), T154I, L166S, R190I 
and K416E variants (Chakraborty et al., 2014) in human cell lines should be performed to check for tRNA 
nucleotidyltransferase levels in the remaining variants. At the same time intracellular localization could 
be explored.  
 In the context of structure, we showed that the human enzyme can adopt a dimeric quaternary 
structure (Fig. 5.6). I would like to further explore how this quaternary structure affects stability, activity 
and localization. I showed that the I326T variant which does not dimerize, has both reduced activity 
(turnover number ~nine fold less than native) and a reduced melting temperature (Fig. 5.3). I propose 
eliminating the disulfide bond from the native enzyme to see if activity and stability are similarly 
reduced. I also will explore whether changes in quaternary structure or tRNA binding have any influence 
on the cellular distribution of tRNA nucleotidyltransferase in humans.  
 While a better understanding how structure, stability, activity and localization define a protein’s 
function will help us to better understand and treat human disease, there is still a big leap from 
understanding the changes in the biochemical and physicochemical properties of tRNA 
nucleotidyltransferase to the changes that lead to a disease phenotype. Our detailed understanding of 
the yeast and Arabidopsis tRNA nucleotidyltransferase have provided a solid foundation to explore the 
human enzyme but much work remains to be done to explore what is happening in human cells to 
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